e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal
year ended December 31,
2010
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number: 001-33304
Converted Organics
Inc.
(Exact Name of registrant as
specified in its charter)
|
|
|
Delaware
(State or other jurisdiction
of
incorporation or organization)
|
|
20-4075963
(I.R.S. Employer
Identification No.)
|
137A Lewis Wharf, Boston, MA 02110
(Address of Principal Executive
Offices and Zip Code)
(617) 624-0111
(Registrants telephone
number, including area code)
Securities
Registered Pursuant to Section 12(b) of the Act:
|
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock $0.0001 Par Value
Class B Warrants to purchase one share of Common Stock
Class H Warrants to purchase one share of Common Stock
|
|
NASDAQ Capital Market
|
Securities
Registered Pursuant to Section 12(g) of the Act:
None
Indicate by checkmark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by checkmark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes o No þ
Indicate by checkmark whether the registrant (1) has filed
all reports required to be filed by Section 13 of 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes
o No o
Indicate by checkmark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company þ
|
|
|
(Do not check if a smaller reporting company)
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
The aggregate market value of the voting and non-voting common
equity held by non-affiliates computed by reference to the price
at which the common equity was last sold, or the average bid and
asked price of such common equity, as of the last business day
of the registrants most recently completed second fiscal
quarter was $25,326,000
The number of shares outstanding of common stock of the
Registrant as of March 29, 2011 was 97,839,127
Documents Incorporated by Reference:
Portions of the registrants definitive proxy statement to
be filed subsequent to the date hereof in connection with the
registrants 2011 annual meeting are incorporated by
reference into Part III of this Report.
PART I
Forward-Looking
Statements
The SEC encourages companies to disclose forward-looking
information so that investors can better understand a
companys future prospects and make informed investment
decisions. This report contains such forward-looking
statements within the meaning of the Private Securities
Litigation Reform Act of 1995.
Words such as may, potential,
anticipate, could, estimate,
expects, projects, intends,
plans, believes and words and terms of
similar substance used in connection with any discussion of
future operating or financial performance identify
forward-looking statements. All forward-looking statements are
managements present expectations of future events and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. Some of the factors which could
cause our results to differ materially from our expectations
include the following:
|
|
|
|
|
the demand for organic fertilizer and the resulting prices that
customers are willing to pay;
|
|
|
|
the continuation of one of our feedstock items to be classified
as an organic ingredient;
|
|
|
|
the unpredictable cost of compliance with environmental and
other government regulation;
|
|
|
|
the time and cost of obtaining USDA, state or other organic
product labeling designations, and changes to such labeling
requirements that may adversely affect our ability to market our
products;
|
|
|
|
our ability to manage expenses;
|
|
|
|
our ability to remain in compliance with standards set by the
National Organic Program;
|
|
|
|
supply of organic fertilizer products from the use of competing
or newly developed technologies;
|
|
|
|
our ability to attract and retain key personnel;
|
|
|
|
to the extent we complete any acquisitions, our ability to
finance those acquisitions, and our ability to efficiently
integrate future acquisitions, if any, or any other new lines of
business that we may enter in the future;
|
|
|
|
adoption of new accounting regulations and standards;
|
|
|
|
adverse changes in the securities markets;
|
|
|
|
our ability to sell sufficient quantities of product to cover
operating expenses;
|
|
|
|
our ability to maintain production levels sufficient to meet
customer demand;
|
|
|
|
our ability to comply with continued listing requirements of the
NASDAQ Capital Market;
|
|
|
|
our ability to find operating locations and to finance the
purchase of Industrial Wastewater evaporator units;
|
|
|
|
our ability to sell licenses for or build our own TerraSphere
facilities;
|
|
|
|
the ability of TerraSphere licensees to raise funds to enable
them to build operating facilities; and
|
|
|
|
the availability of, and costs associated with, sources of
liquidity (including working capital requirements), as well as
our ability to obtain long term financing for future facilities
or projects.
|
Please also see the discussion of risks and uncertainties under
the heading Risk Factors.
In light of these assumptions, risks and uncertainties, the
results and events discussed in the forward-looking statements
contained in this report might not occur. Investors are
cautioned not to place undue reliance on the forward-looking
statements, which speak only as of the date of this report. We
are not under any obligation, and we expressly disclaim any
obligation, to update or alter any forward-looking statements,
whether as a result of new information, future events or
otherwise.
1
General
Converted Organics Inc. (Converted Organics,
we, us, our, or the
Company) utilizes innovative clean technologies to
establish and operate environmentally friendly businesses. We
are dedicated to creating a cleaner, greener future, and we
operate using sustainable business practices that support this
vision.
Converted Organics currently operates in three business areas:
Organic Fertilizer, Industrial Wastewater Treatment, and
Vertical Farming.
Organic Fertilizer. The Company operates a
processing facility that converts food waste and other feedstock
into all-natural fertilizers, biostimulants, and soil amendment
products. Using these products allows agricultural businesses,
lawn care professionals, and home gardeners to grow healthier
crops while simultaneously supporting the recycling of food
waste.
Industrial Wastewater Treatment. Utilizing an
innovative wastewater treatment process, Converted
Organics Industrial Wastewater Resources division
(IWR) provides a means of treating aqueous waste
streams. This technology, which can use waste heat and renewable
energy as fuel, produces only two byproducts: clean water vapor
and landfill-appropriate residual solids.
Vertical Farming. We also engage in vertical
farming through our TerraSphere business, which builds efficient
systems for growing pesticide-free organic produce in a
controlled indoor environment. TerraSpheres clean
technology helps to promote the sustainable consumption of
natural resources by accelerating plant production and
maximizing crop yields. This technology also lessens
environmental footprints through the reduction of carbon
emissions and fuel use associated with traditional crop
production and distribution.
In addition to the business areas listed above, we are
constantly looking for new innovative technologies with which to
supplement and expand our business.
Our principal executive office is located at 137A Lewis Wharf,
Boston, MA 02110, and our phone number is
(617) 624-0111.
The
Development of Our Company
Converted Organics Inc. was incorporated in Delaware in January
of 2006 for the purpose of establishing a
waste-to-fertilizer
business. In February 2007, we successfully completed both a
$9.9 million initial public offering of stock and a
$17.5 million bond offering with the New Jersey Economic
Development Authority. The net proceeds of these offerings were
used to develop and construct a fertilizer manufacturing
facility in Woodbridge, NJ. In January of 2008, we acquired the
assets of both Waste Recovery Industries, LLC (WRI)
and United Organic Products, LLC (UOP), making us
the exclusive owner of the High Temperature Liquid Composting
(HTLC) process, as well as a leading liquid
fertilizer line and a processing facility in Gonzales, CA. Also
in 2008, operations commenced at the Woodbridge plant, with the
production of dry fertilizer product beginning in 2009. We
subsequently began distribution of the dry product in the
professional turf and retail markets through professional
landscaping companies and well known retailers like Home Depot
and Whole Foods. In 2009, we also raised $27 million of
additional capital and the Gonzales facility became cash flow
positive. In 2010, we closed the Woodbridge plant, making the
Gonzales plant our sole fertilizer manufacturing facility (see
Item 7 Results of Discontinued Operations
for more information).
In 2010, the Converted Organics industrial wastewater treatment
division, IWR, was developed as the result of the agreements we
entered into with Heartland Technology Partners, LLC
(HTP) on March 23, 2010. This transaction
provided us with an exclusive, irrevocable license to utilize
HTPs
LM-HT®
Concentrator technology in the U.S. industrial wastewater
(IW) market.
On November 12, 2010, the Company acquired 95% of
TerraSphere Systems LLC (TerraSphere) to establish a
presence in the urban farming sector. TerraSpheres
patented technology enables the design, building, and operation
of highly efficient and scalable systems consisting of
vertically-stacked modules, with individual interior
2
light sources, for the housing of rows of plants. Due to a
controlled indoor environment, the system is capable of
generating fresh, pesticide-free organic produce year-round,
regardless of climate or location.
Our
Businesses
The Company is currently composed of three distinct lines of
business: organic fertilizer, industrial wastewater treatment,
and vertical farming, with the latter two established in 2010.
As of December 2010, only the organic fertilizer and vertical
farming lines were producing revenue (revenues for the organic
fertilizer business began in 2008). In early 2011, we began to
generate revenue from our industrial waste water business.
Organic
Fertilizer
Since July 2010, when operations at our Woodbridge, NJ facility
ceased, our organic fertilizer has been produced exclusively at
our Gonzales, CA plant. At present, the facility is operating at
approximately 60% capacity and produces around 25 tons of
organic fertilizer per day. The plant is currently only equipped
to produce our liquid products, but it may be modified to enable
production of our dry products as well. Revenue from our
fertilizer manufacturing operations is predominately generated
from the sale of liquid product to the agribusiness market in
California, though we do generate a small amount of revenue from
tip fees associated with the receipt of food waste at the
facility. Total revenue generated from the facility in 2010 was
approximately $3.0 million.
We sell and distribute the fertilizer manufactured at the
Gonzales plant through a small group of sales professionals who
seek out large purchasers of fertilizer for distribution in our
target geographic and product markets. Key activities of the
sales organization include the introduction of our products to
target clients and the development of our relationships with
them. Due to our small size, we believe that the most efficient
means of distributing our products is through regional
distributors, and this method currently accounts for the
majority of our sales. To the extent that we make sales directly
to customers, we generally require our customers to handle
delivery of the product.
Technology. To generate product for sale, we
use our proprietary
HTLC®
process to convert food waste and other feedstock into
fertilizer. In simplified terms, the process operates by
encouraging naturally-occurring microbes to consume prepared
feedstock. The action of the microbes on the feedstock is
exothermic (heat-releasing), and causes the temperature of the
feedstock to rise to very high, pathogen-destroying levels.
Subsequently, thermophilic (heat-loving) bacteria naturally
occurring in the food waste utilize oxygen to convert the waste
into a rich blend of nutrients and single-cell proteins (aerobic
digestion). Feedstock preparation, digestion temperature, rate
of oxygen addition, acidity, and inoculation of the microbial
regime are carefully controlled to produce products that are
highly consistent from batch to batch. The
HTLC®
method can be used in any future operating plants, whether owned
by us or licensed.
Operations. As mentioned above, since the
closing of the Woodbridge plant, our Gonzales facility has been
our sole producer of our fertilizer product. In 2010, we
realized approximately $3.0 million of revenue from the
sale of fertilizer from this facility.
During the third quarter of 2010, manufacturing activities at
our New Jersey plant were halted (see Item 7
Discontinued Operations). Prior to the closing of
this plant, in 2010 we had achieved sales of our dry product of
approximately $772,000 and revenue from tip fees of
approximately $82,000 from this facility. We did not achieve
significant sales of liquid product from this location. Sales of
the dry product were primarily to retail and professional lawn
care customers, and in order to maintain relationships with
those customers in the coming year, we outsourced the production
of a dry fertilizer product to be sold to some of our existing
retail and professional lawn care customers in the spring of
2011. We expect the operating profit to be break-even, as our
main objective is to continue to supply the customer base that
we have established. It is our long-range plan to have these
customers supplied by licensed plants that may be built in the
future (see Future Development below).
During 2010 we also achieved fertilizer sales of approximately
$250,000 from the distribution of a poultry-litter-based
fertilizer product. However, the company to which we outsourced
the production of this fertilizer has since filed for bankruptcy
protection and we do not expect further sales of this product.
3
Benefits of Our Fertilizer Products and
Technology. The efficacy of our products has been
demonstrated both in university laboratories and multi-year
growth trials. These field trials have been conducted on more
than a dozen crops including potatoes, tomatoes, squash,
blueberries, grapes, cotton, and turf grass. While these studies
have not been published, peer-reviewed, or otherwise subject to
third-party scrutiny, we believe that the trials and other data
show our solid and liquid products to have several valuable
attributes:
|
|
|
|
|
Plant Nutrition. Historically, growers have
focused on the nitrogen (N), phosphorous (P) and potassium
(K) content of fertilizers. As agronomists have gained a
better understanding of the importance of soil culture, they
have turned their attention to humic and fulvic acids,
phytohormones, and other micronutrients and growth regulators
not present in petrochemical-based fertilizers. We believe that
the presence of such ingredients in our fertilizer may cause its
use to have significant beneficial effects on soil and plant
health.
|
|
|
|
Disease Suppression. Based on field trials
using product produced using our technology, we believe our
products possess disease suppression characteristics that may
eliminate or significantly reduce the need for fungicides and
other crop protection products. The products disease
suppression properties have been observed under controlled
laboratory conditions and in documented field trials. We also
have field reports that have shown the liquid concentrate to be
effective in reducing the severity of powdery mildew on grapes,
reducing verticillium pressure on tomatoes, and reducing scab in
potatoes.
|
|
|
|
Soil amendment. As a result of its
slow-release nature, our dry fertilizer product increases the
organic content of soil, which improves granularity and water
retention and thus reduces NPK leaching and run-off.
|
|
|
|
Pathogen-free. Due to high processing
temperatures, our products are virtually pathogen-free and have
an extended shelf life.
|
In addition to these agricultural benefits, we have also
achieved Organic Materials Review Institute (OMRI)
and/or
Washington State Department of Agriculture (WSDA)
certification for many of our products, allowing growers to use
them in certified organic farming.
Competition. We operate in a very competitive
environment. The organic fertilizer business requires us to
compete in three separate areas organic waste stream
feedstock, technology, and end products each of
which is quickly evolving. We believe we will be able to compete
effectively because of the abundance of the supply of food waste
in our geographic markets, the pricing of our tip fees, and the
quality of our products and technology.
Organic Waste Stream Feedstock. Competition
for the organic waste stream feedstock includes landfills,
incinerators, animal feed, land application, and traditional
composting operations.
Technology. There are a variety of methods
used to treat organic wastes, including composting, digestion,
hydrolysis, and thermal processing. Companies using these
technologies may compete with us for organic material.
|
|
|
|
|
Composting. Composting is a natural process of
decomposition that can be accelerated through the mounding of
waste into windrows to retain the heat given off by bacteria
involved in the decomposition process. Given the difficulties in
controlling this process, the resulting compost is often
inconsistent and generally would command a lower market price
than our product. Further, large-scale composting facilities
require significant amounts of land for operations, which,
particularly in major metropolitan areas, may either not be
readily available or may be too costly.
|
|
|
|
Digestion. Digestion may be either aerobic
(requiring oxygen) like the
HTLC®
process, or anaerobic (occurring without oxygen). Anaerobic
digestion generally takes longer and produces significantly more
odor as a result of the production of ammonia and methane, the
latter of which is also a greenhouse gas. The methane gas
produced has some value as a source of energy, but it is not
readily transported and is thus generally limited to
on-site use.
|
|
|
|
Hydrolysis. Hydrolysis is a chemical process
by which water reacts with another substance, and it is usually
catalyzed through the introduction of an acid. This reaction is
used to convert cellulose present in the organic waste into
sugars, which in turn may be converted into ethanol.
|
|
|
|
Thermal. Thermal technologies work by either
completely or partially combusting organic materials for the
purpose of generating electricity. Partial combustion methods
may also lead to the production of useful
|
4
|
|
|
|
|
and saleable byproducts, such as a variety of gases (e.g.
hydrogen, carbon monoxide, carbon dioxide) and organic liquids.
|
End Products. The organic fertilizer business
is highly fragmented, under-capitalized, and growing rapidly. We
are unaware of any dominant producers or products currently in
the market. There are a number of single-input, protein-based
products, such as fish, bone, and cottonseed meal, that can be
used alone or mixed with chemical additives to create highly
formulated fertilizer blends that target specific soil and crop
needs. In this sense, they are similar to our products and
provide additional competition in the organic fertilizer market.
In the future, large producers of non-organic fertilizer may
also increase their presence in the organic fertilizer market,
and these companies are generally better-capitalized and have
greater financial and marketing resources than we do.
Most of the fertilizer consumed annually in North America is
mined or derived from natural gas or petroleum. These
petroleum-based products generally have higher nutrient content
(NPK) and cost less than organic fertilizers. Traditional
petrochemical fertilizers are highly soluble and readily leach
from the soil, and slow-release products, which must be coated
or specially processed, command a premium. The economic value
offered by petrochemicals, especially for field crops including
corn, wheat, hay, and soybeans, will not be supplanted in the
foreseeable future. We compete with large producers of
non-organic fertilizers, many of which are significantly larger
and better-capitalized than we are. In addition, we compete with
numerous smaller producers of fertilizer.
Despite a large number of new products in the end market, we
believe that our products have a unique set of characteristics.
We believe positioning and branding the combination of nutrition
and disease suppression characteristics will differentiate our
products from other organic fertilizers to develop market
demand, while maintaining or increasing pricing.
Target Markets. In the U.S., the majority of
fertilizer is consumed by agribusiness, with the professional
turf and retail segments consuming the remainder. The concern of
farmers, gardeners, and landscapers about nutrient runoffs, soil
health, and other long-term effects of conventional chemical
fertilizers has increased demand for organic fertilizer. We have
identified three target markets for our products:
|
|
|
|
|
Agribusiness. Conventional farms, organic
farms, horticulture, hydroponics, and aquaculture.
|
|
|
|
Turf Management. Professional lawn care and
landscaping, golf courses, and sod farms, as well as commercial,
government, and institutional facilities.
|
|
|
|
Retail Sales. Home improvement outlets, garden
supply stores, nurseries, Internet sales, and shopping networks.
|
Agribusiness. We believe there are two primary
business drivers influencing commercial agriculture. First,
commercial farmers are focused on improving the economic yield
of their land i.e., maximizing the value derived
from crop output (quantity and quality). Second, commercial
farmers have begun to recognize the importance of reducing the
use of chemical products while also meeting the demand for
cost-effective, environmentally responsible alternatives. We
believe this change in focus is the result of:
|
|
|
|
|
Consumer demand for safer, higher quality food;
|
|
|
|
The limitation on the use of certain synthetic products by
government authorities, including nutrients such as nitrogen and
chemicals such as methyl bromide;
|
|
|
|
Environmental concerns and the demand for sustainable
technologies;
|
|
|
|
Demand for more food for the growing world population.
|
We believe farmers are facing pressures to change from
conventional production practices to more environmentally
friendly practices. U.S. agricultural producers are turning
to certified organic farming methods as a potential way to lower
production costs, decrease reliance on nonrenewable resources
such as chemical fertilizers, increase market share with an
organically grown label and capture premium prices,
thereby boosting farm income. In 2011, we expect that a
significant part of our revenues will be derived from this
specific market.
Turf Management. We believe that the more than
16,000 golf courses in the U.S. will continue to reduce
their use of chemicals and chemical-based fertilizers to limit
potentially harmful effects, such as chemical fertilizer
5
runoff. The United States Golf Association, or USGA, provides
guidelines for effective environmental course management. These
guidelines include using nutrient products and practices that
reduce the potential for contamination of ground and surface
water. Strategies include using slow-release fertilizers and
selected organic products and the application of nutrients
through irrigation systems. Further, the USGA advises that the
selection of chemical control strategies should be utilized only
when other strategies are inadequate. For similar reasons, we
believe that our fertilizer products will be desirable to
professional lawn care companies, who are trending towards the
use of organic fertilizers. We believe that our all-natural,
slow-release fertilizer products will be well-received in the
turf management market.
Retail Sales. The Freedonia Groups
report on Lawn & Garden Consumables indicates that the
U.S. market for packaged lawn and garden consumables is
$7.5 billion and is expected to grow 4.5% per year to
$9.3 billion in 2012. Fertilizers are the largest product
category, generating $2.85 billion, or 38%, of total lawn
and garden consumables sales. Fertilizers, mulch, and growing
media will lead gains, especially rubber mulch, colored mulch,
and premium soils. Organic formulations are expected to
experience more favorable growth than conventional formulations
across all product segments due to increased consumer concern
regarding how synthetic chemical fertilizers and pesticides on
lawns and gardens may affect human/pet health and the
environment. Further, in 2009, The National Gardening
Association reported that 40% of the nations
100 million households with a yard say they are likely to
use all-natural methods in the future due largely to
environmental and health concerns.
Governmental Regulation. Our end products are
regulated by federal, state, county, and local governments, as
well as various agencies thereof, including the United States
Department of Agriculture.
In addition to the regulations governing the sale of our end
products, our current facility and any future facilities are
subject to extensive regulation. Specific permit and approval
requirements are set by the state and state agencies, as well as
local jurisdictions including but not limited to cities, towns,
and counties. Any changes to our plant or procedures would
likely require permit modifications.
Environmental regulations will also govern the operation of our
current facility and any future facilities. Regulatory agencies
may require us to remediate environmental conditions at our
locations.
Future Development. In addition to the tip
fees and product sales revenue we receive as a result of our
fertilizer, the Company is exploring a number of new
fertilizer-related ventures that may provide us with additional
streams of revenue in the future.
SMART Units. Our Scalable Modular AeRobic
Technology (SMART) units will allow third-parties to produce
their own organic fertilizer, and will be suitable for
processing 5 to 50 tons of waste per day. These semi-portable
devices will be capable of operating indoors or outdoors and may
be as sophisticated or as basic in design and function as the
owner/user requires. The SMART units will be delivered to
jobsites in pre-assembled, pre-tested components, and will
include a license to use the
HTLC®
technology. Our target market consists of users who seek to
address waste problems on a smaller scale than would be
addressed by a large processing facility. Our plan contemplates
that purchasers of the devices would receive tip fees for
accepting waste and would sell fertilizer and soil amendment
products in the markets where their units operate. We plan to
market and sell the SMART units in both the United States and
abroad, and are presently in discussions with a former employee
to establish a distributorship outside North America.
Licensing. We have also begun the development
of a licensing program, under which we will license the right to
use our proprietary technology to third parties. The licensing
program consists of a know-how license, which could be
complemented with SMART unit sales so that any individual or
entity buying a SMART unit would also receive a license
agreement to use our technology. We are working to patent our
process and technology and anticipate that we will expand upon
the licensing program when the necessary patent registrations
are achieved.
Mass Organics I. We are currently in
negotiations with MassOrganics I, LLC (MassOrganics
I) regarding the use of Converted Organics
proprietary technology for the manufacture of organic fertilizer
products. On January 25, 2010, we signed a memorandum of
understanding under which MassOrganics I would install and
operate an
HTLC®
system at a new manufacturing facility to be constructed at The
Sutton Commerce Park in Sutton, MA. The memorandum of
understanding provides that MassOrganics I would enter into a
licensing
6
agreement under which MassOrganics I would pay a licensing fee
to Converted Organics. As of the filing date of this report,
construction of the facility has not yet commenced.
Industrial
Wastewater Treatment
Industrial Wastewater Treatment Resources was formed as the
result of a loan and license agreement with Heartland Technology
Partners, LLC (HTP) that Converted Organics entered
into in March of 2010. The agreement provided us with the
exclusive right to utilize HTPs patented means of treating
industrial wastewater in the U.S. IWR will generate revenue
by setting up self-contained treatment systems on
customers sites and processing their wastewater on a
price-per-gallon
basis.
Technology. Our IWR business utilizes the
LM-HT®
Concentrator system (the Concentrator), which
operates by making use of a variety of fuel sources, including
waste heat and renewable fuel, to separate industrial wastewater
(IW) into clean water vapor and residuals. The Concentrator
equipment operates without consumables and has very few moving
parts, allowing the equipment to work with minimal maintenance
and oversight. Simply, IW is fed into the Concentrator and
heated to release clean water vapor, which is then either
released into the air or fed into a condenser. The resulting
concentrated wastewater is then fed through separators, which
isolate the contaminants that have solidified in the evaporation
process from the concentrated wastewater. The concentrated
wastewater is then fed back into the Concentrator to be
retreated, releasing more clean water and more solid
contaminants. Materials captured as a result of the process are
suitable for recycling or ready to be taken to a landfill.
Operations. IWR currently operates an
industrial wastewater concentrator on Glenwood Springs Landfill
Enterprises South Canyon Landfill in Glenwood Springs, CO
as a result of an agreement signed in January of 2011. Under
this agreement, we are paid a per-gallon fee for the amount of
IW that we treat, less labor costs to operate the unit and a
marketing fee to generate IW delivered to the facility. As the
owner of the unit we are also responsible for repairs and
maintenance of the Concentrator. This facility is designed to
treat 15,000 gallons of aqueous waste per day and is fueled by
the combustion of biomass diverted from disposal in the
landfill. Among the IWs to be treated by the plant are septic,
wash waters, process waters, man-camp wastewaters, and
wastewaters from oil and gas exploration activities.
Benefits of the Technology.
|
|
|
|
|
Fuel Source Flexibility. The
LM-HT®
Concentrator can run on a wide range of thermal energy options,
from waste heat, to bio fuels, to conventional fossil fuels.
|
|
|
|
Reduced Carbon Emissions. Utilization of waste
heat and renewable energy sources results in a reduction of
carbon emissions.
|
|
|
|
Simple to Run and Maintain. The equipment is
robust, resistant to corrosion, compact, easy to maintain, has
no membranes or heat exchangers to foul, and has very few moving
parts.
|
|
|
|
Portability. The equipment may be
strategically placed, in locations such as landfills, to
significantly reduce transportation costs.
|
|
|
|
Widely Applicable. The direct hot gas
evaporation technology employed makes it possible to treat a
wide range of industrial waste waters, including IWs with a high
concentration of suspended solids.
|
|
|
|
Clean Water Byproduct. The equipment may be
fitted with a condenser to capture the resultant water vapor and
transform it into clean, non-potable water.
|
|
|
|
Zero Liquid Discharge. The only by-products of
the
LM-HT®
process are clean water vapor and the solidified contaminants
present in the IW.
|
Competition. There are a wide range of
technologies that are currently being used or developed for the
purpose of treating wastewater. The following are some of the
more common methods in practice.
|
|
|
|
|
Physical. The most simple of treatment
methods, physical treatment of wastewater includes both the
coarse screening process and sedimentation. Coarse screening is
an active method that involves running the
|
7
|
|
|
|
|
water through screens of various pore size to filter out debris.
Sedimentation (also called clarification) is a passive process
by which wastewater is held in tanks under quiescent conditions,
allowing many of the solids to settle to the bottom. Both
methods are merely effective for removing the larger
and/or
heavier solid contaminants. Other processes in this category
include filtering and skimming, the latter of which is useful
for separating floating/water-insoluble contaminants.
|
|
|
|
|
|
Chemical. The addition of chemicals to
wastewater is usually for the purpose of either disinfection
(typically by chlorination or oxidation) or neutralization of
acidic or basic wastewater. Chemical treatment can also consist
of coagulation, where the addition of a chemical forms an
insoluble end-product with waste substances in the water for the
purpose of later removal.
|
|
|
|
Solidification/Stabilization. This method
involves curing the waste into solid form to prevent it from
leaching. This can be accomplished either through mixing in
cement or other inorganic setting material.
|
|
|
|
Deep Well Injection. Drilling thousands of
feet below the Earths surface allows access to permeable
areas of extreme salinity, which can absorb aqueous waste. These
areas are buffered by impermeable strata that can prevent the
wastewater from reaching and contaminating any aquifers.
|
|
|
|
Reverse Osmosis. Reverse osmosis operates by
separating two containers, one of contaminated water and the
other clean, by a semi-permeable membrane that allows free flow
of water (the solvent) but not elements dissolved in it (the
solute). Applying high pressure to the waste water side forces
solvent across the membrane barrier and results in separating
water from waste. This process is dependent upon the proper
functioning of the selective membrane, and wastewater must often
be pretreated to remove any agents that are capable of fouling
the membrane.
|
|
|
|
Incineration. Wastewater sludge may be treated
by incineration, but this method is not as common due to the
emissions produced, fuel required, and the difficulty in burning
this type of waste.
|
Target Markets. The benefits of the
LM-HT®
system are best applied to situations where there are
significant transportation costs associated with treating the
wastewater or the wastewater contains many suspended solids,
high biochemical oxygen demand (BOD) values, problematic pH
levels, or recoverable contaminants. Specifically, we are
targeting the following IWs:
|
|
|
|
|
Quench water and boiler/scrubber blow-down wastewater;
|
|
|
|
Process water from the manufacturing/processing of
pharmaceuticals, metals, pulp and paper, petrochemicals, foods,
inks and paints; and
|
|
|
|
Any other IWs where a zero-liquid discharge with an
inside-the-fence
option is desirable.
|
Government Regulation. The processing of
wastewater is regulated by federal, state, county and local
governments as well as various agencies thereof, including the
Environmental Protection Agency. Due to the lack of contaminants
released into surface water from our method, no National
Pollution Discharge Elimination System (NPDES) permits are
required. However, air permits and other operational permits
will need to be obtained prior to commencement of waste
processing.
Future Development. Led by a seasoned
professional in the wastewater treatment business we hired in
March 2010 to serve as President and General Manager of IWR, IWR
is seeking customers for its wastewater treatment services and
intends to operate on a build-own-operate business model whereby
we provide
inside-the-fence
industrial wastewater treatment solutions. We anticipate such
arrangements being under terms similar to those in the Glenwood
Springs Landfill agreement, where we would pay for labor,
repairs, and marketing (if required) at the site and derive
revenue from the per-gallon fee that would be charged for the
treatment of customers aqueous waste. As new agreements
are signed, we will have to obtain specific project financing
for each Concentrator. We expect that in 2011 we will be able to
begin operations on at least one other site in addition to the
CO facility if adequate financing can be obtained.
8
Vertical
Farming
Converted Organics vertical farming business commenced
operations in November 2010 with our acquisition of 95% of
TerraSphere Systems LLC, which currently operates a research and
manufacturing facility in Vancouver, British Columbia. We plan
on leveraging TerraSpheres technology to generate revenue
through selling produce grown at facilities that we
build-own-and-operate, as well as from licensing our technology.
Selling licenses not only provides us with an up-front licensing
fee, but also opens up additional revenue streams from sales of
specialized equipment to licensees and receipt of royalties from
their product sales. In December of 2010, we purchased a
majority stake in a Terrasphere licensee so that we could build
and own the facility that the licensee would operate.
Technology. TerraSpheres patented system
grows crops in an arrangement of rows of plants in stacked,
collapsible tray racks. Each tray has an individual light
source, which can be adjusted to promote maximum growth by
conforming its output to meet plants needs at their given
level of maturation. The plants are watered by a high pressure
system that ensures an even distribution of water and nutrients.
Farming in this controlled environment results in an abundance
of plants with strong, compact, even growth, and this technology
may be used to grow a variety of crops, from lettuce, to tree
seedlings, to rare medicinal herbs.
Operations. We currently operate one vertical
farm, located in Vancouver, British Columbia, under an agreement
with our licensee, the Squamish Indian Nation. This facility
serves as both a research and small-scale manufacturing
facility. The produce grown at this site is sold locally to
Choices Markets in the greater Vancouver area, the largest
natural foods grocer in Western Canada.
Benefits of the Products and Technology.
|
|
|
|
|
Higher Productivity. Growing in three
dimensions allows for a vastly more efficient use of growing
space, enabling more crops to be grown at once. Additionally,
growing in a highly-regulated environment enables greater yields
as a result of the absence of pests, disease, and variable
weather/soil conditions. The ability to grow crops year-round
also increases productivity.
|
|
|
|
Lower Energy Costs. We believe that a
TerraSphere facility will use less energy than traditional
agricultural methods.
|
|
|
|
Controlled Environment. TerraSpheres
closed-system method of growing plants prevents the
cross-contamination of products, eliminates the danger of water
contamination, and allows complete control of fertilizer type
and quality.
|
|
|
|
Versatility in Facility Placement and
Products. With this system, crops may be grown in
any location, regardless of geography or climate, year round.
Additionally, the TerraSphere system is designed to be installed
in existing structures, and is compatible with any
industrial/warehouse building with a minimum clearance of
25 feet.
|
|
|
|
Extended Produce Shelf Life. The ability to
locate facilities near end markets, regardless of geography or
climate, means that produce that is fresher for the consumer and
has a longer shelf life, which means less spoilage for the
retailer.
|
|
|
|
Lower Cleaning and Product Preparation
Costs. By controlling growing conditions, we can
avoid exposing our plants to impurities and thus minimize
cleaning and product preparation costs during harvest.
TerraSphere products are free from exposure to the pesticides,
fuel/oil leakage from machinery, and impurities from the soil
and rain that are associated with traditional field farming
methods.
|
|
|
|
Minimal Fertilizer and No Pesticides. As a
result of our controlled growth conditions, plants grown in the
TerraSphere system require less fertilizer than plants grown in
the field or in a greenhouse, and pesticides are not required.
|
|
|
|
Water Conservation. The TerraSphere system
uses significantly less water than traditional growing methods,
and the watering injection system enables the recycling of water
and the generation of very little wastewater. Not only is
wastewater a major environmental concern, but water represents a
significant cost for traditional farms and greenhouses.
|
9
|
|
|
|
|
Lessened Transportation Costs. Growing and
selling locally will greatly reduce the cost of transporting
goods, as well as lessen the carbon footprint, of many common
crops.
|
Competition. We face considerable competition
from both users of traditional growing methods and from other
companies with competing innovative growing technologies.
|
|
|
|
|
Field Agriculture. The overwhelming majority
of the produce sold today is still generated using traditional
field agriculture methods, and the infrastructure required is
generally already in place and considerably less than that of
the vertical farms we envision. As such, the up-front cost of
growing produce via traditional methods is likely less than that
of our method. Further, the rise in organic growing standards
has already presented consumers with a more naturally-grown and
arguably higher-quality product option, albeit at an often
substantially higher cost. However, field agriculture is limited
by the availability of land that is suitable for growing crops.
Crop quality is also affected by a substantial number of
variables, from weather and temperature fluctuations to
infestations of pests and disease. Field-grown produce must also
often travel to reach consumers, which reduces shelf life and
increases costs.
|
|
|
|
Greenhouses/Hydroponic Growers. Some produce
is already grown indoors, which provides the advantage of being
able to better regulate growing conditions through the
elimination of many environmental factors. However, building
greenhouses large enough to grow substantial amounts of produce
is not incredibly cost-effective considering the energy required
to regulate the indoor environment versus the product yield.
Further, light exposure must be carefully monitored, and the
location of a greenhouse is still a very important factor if
natural light is used instead of artificial light.
|
|
|
|
Other Urban Farming Technologies. There are a
small number of other companies who have developed or are in the
process of developing technology that enables the growing of
crops in environments that lack available land or proper growing
conditions. This includes variations of our vertical farming
method and other modes of controlled indoor environment
agriculture.
|
Target Markets. We intend to operate our
vertical farming business by supplying food sellers with our
produce that are local to our farms. This includes natural
products retailers, supermarket chains, as well as restaurants
and schools.
Government Regulation. In order to sell our
produce, we must follow applicable food safety regulations. At
minimum we must comply with laws enforced by federal agencies
such as the FDA and USDA, and some states may impose stricter
standards than those of the federal government. In Canada, we
must also comply with laws enforced by the Canadian Food
Inspection Agency and other regulatory bodies.
Future Development. To expand our business,
TerraSphere will seek financing in order to build and operate
TerraSphere facilities and continue to market its exclusive
licensing agreements to interested third parties throughout
North America, Asia and Europe. On December 30, 2010 we
acquired an 83.34% ownership in GoLocalProduceRI, LLC (an
independent TerraSphere licensee) for the purpose of building
and owning a TerraSphere facility.
In addition to growing produce, TerraSphere also plans on using
its growing technology for the production of high-value
medicinal biocompounds sourced from plants. This venture, to be
operated by PharmaSphere, LLC, a wholly-owned subsidiary of
TerraSphere, will sell these isolated biocompounds for use as
active pharmaceutical agents and grow its own transgenic plants
for sale in the biotechnology industry. PharmaSphere has a
subsidiary, PharmaSphere Worcester, LLC, which was formed to
build a facility in Worcester, MA utilizing PharmaSpheres
business plan. The building of the facility has not commenced
and PharmaSphere has no revenue to date.
10
PRO FORMA
CONDENSED FINANCIAL INFORMATION FOR TERRASPHERE AND
GOLOCALPRODUCERI
(In thousands, except per share information)
The following pro forma condensed statement of operations
information is presented to illustrate the effects upon the full
year 2010 and 2009 had the Terrasphere and GoLocalProduceRI
acquisitions had been completed on January 1, 2009. The pro
forma presentation is based upon available information and
certain assumptions that we believe are reasonable. The
unaudited supplemental pro forma information does not purport to
represent what the Companys results of operations would
actually have been had these transactions in fact occurred as of
the dates indicated above or to project the Companys
results of operations for the period indicated or for any other
period. Pro forma balance sheet information is not presented as
the acquisitions are presented in the 2010 historical balance
sheet.
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
2010
|
|
2009
|
|
Revenue
|
|
$
|
8,862,980
|
|
|
$
|
2,670,514
|
|
Net loss
|
|
$
|
(48,629,191
|
)
|
|
$
|
(22,321,742
|
)
|
Net loss per share, basic and diluted
|
|
$
|
(0.65
|
)
|
|
$
|
(0.47
|
)
|
Weighted average common shares outstanding
|
|
|
74,276,495
|
|
|
|
47,094,769
|
|
Employees
As of March 31, 2011, we had 26 employees, 3 of whom
were in sales, 14 in management and administration, and 9 in
operations (6 employees at our Gonzales facility and
3 employees at our TerraSphere Vancouver TerraSphere
facility).
Our
Website and Availability of Sec Reports and Other
Information
Our corporate website is located at
www.convertedorganics.com. We file with or furnish to the
SEC Annual Reports on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Current Reports on
Form 8-K
and any amendment to those reports, proxy statements and annual
reports to shareholders, and, from time to time, other
documents. The reports and other documents filed with or
furnished to the SEC are available to investors on or through
our corporate website free of charge as soon as reasonably
practicable after we electronically file them with or furnish
them to the SEC. In addition, the public may read and copy any
of the materials we file with the SEC at the SECs Public
Reference Room at 100 F Street, NE, Washington DC
20549. The public may obtain information on the operation of the
Public Reference Room by calling the SEC at
1-800-SEC-0330.
The SEC maintains an internet site that contains reports, proxy
and information statements and other information regarding
issuers, such as the company, that file electronically with the
SEC. The address of that website is
http://www.sec.gov.
Our SEC filings and our Code of Ethics may be found on the
Investor Relations page of our website at
ir.convertedorganics.com. These documents are available
in print to any shareholder who requests a copy by writing or
calling our corporate headquarters.
Investors in our securities should carefully consider the risks,
uncertainties and other factors described below because they
could materially and adversely affect our business, financial
condition, operating results and prospects and could negatively
affect the market price of our securities. Investors in our
securities should also refer to the other information contained
in this Annual Report on
Form 10-K,
including our consolidated financial statements and the related
notes.
Risks
Related to our Business
We
could fail to remain a going concern. We will need to raise
additional capital to fund our operations through the near term,
and we do not have any commitments for that
capital.
There exists substantial doubt regarding our ability to continue
as a going concern. Our independent registered public accounting
firm has added an explanatory paragraph to their report for our
fiscal year December 31, 2010
11
with respect to our ability to continue as a going concern. Our
consolidated financial statements have been prepared on the
basis of a going concern, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course
of business. If we became unable to continue as a going concern,
we would have to liquidate our assets and we might receive
significantly less than the values at which they are carried on
our consolidated financial statements. The inclusion of a going
concern modification in our independent registered public
accounting firms audit opinion for the year ended
December 31, 2010 may materially and adversely affect
our stock or our ability to raise new capital.
As reflected in our financial statements, for the year ended
December 31, 2010, we incurred a net loss of approximately
$50.7 million and as of December 31, 2010, had an
accumulated deficit of $100.5 million, and had a working
capital deficiency. If the Series B warrants issued in our
December 17, 2010 convertible note financing are exercised,
we believe we will have sufficient capital to fund our current
operations through the end of 2011. However, in the months
following the issuance of the Series B warrants, the stock
price has closed at both above and below the exercise price of
these warrants. It is unlikely that any warrants will be
exercised at a time when the price of our stock is below that of
the exercise price.
We will need additional capital
and/or
increased sales to execute our business strategy, and if we are
unsuccessful in either raising additional capital or achieving
desired sales levels we will be unable to fully execute our
business strategy on a timely basis, if at all. If we raise
additional capital through the issuance of debt securities, the
debt securities may be secured and any interest payments would
reduce the amount of cash available to operate and grow our
business. If we raise additional capital through the issuance of
equity securities, such issuances will likely cause dilution to
our stockholders, particularly if we are required to do so
during periods when our common stock is trading at historically
low price levels.
Additionally, we do not know whether any financing, if obtained,
will be adequate to meet our capital needs and to support our
growth. If we are unsuccessful in raising additional capital, we
may be unable to fully execute our business strategy on a timely
basis, if at all. If adequate capital cannot be obtained on
satisfactory terms, we may curtail or delay implementation of
updates to our facilities or delay the expansion of our sales
and marketing capabilities, any of which could cause our
business to fail.
We
will need to obtain additional debt and equity financing to
complete subsequent stages of our business plan, including the
funds required to expand our Fertilizer, Industrial Waste Water
and Vertical Farming businesses.
To meet future capital requirements necessary for the expansion
of our business, we may issue additional securities in the
future with rights, terms and preferences designated by our
Board of Directors, without a vote of stockholders, which could
adversely affect stockholder rights. Additional financing will
likely cause dilution to our stockholders and could involve the
issuance of securities with rights senior to our currently
outstanding shares. There is no assurance that such financing
will be sufficient, that the financing will be available on
terms acceptable to us and at such times as required, or that we
will be able to obtain the additional financing required, if
any, for the continued operation and growth of our business. Any
inability to raise necessary capital will have a material
adverse effect on our ability to implement our business strategy
and will have a material adverse effect on our revenues and net
income.
If the
National Organic Program changes its standards with respect to
the use of corn steep liquor in organic crop production, we may
no longer be allowed to sell certain of our products into the
organic markets, which would materially lower our sales at our
Gonzales facility.
In April 2011, the National Organic Standards Board (NOSB) is
expected to make a decision regarding the status of corn steep
liquor as a synthetic or non-synthetic product, and whether it
can remain as an accepted ingredient in organic crop production.
A decision by the NOSB that corn steep liquor is a synthetic
ingredient no longer allowed in organic crop production would
have a significant negative effect on approximately 60% of our
current sales from the Gonzales facility. The two products that
currently account for the majority of our sales from the
Gonzales facility into the organic agriculture market are both
derived from corn steep liquor. If the NOSB issues an
unfavorable decision, it is unlikely we would see sales growth
in 2011 and we would face a loss in sales for that
12
time period. In addition, we would have to reformulate our
highest selling products and then have the products certified
for sale into the organic market. Organic certification can take
months to achieve and it is unclear if we would be able to find
an ingredient suitable to replace corn steep liquor.
We
expect to incur significant losses for some time, and we may
never operate profitably.
From inception through December 31, 2010, we have incurred
an accumulated net loss of approximately $100.4 million.
The revenues that we began to generate from our Gonzales
facility in February 2008 and from our TerraSphere acquisition
have not yet resulted in our earning a profit, and we will
continue to incur significant losses for at least the near
future. There is no assurance that our operations will ever
become profitable.
We
have limited operating history, we have recently added new lines
of unproven businesses, and our prospects are difficult to
evaluate.
We have not operated any facility other than our Gonzales
facility, which we purchased in January 2008 and our Woodbridge
facility, which we operated in 2009 and part of 2010. In
addition, during the last year we added our IW treatment
business and our vertical farming business, each of which are
unproven businesses. Our activities to date have been primarily
limited to developing our business, and consequently there is
limited historical financial information related to operations
available upon which you may base your evaluation of our
business and prospects. The revenue and income potential of our
business is unproven. If we are unable to develop our business,
we will not achieve our goals and could suffer economic loss or
collapse, which may have a material negative effect on our
financial performance.
If we
are unable to manage our transition to a diversified operating
company effectively, our operating results will be adversely
affected.
Failure to effectively manage our transition to a diversified
operating company will harm our business. To date, substantially
all of our activities and resources have been directed at
developing our business plan, arranging financing, licensing
technology, obtaining permits and approvals, securing a lease
for our Woodbridge facility and options for additional
facilities, hiring and training a sales force, and purchasing
our Gonzales facility. The transition to a diversified company
with three divisions requires effective planning and management.
In addition, future expansion will be expensive and will likely
strain our management and other resources. We may not be able to
effectively manage our transition to operating a diversified
company.
We are
exposed to risks from legislation requiring companies to
evaluate internal control over financial
reporting.
Section 404 of the Sarbanes-Oxley Act of 2002
(Section 404) required our management to begin
to report on the operating effectiveness of our internal control
over financial reporting for the year ended December 31,
2009. We must continue an ongoing program of system and process
evaluation and testing necessary to comply with these
requirements. We expect that this program will require us to
incur significant expenses and to devote additional resources to
Section 404 compliance on an ongoing annual basis. We
cannot predict how regulators will react or how the market
prices of our securities will be affected in the event that our
Chief Executive Officer and Chief Financial Officer determine
that our internal control over financial reporting is not
effective as defined under Section 404.
Our
future success is dependent on our existing key employees and
hiring and assimilating new key employees; our inability to
attract or retain key personnel in the future would materially
harm our business and results of operations.
Our success depends on the continuing efforts and abilities of
our current management team. In addition, our future success
will depend, in part, on our ability to attract and retain
highly skilled employees, including management, technical and
sales personnel. We may be unable to identify and attract highly
qualified employees in the future. In addition, we may not be
able to successfully assimilate these employees or hire
qualified personnel to replace them if they leave the Company.
The loss of the services of any of our key personnel, the
inability to attract
13
or retain key personnel in the future, or delays in hiring
required personnel could materially harm our business and
results of operations.
We may
be unable to establish marketing and sales capabilities
necessary to commercialize and gain market acceptance for our
products.
We currently have limited resources with which to expand our
sales and marketing capabilities. Co-promotion or other
marketing arrangements to commercialize our planned products
could significantly limit the revenues we derive from our
products, and the parties with whom we would enter into such
agreements may fail to commercialize our products successfully.
Our products address different markets and can be offered
through multiple sales channels. Addressing each market
effectively will require sales and marketing resources tailored
to the particular market and to the sales channels that we
choose to employ, and we may not be able to develop such
specialized marketing resources.
Energy
and fuel cost variations could adversely affect operating
results and expenses.
Energy costs, particularly electricity and natural gas,
constitute a substantial portion of our operating expenses. The
price and supply of energy and natural gas are unpredictable and
fluctuate based on events outside our control, including demand
for oil and gas, weather, actions by OPEC and other oil and gas
producers, and conflict in oil-producing countries. Price
escalations in the cost of electricity or reductions in the
supply of natural gas could increase operating expenses and
negatively affect our results of operations. We may not be able
to pass through all or part of the increased energy and fuel
costs to our customers.
Successful
infringement claims by third parties could result in substantial
damages, lost product sales and the loss of important
proprietary rights.
We may have to defend ourselves against patent and other
infringement claims asserted by third parties regarding the
technology we own or have licensed, resulting in diversion of
management focus and additional expenses for the defense of
claims. In addition, if a patent infringement suit was brought,
we might be forced to stop or delay the development, manufacture
or sales of potential products that were claimed to infringe a
patent covering a third partys intellectual property
unless that party granted us rights to use its intellectual
property. We may be unable to obtain these rights on terms
acceptable to us, if at all. If we cannot obtain all necessary
licenses or other such rights on commercially reasonable terms,
we may be unable to continue selling such products. Even if we
are able to obtain certain rights to a third partys
patented intellectual property, these rights may be
non-exclusive, and therefore our competitors may obtain access
to the same intellectual property. Ultimately, we may be unable
to commercialize our potential products or may have to cease
some or all of our business operations as a result of patent
infringement claims, which could severely harm our business.
Defects
in our products or failures in quality control could impair our
ability to sell our products or could result in product
liability claims, litigation and other significant events with
substantial additional costs.
Detection of any significant defects in our products or failure
in our quality control procedures may result in, among other
things, delay in
time-to-market,
loss of sales and market acceptance of our products, diversion
of development resources, and injury to our reputation. The
costs we may incur in correcting any product defects may be
substantial. Additionally, errors, defects or other performance
problems could result in financial or other damages to our
customers, which could result in litigation. Product liability
litigation, even if we prevail, would be time consuming and
costly to defend, and if we do not prevail, could result in the
imposition of a damages award. We presently maintain product
liability insurance; however, it may not be adequate to cover
any claims.
Changes
in environmental regulations or violations of such regulations
could result in increased expense and could have a material
negative effect on our financial performance.
We are subject to extensive air, water and other environmental
regulations and need to maintain our environmental permits, and
need to obtain a number of environmental permits to construct
and operate our planned facilities. If for any reason any of
these permits are not maintained or granted, construction costs
for our
14
facilities may increase, or the facilities may not be
constructed at all. Additionally, any changes in environmental
laws and regulations, both at the federal and state level, could
require us to invest or spend considerable resources in order to
comply with future environmental regulations. We have been fined
for alleged environmental violations in connection with the
operation of our Woodbridge facility, and are currently
contesting certain alleged environmental violations. Our failure
to comply with environmental regulations could cause us to lose
our required permits, which could cause the interruption or
cessation of our operations. Furthermore, the expense of
compliance could be significant enough to adversely affect our
operation and have a material negative effect on our financial
performance.
Our
facilities will require certain permits to operate, which we may
not be able to obtain at all or obtain on a timely
basis.
For our Gonzales facility, we have obtained the permits and
approvals required to operate the facilities. We may not be able
to secure all the necessary permits for future facilities on a
timely basis or at all, which may prevent us or potential
licensees from operating such facilities according to our
business plan.
For future facilities, particularly in the organic fertilizer
and IW areas, we may need certain permits to operate solid waste
or recycling facilities, as well as permits for our sewage
connection, water supply, land use, air emission, and wastewater
discharge. The specific permit and approval requirements are set
by the state and the various local jurisdictions, including but
not limited to city, town, county, township, and state agencies
having control over the specific properties. Permits once given
may be withdrawn. Inability to obtain or maintain permits to
construct, operate or maintain our facilities will severely and
adversely affect our business.
The
fertilizer industry is highly competitive, which may adversely
affect our ability to generate and grow sales.
Chemical fertilizers are manufactured by many companies, are
plentiful, and are relatively inexpensive. In addition, there
are over 1,700 crop products registered as
organic with the Organic Materials Review Institute,
a number that has more than doubled since 2002. If we fail to
keep up with changes affecting the markets that we intend to
serve, we will become less competitive, thereby adversely
affecting our financial performance.
Pressure
by our customers to reduce prices and agree to long-term supply
arrangements may adversely affect our net sales and profit
margins.
Our current and potential customers, especially large
agricultural companies, are often under budgetary pressure and
are very price sensitive. Our customers may negotiate supply
arrangements with us well in advance of delivery dates, thereby
requiring us to commit to product prices before we can
accurately determine our final costs. If this happens, we may
have to reduce our conversion costs and obtain higher volume
orders to offset lower average sales prices. If we are unable to
offset lower sales prices by reducing our costs, our gross
profit margins will decline, which could have a material
negative effect on our financial performance.
Our
HTLC®
technology imposes obligations on us related to infringement
actions that may become burdensome.
If the use of our
HTLC®
technology is alleged to infringe the intellectual property
of a third party, we may become obligated to defend such
infringement action. In such an event, we may become obligated
to find alternative technology or to pay a royalty to a third
party in order to continue to operate.
If a third party is allegedly infringing any of our
HTLC®
technology, then we may attempt to enforce our intellectual
property rights. In general, our possession of rights to use the
know-how related to our
HTLC®
technology will not be sufficient to prevent others from
employing similar technology that we believe is infringing. Any
such enforcement action against alleged infringers may be
required at our expense. The costs of such an enforcement action
may be prohibitive, reduce our net income, if any, or prevent us
from continuing operations.
15
Our
Gonzales and discontinued Woodbridge facilities, as well as
future facility sites, may have unknown environmental problems
that could be expensive and time-consuming to
correct.
There can be no assurance that we will not encounter hazardous
environmental conditions at the Gonzales facility site or at any
additional future facility sites that may delay the construction
of our food waste conversion facilities or require us to incur
significant
clean-up or
correction costs. Upon encountering a hazardous environmental
condition, our contractor may suspend work in the affected area.
If we receive notice of a hazardous environmental condition, we
may be required to correct the condition prior to continuing
construction. The presence of a hazardous environmental
condition will likely delay construction of the particular
facility and may require significant expenditures to correct the
environmental condition. If we encounter any hazardous
environmental conditions during construction that require time
or money to correct, such event could delay our ability to
generate revenue.
Although we have discontinued our operations at our former
Woodbridge facility, terminated our lease agreement, and
surrendered the property to the landlord, we have received no
formal notification from the New Jersey Department of
Environmental Protection (NJDEP) that the plant shut-down has
been deemed to be final. As such, there is still a possibility
that the NJDEP could determine that additional closure
activities may be required at the site to complete the final
permit termination.
We
have little or no experience in the fertilizer industry, which
increases the risk of our inability to build or license our
facilities and operate our business.
We are currently, and are likely for some time to continue to
be, dependent upon our present management team. Most of these
individuals are experienced both in business generally and in
the government and operation of public companies. However, our
present management team does not have experience in organizing
the construction, equipping, and
start-up of
a food waste conversion facility, except for our Gonzales and
our former Woodbridge facilities. In addition, none of our
directors has any prior experience in the food waste conversion
or fertilizer products industries. As a result, we may not
develop our business successfully.
The
communities where our facilities may be located may be averse to
hosting waste handling and manufacturing
facilities.
Local residents and authorities in communities where our
facilities may be located may be concerned about odor, vermin,
noise, increased truck traffic, air pollution, decreased
property values, and public health risks associated with
operating a manufacturing facility in their area. These
constituencies may oppose our permitting applications or raise
other issues regarding our proposed facilities or bring legal
challenges to prevent us from constructing or operating
facilities.
During the
start-up
phase at the former Woodbridge facility, we experienced
odor-related issues. As a result of these issues, we were
assessed fines from the Health Department of Middlesex County,
New Jersey and have been named as a party in a lawsuit by a
neighboring business. With respect to the fines assessed by the
Health Department, we have negotiated a settlement agreement for
the full amount of fines assessed. With respect to the
litigation, the plaintiff has alleged various causes of action
connected to the odors emanating from the facility and in
addition to monetary damages, is seeking enjoinment of any and
all operations which in any way cause or contribute to the
alleged pollution. If we are unsuccessful in defending the above
litigation or any new litigation, we may be subject to judgments
or fines, or our operations may be interrupted or terminated.
Even though we have discontinued the operations at our
Woodbridge facility these issues could occur at future owned or
licensed facilities.
We are
dependent on a small number of major customers for our revenues
and the loss of any of these major customers would adversely
affect our results of operations.
Our Gonzales facility relies on a few major customers for a
majority of their revenues. During 2010, approximately 70% of
the revenues generated by the Gonzales facility were from a
total of three customers. We do not have any long-term
agreements with any of our customers. The loss of any of our
major customers could adversely affect our results of operations.
16
The
operation of our Concentrators will require routine ongoing
maintenance, which we are responsible for.
Our current and future agreements with customers will require us
to operate the Concentrators and make repairs as necessary.
Hiring employees local to the operating site that are capable of
performing these tasks is essential to our success.
Expansion
of our IW business is dependent upon our ability to secure
project financing for the building of new
Concentrators.
Even if we are able to enter into an agreement with a new
customer to provide wastewater treatment services, we would be
unable to perform under the contract should we be unable to
finance the building of a unit to be used at the customers
site. Our IW business is new and to date we have not obtained
financing for any IW project. As such, we do not know whether we
will be able to obtain such project financing in the future, or
what the terms of such project financing would be if we were
able to obtain the financing. We will not be able to finance the
purchase of new Concentrators from our internal working capital.
Therefore, the failure to obtain project financing in the future
is critical to our ability to develop and commercialize our IW
business.
TerraSphere
has a limited operating history and its prospects are difficult
to evaluate.
When we acquired TerraSphere in November of 2010, it was an
early stage company whose activities had been primarily limited
to the development of its technology. As such, there is limited
historical financial information available, and the revenue and
income potential of TerraSpheres business is unproven. If
TerraSphere is unable to develop its business and consequently
suffers economic loss or collapse, there may be a material
negative effect on the Companys financial performance.
TerraSpheres
licensees are generally early stage companies and the failure of
such licensees to be successful may adversely affect
TerraSpheres future revenues.
TerraSphere generates revenues from its licensee partners
initially from license fees, followed by such partners
purchasing equipment from TerraSphere and finally from royalties
from product sales. If these licensees are not successful in
securing the initial capital required to begin operations, they
may not be in a position to pay TerraSphere future license fees,
purchase equipment, or pay royalties. The failure of
TerraSpheres licensees may have a material adverse effect
on TerraSpheres future revenues.
TerraSphere
is dependent on a small number of major customers for its
revenues.
To date, TerraSphere has relied on a few major customers for a
majority of its revenues. We have established a reserve for
certain TerraSphere customer accounts receivable balances due us
as of December 31, 2010, and the loss of any of
TerraSpheres major customers could slow down or curtail
our plans for growing the business.
Sale
of product produced from a Terrasphere facility will be subject
to certain food safety regulations
In order to sell our produce, we must follow applicable food
safety regulations. At minimum, we must comply with laws
enforced by federal agencies such as the FDA and USDA, and some
states may impose stricter standards than those of the federal
government. In Canada we must also comply with laws enforced by
the Canadian Food Inspection Agency and other regulatory bodies.
We
have a significant number of warrants outstanding, and while
these warrants are outstanding, it may be more difficult to
raise additional equity capital. Additionally, certain of these
warrants contain
anti-dilution
and price-protection provisions that may result in the reduction
of their exercise prices in the future.
We have the following outstanding warrants as of the date of
this report:
|
|
|
|
|
2,648,029 Class B warrants to purchase a total of
3,892,602 shares of common stock at $11.00 per share;
|
|
|
|
885,000 Class C warrants exercisable at $1.00 per share;
|
17
|
|
|
|
|
415,000 Class D warrants exercisable at $1.02 per share;
|
|
|
|
1,500,000 Class E warrants exercisable at $1.63 per share;
|
|
|
|
585,000 Class F warrants exercisable at $1.25 per share
|
|
|
|
2,500,000 Class G warrants exercisable at $1.25 per share;
|
|
|
|
17,250,000 Class H warrants exercisable at $1.30 per share
(this includes 300,000 Class H warrants underlying
underwriter purchase options issued in our October 2009
offering).
|
|
|
|
1,163,632 Class I warrants exercisable at $1.06 per
share; and
|
|
|
|
2,780,740 Class J and K warrants exercisable at $0.54 per
share.
|
|
|
|
Warrants issued in connection with our December 2010 financing
|
|
|
|
|
¡
|
2,495,000 Series A warrants exercisable at $0.312 per share.
|
|
|
¡
|
14,463,768 Series B warrants exercisable at $0.345 per share
|
|
|
¡
|
2,495,000 Series C warrants exercisable at $0.312 per share
|
The holders of these warrants are given the opportunity to
profit from a rise in the market price of our common stock. We
may find it more difficult to raise additional equity capital
while these warrants are outstanding. At any time during which
these public warrants are likely to be exercised, we may be able
to obtain additional equity capital on more favorable terms from
other sources. Furthermore, the Class C, D, G, and I
warrants, and the warrants issued in our December 2010
financing, contain price-protection provisions under which, if
were to issue securities at a price lower than the exercise
price of such warrants, the exercise price of the warrants would
be reduced, with certain exceptions, to the lower price.
If we
issue shares of preferred stock, your investment could be
diluted or subordinated to the rights of the holders of
preferred stock.
Our Board of Directors is authorized by our Certificate of
Incorporation to establish classes or series of preferred stock
and fix the designation, powers, preferences and rights of the
shares of each such class or series without any further vote or
action by our stockholders. Any shares of preferred stock so
issued could have priority over our common stock with respect to
dividend or liquidation rights. The issuance of shares of
preferred stock, or the issuance of rights to purchase such
shares, could be used to discourage an unsolicited acquisition
proposal. For instance, the issuance of a series of preferred
stock might impede a business combination by including class
voting rights that would enable a holder to block such a
transaction. In addition, under certain circumstances, the
issuance of preferred stock could adversely affect the voting
power of holders of our common stock. Although our Board of
Directors is required to make any determination to issue
preferred stock based on its judgment as to the best interests
of our stockholders, our Board could act in a manner that would
discourage an acquisition attempt or other transaction that
some, or a majority, of our stockholders might believe to be in
their best interests or in which such stockholders might receive
a premium for their stock over the then-market price of such
stock. Presently, our Board of Directors does not intend to seek
stockholder approval prior to the issuance of currently
authorized preferred stock, unless otherwise required by law or
applicable stock exchange rules. Although we have no plans to
issue any additional shares of preferred stock or to adopt any
new series, preferences or other classification of preferred
stock, any such action by our Board of Directors or issuance of
preferred stock by us could dilute your investment in our common
stock and warrants or subordinate your holdings to such shares
of preferred stock.
Future
issuances or sales, or the potential for future issuances or
sales, of shares of our common stock, the exercise of warrants
to purchase our common stock, or the conversion of convertible
notes into our common stock, may cause the trading price of our
securities to decline and could impair our ability to raise
capital through subsequent equity offerings.
During 2010, we issued a significant number of shares of our
common stock, warrants to acquire shares of our common stock,
preferred stock convertible into shares of our common stock, and
convertible notes that may be
18
converted into our common stock in connection with various
financings and the repayment of debt, and we anticipate that we
will continue to do so in the future. The additional shares of
our common stock issued and to be issued in the future upon the
exercise of warrants or options or the conversion of debt could
cause the market price of our common stock to decline, and could
have an adverse effect on our earnings per share if and when we
become profitable. In addition, future sales of a substantial
number of shares of our common stock or other securities in the
public markets, or the perception that these sales may occur,
could cause the market price of our common stock and our
Class H and Class B warrants to decline, and could
materially impair our ability to raise capital through the sale
of additional securities.
We may
not be able to adequately raise the bid price of our common
stock to remain compliant with NASDAQ listing
standards.
On June 27, 2010, we received notice from the NASDAQ Stock
Market stating that the closing bid price of our common stock
had fallen below $1.00 for thirty consecutive business days and
that therefore, we were not in compliance with NASDAQ Listing
Rule 5550(a)(2). As of December 27, 2010, we have been
provided a 180 day grace period, through June 27,
2011, to regain compliance with the Rule. To regain compliance,
the bid price for our common stock must close at $1.00 or higher
for a minimum of 10 consecutive business days within the grace
period. NASDAQ has notified us that we are not eligible for an
additional grace period, and if we dont achieve the
required stock price within this current grace period we would
either have to effect a reverse stock split, although this will
not guarantee compliance, or delist our shares from NASDAQ. In
order for us to effect a reverse stock split in the timeline
described above we intend to seek shareholder approval for the
reverse stock split in our annual meeting proxy statement which
we plan to file in April 2011.
Even
if we are able to gain compliance with NASDAQs minimum bid
price requirement, we may not be able to maintain the other
listing requirements to remain compliant with NASDAQ listing
standards.
In addition to NASDAQs minimum bid price requirement
discussed above, NASDAQ requires that listed companies without
sufficient net income maintain either a minimum
stockholders equity of $2.5 million or a market value
of listed securities of $35.0 million. As of
December 31, 2010, we met the minimum stockholders
equity requirement. Based on our current stock price, we do not
meet the market value of listed securities requirement. Although
our equity as of December 31, 2010 was greater than the
required minimum, there is no guarantee that we will continue to
maintain compliance with this standard. If we fail to meet the
listing requirements, our common stock will be removed from the
NASDAQ Stock Market, which will likely reduce the liquidity of
our common stock and adversely affect the price of our common
stock.
|
|
ITEM 1B.
|
UNRESOLVED
STAFF COMMENTS
|
On March 9, 2011, we responded to a comment letter from the
staff of the United States Securities and Exchange Commission
(the SEC) whereby they requested certain information
regarding a possible change in organic certification of one of
the ingredients used in the products we produce in California.
Additionally, the staff requested a detailed analysis concerning
the facts and circumstances associated with the impairment of
long lived assets at the Woodbridge, NJ facility. We continue to
work with the staff to address their open comments.
We have a lease for land in Gonzales, California, where our
Gonzales facility is located. The land is leased from VLH, a
California LLC whose sole member is a former officer and
director of the Company, and which was consolidated in our
financial statements from January 2008 through April 2009. The
lease provides for a monthly rent of $9,300. The lease is
renewable for three
5-year terms
after the expiration of the initial
10-year
term. In addition, we own the Gonzales facility and the
operating equipment used in the facility.
On November 24, 2009 we signed a lease for office space for
our headquarters in Boston, Massachusetts. The lease is for
3 years and provides 4,510 square feet of usable space
for a monthly rent of $9,772. In addition, we lease, on a
month-to-month
basis, approximately 2,500 square feet of additional office
space in Boston, Massachusetts.
19
We pay rent of $2,800 per month for this space. We may terminate
this additional lease at any time upon 30 days advance
written notice.
On November 12, 2010, we assumed the lease of TerraSphere,
LLCs Vancouver facility, which commenced November 1,
2009 and has a five year term. Rent is $89,900 per year for 2011
through 2013, and $74,990 for 2014. Under the operating lease
agreement, the Company has the right to extend this lease for an
additional five years.
|
|
ITEM 3.
|
LEGAL
PROCEEDINGS
|
On December 11, 2008, we received notice that a complaint
had been filed in a putative class action lawsuit on behalf of
59 persons or entities that purchased units pursuant to a
financing terms agreement, or FTA, dated April 11, 2006,
captioned Gerald S. Leeseberg, et al. v. Converted
Organics, Inc., filed in the U.S. District Court for the
District of Delaware. The lawsuit alleges breach of contract,
conversion, unjust enrichment, and breach of the implied
covenant of good faith in connection with the alleged failure to
register certain securities issued in the FTA, and the
redemption of our Class A warrants in November 2008. The
lawsuit seeks damages related to the failure to register certain
securities, including alleged late fee payments, of
approximately $5.25 million, and unspecified damages
related to the redemption of the Class A warrants. In
February 2009, we filed a Motion for Partial Dismissal of
Complaint. On October 7, 2009, the Court concluded that
Leeseberg has properly stated a claim for actual damages
resulting from our alleged breach of contract, but that
Leeseberg has failed to state claims for conversion, unjust
enrichment and breach of the implied covenant of good faith, and
the Court dismissed such claims. On November 6, 2009, we
filed our answer to the Complaint with the Court. On
March 4, 2010, the parties participated in a conference,
and began discussing discovery issues. Plaintiff filed a Motion
for Class Certification on June 22, 2010, which was
denied on November 22, 2010. On March 3, 2011, the
court denied our motion for partial summary judgment. On
March 25, 2011, some individual investors filed a new
complaint against us asserting similar claims to those in the
Leeseberg litigation. This case will likely be consolidated with
the Leeseberg action. We plan to vigorously defend these matters
and are unable to estimate any losses that may or may not be
incurred as a result of this litigation and new complaint and
their eventual disposition. Accordingly, no loss has been
recorded related to these matters.
Related to the above matter, in December 2009, we filed a
complaint in the Superior Court of Massachusetts for the County
of Suffolk, captioned Converted Organics Inc. v.
Holland & Knight LLP. We claim that in the event we
are required to pay any monies to Mr. Leeseberg and his
proposed class in the matter of Gerald S. Leeseberg,
et al. v. Converted Organics, Inc., that
Holland & Knight should make us whole, because its
handling of the registration of the securities at issue in the
Leeseberg lawsuit caused any loss that Mr. Leeseberg and
other putative class members claim to have suffered.
Holland & Knight has not yet responded to the
complaint. Holland and Knight has threatened to bring
counterclaims against Converted Organics for legal fees
allegedly owed, which we would contest vigorously. On
May 12, 2010, the Superior Court stayed the proceedings,
pending resolution of the Leeseberglitigation. At this
early stage in the case, the Company is unable to predict the
likelihood of an unfavorable outcome, or estimate any loss/gain.
On May 19, 2009, we received notice that a complaint had
been filed in the Middlesex County Superior Court of New Jersey,
captioned Lefcourt Associates, Ltd. v. Converted Organics
of Woodbridge, et al. The lawsuit alleged private and public
nuisances, negligence, continuing trespasses and consumer
common-law fraud in connection with the odors emanating from our
Woodbridge facility and our alleged, intentional failure to
disclose to adjacent property owners the possibility of our
facility causing pollution and was later amended to allege
adverse possession, acquiescence and easement. The lawsuit
sought enjoinment of any and all operations which in any way
cause or contribute to the alleged pollution, compensatory and
punitive damages, counsel fees and costs of suit and any and all
other relief the Court deems equitable and just. On
April 12, 2010, the Middlesex County Superior Court of
New Jersey issued an administrative order settlement
dismissing without prejudice the matter of Lefcourt Associates,
Ltd. v. Converted Organics of Woodbridge, et al. On
June 8, 2010, Lefcourt Associates, Ltd re-filed their
lawsuit but before a different court, the Chancery Division in
Bergen County. We filed a motion to transfer the action back to
the original court in Middlesex County, which was granted and we
sought to have the lawsuit dismissed, which was granted in part
on August 27, 2010. The Court limited the plaintiffs
claims to the events in part that occurred after the dismissal
of the prior action. The case was recently transferred to the
Law Division and a trial date as to damages is currently
scheduled for June 6, 2011. We plan to vigorously defend
this matter and are
20
unable to estimate any losses that may or may not be incurred as
a result of this litigation and its eventual disposition.
Accordingly, no loss has been recorded related to this matter.
|
|
ITEM 4.
|
[REMOVED
AND RESERVED]
|
|
|
ITEM 5.
|
MARKET
FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
|
Market
Information
Our common stock has been listed on the NASDAQ Capital Market
under the symbol COIN since March 16, 2007.
Prior to March 16, 2007, there was no public market for our
common stock. The following table sets forth the range of high
and low closing prices per share as reported on NASDAQ for the
periods indicated.
|
|
|
|
|
|
|
|
|
2009
|
|
High
|
|
Low
|
|
First Quarter
|
|
$
|
4.05
|
|
|
$
|
0.76
|
|
Second Quarter
|
|
$
|
2.19
|
|
|
$
|
0.76
|
|
Third Quarter
|
|
$
|
1.48
|
|
|
$
|
0.95
|
|
Fourth Quarter
|
|
$
|
1.30
|
|
|
$
|
0.59
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
High
|
|
|
Low
|
|
|
First Quarter
|
|
$
|
1.14
|
|
|
$
|
0.68
|
|
Second Quarter
|
|
$
|
1.18
|
|
|
$
|
0.61
|
|
Third Quarter
|
|
$
|
0.72
|
|
|
$
|
0.39
|
|
Fourth Quarter
|
|
$
|
0.58
|
|
|
$
|
0.32
|
|
Holders
As of March 28, 2011, there were approximately 1,000
beneficial holders of the Companys common stock.
Dividends
We have not declared or paid any cash dividends and do not
intend to pay any cash dividends in the foreseeable future. We
intend to retain any future earnings for use in the operation
and expansion of our business. Any future decision to pay cash
dividends on common stock will be at the discretion of our Board
of Directors and will depend upon, our financial condition,
results of operation, capital requirements and other factors our
Board of Directors may deem relevant.
Recent
Sales of Unregistered Securities
During the last quarter of 2010, we issued 165,000 unregistered
shares of common stock to New Castle Consulting for consulting
services with regard to investor relations. This transaction was
exempt from the registration requirement of the Securities Act
of 1933, as amended (the 1933 Act), pursuant to
Section 4(2) under the 1933 Act, as the recipient is
an accredited investor as defined in the
1933 Act.
Use of
Proceeds from Registered Securities
See the discussion below under Managements
Discussion and Analysis of Financial Condition and Results of
Operations.
Purchase
of Equity Securities by the Small Business Issuer and Affiliated
Purchasers
None.
21
|
|
ITEM 6.
|
SELECTED
FINANCIAL DATA
|
As a smaller reporting company, we are not required to provide
information typically disclosed under this section.
|
|
ITEM 7.
|
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The following discussion of our plan of operation should be read
in conjunction with the consolidated financial statements and
related notes to the consolidated financial statements included
elsewhere in this report. This discussion contains
forward-looking statements that relate to future events or our
future financial performance. These statements involve known and
unknown risks, uncertainties and other factors that may cause
our actual results, levels of activity, performance or
achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or
implied by these forward-looking statements. These risks and
other factors include, among others, those listed under
Risk Factors and those included elsewhere in this
document. Actual results could differ materially from these
forward-looking statements. Converted Organics Inc. is sometimes
referred to herein as we, us,
our and the Company.
Introduction
We presently have three lines of business, which are
(1) organic fertilizer, (2) industrial waste water
treatment and (3) vertical farming. Based on the nature of
products and services offered, the Company has determined that
there are two reportable segments: (1) organic fertilizer
and (2) vertical farming at December 31, 2010. The
industrial wastewater treatment segment is not separately
reported as it is in the developmental stage and there is no
discreet financial information to report at December 31,
2010. We evaluate performance based on several factors, of which
the primary financial measure is business segment operating
income. The discreet financial information presented below is
derived from the continuing operations as of December 31,
2010. The results of continuing operations are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic
|
|
Vertical
|
|
Corporate and
|
|
|
|
|
Fertilizer
|
|
Farming
|
|
Eliminations
|
|
Consolidated
|
|
Revenues
|
|
$
|
3,275,325
|
|
|
$
|
250,000
|
|
|
$
|
|
|
|
$
|
3,525,325
|
|
Net loss from continuing operations(1)
|
|
|
(1,279,055
|
)
|
|
|
(2,562,517
|
)
|
|
|
(12,197,453
|
)
|
|
|
(16,039,025
|
)
|
Depreciation and amortization(2)
|
|
|
369,544
|
|
|
|
85,403
|
|
|
|
34,656
|
|
|
|
489,603
|
|
Interest expense(3)
|
|
|
|
|
|
|
11,169
|
|
|
|
1,714,782
|
|
|
|
1,725,951
|
|
Total assets net of discontinued operations(4)
|
|
|
2,973,568
|
|
|
|
12,618,892
|
|
|
|
4,032,496
|
|
|
|
19,624,,956
|
|
Goodwill
|
|
|
|
|
|
|
1,667,957
|
|
|
|
|
|
|
|
1,667,957
|
|
Property and equipment additions
|
|
|
294,878
|
|
|
|
29,157
|
|
|
|
|
|
|
|
324,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Net loss from continuing operations of the principal businesses
exclude corporate compensation, marketing expense, professional
fees and other unallocated expenses. |
|
(2) |
|
Depreciation and amortization expense associated with property
and equipment and intangibles. Corporate amortization expense
relates to intangible asset technological know how. |
|
(3) |
|
Corporate interest expense is primarily related to a convertible
note payable. |
|
(4) |
|
Total business assets are the owned or allocated assets used by
each business. Corporate assets consist of cash, intangibles and
certain other assets. |
Revenues are attributable to geographic areas based on location
of the customer, primarily within the continental United States.
Converted Organics derived approximately $1.9 million or
63% of its revenues from three customers and TerraSphere Inc.
derived 100% of its revenue from one customer as of
December 31, 2010. As of December 31, 2009, the
Company was a single reportable segment.
Our operating structure is composed of our parent company,
Converted Organics, Inc.(COIN) and the subsidiaries
listed below. Expenditures at the corporate level (items paid
for by COIN) include management and
22
public company expenses, along with the expenses associated with
its Industrial Wastewater Treatment business, and the
outsourcing of dry product fertilizer production. It is the
intention of management to transfer the operations of IWR and
the dry fertilizer product to a subsidiary level when business
volumes become appropriate. The current subsidiaries of COIN are
as follows:
|
|
|
|
|
Converted Organics of California, LLC, a wholly-owned subsidiary
of COIN, which includes the operation of our Gonzales,
California facility.
|
|
|
|
Converted Organics of Woodbridge, LLC, a wholly-owned subsidiary
of COIN, which includes the discontinued operation of our
Woodbridge, New Jersey facility.
|
|
|
|
Converted Organics of Mississippi, LLC, a wholly-owned
subsidiary of COIN, established for the purpose of adding a
poultry litter-based fertilizer product to the Companys
existing product lines.
|
|
|
|
Converted Organics of Rhode Island, LLC, a 92.5% owned
subsidiary of COIN , which currently has no operating activity
and which was originally established to include the operation of
a previously planned fertilizer facility in Rhode Island. On
February 25, 2010, we signed a letter of intent with the
non-controlling member in Converted Organics of RI to sell
substantially all of the assets and a limited select amount of
liabilities of Converted Organics of RI. This entity is
currently inactive.
|
|
|
|
TerraSphere Inc. (TerraSphere Inc), a Delaware C
corporation and wholly owned subsidiary of COIN, was established
to hold COINs investment in TerraSphere Systems LLC
(Systems LLC) in which COIN acquired a 95% interest
on November 12, 2010. Systems, LLC owns 85% of TerraSphere
Canada, LLC and 100% of Pharmasphere LLC, which in turn owns
100% of PharmaSphere Worcester, LLC. COINs acquisition of
its interest in Systems LLC was approved by our shareholders at
a special meeting held on September 16, 2010.
|
|
|
|
GoLocalProduceRI, LLC, a 83.34% owned subsidiary of COIN, which
we acquired on December 30, 2010 for the purpose of
building and operating a Terrasphere facility.
|
Organic
Fertilizer Business
We operate a processing facility (Gonzales, CA) that uses food
and agricultural waste as raw materials to manufacture
all-natural fertilizer and soil amendment products combining
nutritional and disease suppression characteristics for sales to
our agribusiness market. During 2010 we also had sales generated
from our production facility in Woodbridge NJ, but operations at
that facility were discontinued and we will not have sales from
that facility in 2011. However, in early 2011 we contracted with
a third party manufacturer and packager to produce our 8-1-4 dry
product to sell to our established retail and turf management
customers that were previously serviced by our Woodbridge, NJ
facility. During 2010 we also had some sales from a
poultry-litter-based fertilizer product, but do not expect to
have revenue from this product in 2011. We also hope to achieve
additional revenue by licensing the use of our technology to
others, developing our Industrial Wastewater Resources division,
and expanding our newly acquired vertical farming division,
TerraSphere Inc.
Converted
Organics of California, LLC Gonzales
Facility
The Gonzales facility is our production facility that services a
strong West Coast agribusiness customer base through established
distribution channels. This facility uses our proprietary
technology and process known as High Temperature Liquid
Composting, or
HTLC®,
which processes various biodegradable waste products into liquid
and food waste-based fertilizer and a limited amount of solids
that could be further processed into a useable form for use in
agriculture, retail, and professional turf markets.
The Gonzales facility began to generate positive cash flow in
June 2009 and has continued to do so through 2010. For year
ended December 31, 2010, the Gonzales facility generated
revenues of $3,021,000 and a positive gross margin of $634,000,
or 21% (based on no allocation of corporate overhead). We plan
to continue to improve this operating margin by maximizing the
production capacity at the facility, as discussed below, by
generating tip fees from receiving additional quantities of food
processing waste and by reducing the amount of raw material and
freight costs currently associated with the production process.
We estimate that the plant, in its current configuration
23
and based on current market prices, has the capacity to generate
monthly sales in the range of $350,000 to $400,000. In addition,
we have plans to triple production capacity of the Gonzales
plant and further modify it to enable production of both liquid
and solid fertilizers. We have completed certain aspects of the
planned upgrades which allow us to receive solid food waste for
processing, but have delayed the upgrades which would allow us
to produce dry product due to a lack of market demand for a dry
product within the area the Gonzales facility serves. As we will
have to obtain the proper building permits for continued
expansion, further development of the Gonzales facility will be
delayed until additional market research has been completed and
those permits are obtained. If sales increase above the current
per month level, we expect the additional cash flow from the
Gonzales facility will be used to offset operating expenses at
the corporate level.
In 2008 we entered into certain arrangements whereby we became
the exclusive owner of the
HTLC®
system, which enables the processing of various
biodegradable waste products into liquid and solid food
waste-based fertilizer and feed products. In addition, the
acquisition of this technology provides for a technology fee
payment of $5,500 per ton of waste-processing capacity for
capacity that is either added to plants that were not planned at
the time of this acquisition and that use this technology. There
is a 10-year
cap for these processing capacity charges, and no minimum
payment is required. This fee did not apply to the Woodbridge
facility and does not apply to the Gonzales facility, including
the currently planned addition thereto, but expansion in excess
of the current plan will trigger payable fees for that excess.
The agreement also provides for a 50% profit share with the
seller on any portable facilities.
We are also party to an agreement with Pacific Seafoods Inc.
(Pacific Seafoods) whereby we agreed to pay Pacific
Seafoods 50% of the profits from the development of a fish-waste
product. Under this agreement, the seller of the HTLC technology
would also be entitled to 50% of our profits from this joint
venture. Our profits from this arrangement are thus 25% of the
total profits from the enterprise (50% of total profits net half
of the remainder). To date, no profits have been earned from the
fish-waste product.
Combined payments of both the $5,500 per ton technology fee and
the profits paid from the fish waste-processing product, if any,
are capped at $7.0 million, with no minimum payment
required. It is our intention to expense the payments, if any,
that are paid on either the profits from the fish
waste-processing product or the
$5,500 per-ton
technology fee.
Converted
Organics of Mississippi, LLC
On January 26, 2010, we formed Converted Organics of
Mississippi, LLC, a Mississippi limited liability company and a
wholly owned subsidiary of the Company. We established this
entity for the purpose of adding a poultry litter-based
fertilizer to our existing product lines, and we outsourced the
production of this product. From the date of inception through
December 31, 2010, Converted Organics of Mississippi, LLC
recorded product sales revenue of approximately $255,000. In the
later part of 2010, the company from whom we outsourced the
product filed for protection under Chapter 7 and we do not
expect to have future sales of this product.
Converted
Organics of Woodbridge,, LLC
During the third quarter of 2010 we discontinued the operations
of our Woodbridge facility which is discussed further in this
section under the caption Results of Discontinued
Operations.
Industrial
Wastewater Treatment Business
In March 2010, we began to operate an Industrial Wastewater
Resources division of the Company (IWR) to leverage our
exclusive license of the
LM-HT®
Concentrator technology for the treatment of industrial
wastewater (IW). Due to its unique, energy efficient design, the
LM-HT®
Concentrator provides a highly cost-effective alternative to
traditional IW treatment technology. Since IWRs inception
in March of 2010, we have entered into strategic discussions
with numerous interested parties, which may lead to us supplying
Concentrator units at waste treatment facilities on landfills
and other waste processing facilities. Once the
LM-HT®
Concentrators are installed, we plan to apply for carbon
credits and government grants based on the technologys
ability to reduce carbon emissions and energy consumption
through its use of waste heat and renewable energy as thermal
fuel.
24
On March 23, 2010, we entered into a loan and license
agreement with Heartland Technology Partners, LLC
(HTP). The loan agreement required us to advance
$500,000 to HTP in three monthly installments that commenced
upon signing of the loan. The outstanding principal balance of
the loan is due if either a change of control of HTP or the
completion by HTP of a financing in excess of $10 million
occurs on or before June 30, 2012. In consideration for
entering into the loan agreement, we were granted an exclusive,
irrevocable license to utilize HTPs patented
LM-HT®
Concentrator technology in the U.S. industrial wastewater
market. The IW market involves the treatment of waters that have
been contaminated by anthropogenic industrial or commercial
activities, prior to their reuse or release into the
environment. The
LM-HT®
Concentrator reduces carbon emissions compared to
traditional technologies by using waste heat and renewable
energy as thermal fuel. We have hired a senior executive in the
wastewater processing industry and have begun to develop plans
to operate our Industrial Wastewater Resources division. On
July 30, 2010, we signed a letter of intent with Spirit
Services, Inc. to jointly develop an energy and IW treatment
facility using our exclusively licensed technology to evaporate
IW at a facility in South Boston, Virginia. We have subsequently
signed additional agreements to establish relationships to
jointly develop IW treatment facilities at certain established
waste treatment facilities in the United States. Such
relationships are in the development stage and we expect to
build upon them, as well as secure new partnerships in 2011.
IWR currently operates an industrial wastewater concentrator on
Glenwood Springs Landfill Enterprises South Canyon
Landfill in Glenwood Springs, CO as a result of an agreement
signed in January of 2011. This facility is designed to treat
15,000 gallons of aqueous waste per day and will be fueled by
the combustion of biomass diverted from disposal in the
landfill. Among the IWs to be treated by the plant are septic,
wash waters, process waters, man-camp wastewaters, and
wastewaters from oil and gas exploration activities. Under this
agreement we are paid a per gallon fee for the amount of IW that
we treat, less labor costs to operate the unit and a marketing
fee to generate IW delivered to the facility. In addition, we
are responsible for repairs and maintenance of the evaporator
unit. We are responsible for the purchase of the evaporator unit
and will own it. As of January 2011 we began to generate revenue
under this agreement from South Canyon Landfills
traditional method of wastewater treatment as we waited for
conditional air permits. Such permits were received in March of
2011, at which time we paid $600,000 of the $1.6 million
purchase price of the evaporator and the unit commenced
operations.
Our plan to increase business and revenues for IWR is to seek
out municipal and industrial locations to locate our owned
evaporator units and to charge a per gallon fee to treat
industrial wastewater. We plan to follow the current agreement
model where we would pay for labor, repairs and marketing (if
required) at the location. We will have to seek specific project
financing for each evaporator unit. Presently, we are in
discussion with four potential owners of locations where an
evaporator unit could be located. We expect that in 2011, if we
are able to secure project financing that we will be able to
begin operations on a second evaporator unit, in addition to the
one being operated at the Glenwood Springs Landfill.
Vertical
Farming Business
On May 20, 2010, we formed TerraSphere Inc., a Delaware C
corporation and a wholly owned subsidiary of the Company, for
the purpose of acquiring the membership interests of TerraSphere
Systems LLC (TerraSphere Systems). On July 6,
2010, a membership interest purchase agreement was entered into
by the Company, TerraSphere Inc., TerraSphere Systems, and the
members of TerraSphere Systems, pursuant to which we agreed to
acquire the membership interests of TerraSphere Systems. The
maximum total shares that could be issued for TerraSphere
Systems is estimated to be 34,166,667 shares of our common
stock, which includes earn-out share payments of up to
14,603,175 shares of our common stock. Pursuant to the
purchase agreement, the acquisition was approved by our
shareholders on September 16, 2010, and the Company
acquired 95% of the membership interest of TerraSphere Systems
on November 12, 2010. We will issue up to
32,777,778 shares of our common stock to the members of
TerraSphere Systems in exchange for 95% of the units of
TerraSphere Systems, subject to certain anti-dilution
adjustments. Of these shares, 18,174,603 shares were issued
on November 12, 2010, the closing of the acquisition, and
the remainder of the shares will be issued if TerraSphere
achieves four milestones. As of the filing date of this report,
only one of the four milestones, TerraSpheres collection
of $2.0 million of its accounts receivable by
February 28, 2011, was subject to measurement. This
milestone was not met, and as a result we will not issue the
1,825,397 shares of our common stock associated with that
milestone. Two of three remaining
25
milestones (market capitalization and gross margin), are to be
measured as of December 31, 2011, and the final milestone
(gross margin) is to be measured at December 31, 2012.
TerraSphere Systems is in the business of designing, building,
and operating highly efficient and scalable systems, featuring a
patented, proprietary technology that utilizes
vertically-stacked modules to house rows of plants, which are
then placed perpendicular to an interior light source to grow
pesticide and chemical-free organic fruits and vegetables. Due
to a controlled, indoor environment, the system generates fresh
produce year-round in any location or climate world-wide. We
believe the acquisition of TerraSphere Systems will expand our
portfolio of sustainable, environmentally-friendly businesses,
and will provide us with an immediate revenue stream.
2010
Financing Activities
On April 22, 2010, we entered into an agreement with a
single institutional investor, pursuant to which we issued to
the investor: (i) 2,400,000 shares of common stock and
(ii) five-year warrants to purchase 1,163,362 shares
of common stock at an exercise price of $1.06 per share
(Class I warrants). The warrants may be exercised at any
time on or following a date one year after the date of issuance
and expire five years from the date of issuance. The transaction
closed on April 22, 2010 and provided us with net proceeds
of approximately $2.4 million.
On October 18, 2010, we entered into an Exchange Agreement
with Oppenheimer Rochester National Municipals and Oppenheimer
New Jersey Municipal Fund, each a series of Oppenheimer
Multi-State Municipal Trust, a Massachusetts business trust
(together, the Bond Holder). The Bond Holder was the
sole holder of $17,500,000 aggregate principal amount Solid
Waste Facilities Revenue Bonds (the Bonds) that were
issued on behalf of Converted Organics of Woodbridge, LLC, a
wholly-owned subsidiary of the Company. Pursuant to the Exchange
Agreement, the Bond Holder agreed to exchange: (i) the
Bonds (which represented 100% of all Bonds), and
(ii) Class B Warrants to purchase
2,284,409 shares the Companys Common Stock for
17,500 shares of the Companys newly authorized 1%
Series A Convertible Preferred Stock. In addition, the Bond
Holder agreed to waive all interest accrued and unpaid from
February 1, 2010 until the date of the Exchange Agreement
on the Bonds, and agreed to transfer to the Company
approximately $600,000 that the Company had previously deposited
into certain reserve accounts in connection with the Bonds. To
designate and establish the shares of Series A Preferred,
the Companys Board of Directors approved, and on
October 18, 2010, the Company filed with the Delaware
Secretary of State, a Certificate of Designation of Preferences,
Rights and Limitations of Series A Preferred Stock (the
Certificate of Designation). Each share of
Series A Preferred is convertible into a number of shares
of Common Stock equal to (i) the stated value of the share
($1,000), divided by (ii) $0.543 (the Conversion
Price). Holders of the Series A Preferred are
entitled to receive cumulative dividends at the rate per share
(as a percentage of the stated value per share) of 1% per annum
(subject to increase in certain circumstances), payable annually
and on each conversion date. The dividends are payable during
the first three years after issuance at the election of the
Company, and thereafter at the election of the holder, in cash
or in shares of Company common stock valued at the Conversion
Price (or in some combination thereof).
On December 17, 2010, we entered into a Securities Purchase
Agreement with certain institutional investors (the
Buyers) whereby we agreed to sell to Buyers
convertible notes in the aggregate original principal amount of
$4,990,000 (the Notes), which are convertible into
shares of our common stock. The Notes were issued with an
original issue discount of approximately 4.8%, and the purchase
price of the Notes was $4,750,000. The Notes are not interest
bearing, unless we are in default on the Notes, in which case
the Notes carry an interest rate of 18% per annum. On
December 17, 2010 we sold to the Buyer $3,940,000 of the
Notes and on March 3, 2011 we sold the Buyer the remaining
$1,050,000 of the notes. We are required to repay the Notes in
six equal installments commencing February 1, 2011, with
respect to $3.9 million of the Notes, and April 8,
2011, with respect to $1.1 million of the Notes, either in
cash or in shares of our common stock. If we choose to utilize
shares of our common stock for the payment, the value of our
shares will be equal to the lower of (i) the conversion
price then in effect and (ii) 85% of the average of the
three lowest closing sale prices of our common stock during the
20 trading day period prior to payment of the installment
amount. We also have the right, at our option, to permit the
holder of the Notes to convert at a lower price specified by us
for a period specified by us.
26
In addition, we also issued to the Buyers warrants to acquire
shares of common stock, in the form of three warrants:
(i) Series A Warrants,
(ii) Series B Warrants, and
(iii) Series C Warrants (collectively, the
Warrants).
The Series B Warrants became exercisable on
February 28, 2011, the date upon which shareholder approval
was obtained in connection with the financing, and expire on
November 28, 2011. The Series B Warrants provide that
the holders are initially entitled to purchase an aggregate of
4,990,000 shares at an initial exercise price of $1.00 per
share. If we make certain dilutive issuances (with limited
exceptions), the exercise price of the Series B Warrants
will be lowered to the per share price for the dilutive
issuances. In addition, the exercise price of the Series B
Warrants will adjust to the average of the conversion prices
used to repay the Notes discussed above. The floor price for the
exercise price of the Series B Warrants is $0.345. The
number of shares underlying the Series B Warrants will
adjust whenever the exercise price adjusts, such that at all
times the aggregate exercise price of the Series B Warrants
will be $4,990,000. As of the date hereof, the exercise price of
the Series B Warrants is $0.345 per share and there are
14,463,768 shares underlying the Series B Warrants.
The Series A and Series C Warrants became exercisable
on February 28, 2011, the date upon which shareholder
approval was obtained in connection with the financing, and have
a five year term.
Should we make certain dilutive issuances (with limited
exceptions), the exercise price of the Series A and
Series C Warrants will be lowered to the per share price
for the dilutive issuances. In addition, the exercise price of
the Series A and Series C Warrants will adjust to the
average of the conversion prices used to repay the Notes
discussed above. As of the date hereof, the exercise price of
the Series A Warrants and Series C Warrants is $0.312
per share.
Acquisitions
TerraSphere
Systems LLC Acquisition
On November 12, 2010, we acquired 95% of the membership
interests of TerraSphere Systems LLC. The acquisition will
enable us to license TerraSpheres patented Growth System,
which is a system of modules and processes for growing plants in
a controlled environment. The system uses and controls precise
combinations of light, water, nutrition, gravity, centrifugal
forces, and gasses to produce growing conditions that can be
controlled and manipulated to result in desired plant growth and
maximum crop production.
The membership interest purchase agreement
(Agreement) entered on July 6, 2010 allows for
an election by TerraSphere members to accept
1) 27,777,778 shares of common stock upon closing of
the transaction (with a 6 month holding period)
(Option One) or 2) 15,873,016 shares of
Company common stock upon closing of the transaction with an
option to earn an additional 21,164,021 shares of Company
common stock in contingent consideration based upon TerraSphere
achieving certain milestones and agreeing to an 18 month
holding period on stock distributed to them (Option
Two). Based on 26% of TerraSphere members electing
Option One and 69% electing Option Two, the maximum total shares
that could be issued is 32,777,778 of Company common stock. Per
the Agreement, TerraSphere members who elected Option One
received 7,222,222 shares of Company common stock upon
closing and members electing Option Two received
10,952,381 shares of Company common stock upon closing with
an additional 14,603,175 shares of Company common stock
issueable upon achieving the following milestones (contingent
consideration):
Milestone One Payment: 4,563,492 shares
of Company common stock, if between the date of the Agreement
and the 90th day following the closing date or the
180th day following the date of the Agreement, the
following occurs: for a period of five consecutive trading days,
the Companys market capitalization exceeds the sum of:
(1) the Companys initial market capitalization on the
date of execution of the Agreement, plus (2) the closing
price per share, multiplied by the number of shares of Company
common stock to be issued at closing pursuant to the Agreement.
If between the date of the Agreement and the 90th day
following the closing date or the 180th day following the
date of the Agreement, the Company completes an equity
financing, the cash received from the equity financing during
such period shall be added to the market capitalization. If
between the closing date and December 31, 2011, the Company
sells equity of either the
27
Company or any of the Companys subsidiaries, any cash
received from such equity sales during such period shall be
added to the market capitalization;
Milestone Two Payment: 1,825,397 shares
of Company common stock, if $2,000,000 of TerraSpheres
accounts receivable as of the date of the Agreement are received
prior to February 28, 2011. This Milestone was not met;
Milestone Three Payment: 4,563,492 shares
of Company common stock, if we generate gross margin of
$6,000,000 (gross margin target) from our operations during the
period commencing as of the date of the Agreement and ending on
December 31, 2011; provided that, if we generates gross
margin of at least $4,200,000 (gross margin threshold) from our
operations during such period, a pro rata portion of the Company
common stock shall be granted the applicable TerraSphere
members; and
Milestone Four Payment: 3,650,794 shares
of Company common stock, if the Company generates gross margin
of $4,000,000 from its operations during any nine-month period
commencing on the Agreement date and ending on December 31,
2012; provided that, if the Company achieves the Milestone Three
gross margin threshold, but does not achieve the Milestone Three
gross margin target, 83.3% of the difference between the
Milestone Three gross margin target and the actual gross margins
achieved pursuant to the Agreement (the Milestone Three
Deficiency) may be added by the Sellers to the Milestone
Four Payment and the Milestone Four gross margin target.
Notwithstanding anything to the contrary herein, the total
amounts payable pursuant to the Milestone Three Payment and
Milestone Four Payment shall be no more than
8,214,286 shares of Company common stock.
In addition, the Agreement contains an anti-dilution provision
due to which the Company estimated it would need to issue an
additional 2,040,000 shares of Company common stock.
The estimated purchase price at fair value is as follows:
|
|
|
|
|
Election of Option One
|
|
$
|
2,961,000
|
|
Election of Option Two
|
|
|
4,490,000
|
|
Milestone one payment
|
|
|
1,403,000
|
|
Milestone two payment
|
|
|
711,000
|
|
Milestones three and four payments
|
|
|
1,684,000
|
|
Anti-dilution provision
|
|
|
837,000
|
|
|
|
|
|
|
|
|
$
|
12,086,000
|
|
|
|
|
|
|
The estimated purchase price has been allocated to the assets
acquired and liabilities assumed on a preliminary basis using
estimated fair value information currently available. The
allocation of the purchase price to the assets and liabilities
will be finalized within a year as the Company obtains more
information regarding asset valuations, liabilities assumed,
contingent consideration and revisions of preliminary estimates
of fair value made at the date of purchase. The fair value of
the noncontrolling interest totaling $648,644 was determined
based on the fair value assigned for the 95% of TerraSphere
Systems that the Company acquired.
The preliminary purchase price allocation is as follows:
|
|
|
|
|
Cash
|
|
$
|
41,679
|
|
Accounts receivable
|
|
|
2,690,000
|
|
Other assets
|
|
|
274,313
|
|
Leasehold improvements
|
|
|
176,181
|
|
Construction-in-process
|
|
|
97,306
|
|
Patents and patent related costs
|
|
|
10,000,000
|
|
Goodwill
|
|
|
1,193,600
|
|
Assumption of liabilities
|
|
|
(1,738,435
|
)
|
Noncontrolling interest
|
|
|
(648,644
|
)
|
|
|
|
|
|
Total allocation of purchase price
|
|
$
|
12,086,000
|
|
|
|
|
|
|
28
Changes in the fair value of contingent consideration that the
Company recognizes after the acquisition date may be the result
of additional information about facts and circumstances that
existed at the acquisition date that the Company obtained after
that date. Such changes are considered to be measurement period
adjustments and would adjust the purchase price to the extent
they occur within one year from the acquisition date. Contingent
consideration classified as an asset or a liability that changes
beyond a year from the acquisition date is remeasured at fair
value and recognized in earnings.
Converted Organics, Inc recorded the above transaction on
November 12, 2010 as follows:
|
|
|
|
|
Obligations to issue shares
|
|
|
1,684,000
|
|
Derivative liability related to anti-dilution provision
|
|
|
837,000
|
|
Equity
|
|
|
9,565,000
|
|
|
|
|
|
|
Total
|
|
$
|
12,086,000
|
|
|
|
|
|
|
We determined that Milestones three and four contained in the
Agreement meet the definition of a liability under ASC 480
Distinguishing Liabilities from Equity and therefore this
obligation to issue shares is treated as a liability rather than
equity when recording the fair value of the acquisition.
Obligations to issue shares represents the estimated fair value
of shares to be issued for Milestones three and four as
described above. In addition, the Company determined that the
anti-dilution provision contained in the Agreement meets the
definition of a derivative liability. The Company considered
various scenarios and possibilities of an occurrence of an event
that would trigger the anti-dilution provision. Based on the
various scenarios and possibilities the Company estimated it
would need to issue an additional 2,040,000 shares to the
former members of TerraSphere Systems related to this provision.
GoLocalProduceRI,
LLC Acquisition
On December 30, 2010, we acquired 83.34% of
GoLocalProduceRI, LLC issuing 1,371,428 shares of Company
common stock valued at approximately $480,000, marking its
entrance into the vertical farming industry as owners and
operators of what is expected to be the first TerraSphere
facility in the United States.
The estimated purchase price has been allocated to the assets
acquired and liabilities assumed on a preliminary basis using
estimated fair value information currently available. The
allocation of the purchase price to the assets and liabilities
will be finalized within a year as the Company obtains more
information regarding asset valuations, liabilities assumed,
contingent consideration and revisions of preliminary estimates
of fair value made at the date of purchase. The fair value of
the noncontrolling interest totaling $95,954 was determined
based on the fair value assigned for the 83.34% of
GoLocalProduceRI, LLC that the Company acquired.
The preliminary purchase price allocation is as follows:
|
|
|
|
|
Cash
|
|
$
|
56,597
|
|
Prepaid and other current assets
|
|
|
45,000
|
|
Goodwill
|
|
|
474,357
|
|
Noncontrolling interest
|
|
|
(95,954
|
)
|
|
|
|
|
|
Total
|
|
$
|
480,000
|
|
|
|
|
|
|
|
|
|
|
|
Trends
and Uncertainties Affecting our Operations
We will be subject to a number of factors that may affect our
operations and financial performance. These factors include, but
are not limited to, the available supply and price of organic
food waste, the market for liquid and solid organic fertilizer,
increasing energy costs, the unpredictable cost of compliance
with environmental and other government regulation, and the time
and cost of obtaining USDA, state or other product labeling
designations. Demand for organic fertilizer and the resulting
prices customers are willing to pay also may not be as high as
our market studies suggest. In addition, supply of organic
fertilizer products from the use of other technologies or other
competitors may adversely affect our selling prices and
consequently our overall profitability. In addition, a
significant part of our growth strategy is based upon generating
revenues from both our Industrial Wastewater business and from
the acquisition of
29
TerraSphere Systems, both of which are in early stages of
development. This strategy requires licensees to raise the
funding necessary to construct facilities, which has proven
difficult. Furthermore our plan calls for raising additional
debt and/or
equity financing to construct additional operating facilities.
Currently there has been a slowdown in lending in both the
equity and bond markets which may hinder our ability to raise
the required funds.
Liquidity
and Capital Resources
At December 31, 2010, we had total current assets of
approximately $4.3 million consisting primarily of cash and
accounts receivable, and had current liabilities of
approximately $7.8 million, consisting primarily of term
and convertible notes payable, accounts payable and liabilities
from discontinued operations leaving us with negative working
capital of approximately $3.5 million. Non-current assets
totaled approximately $15.3 million and consisted primarily
of property and equipment and intangible assets. Non-current
liabilities consist of derivative liabilities totaling
approximately $8.7 million at December 31, 2010. We
have an accumulated deficit at December 31, 2010 of
approximately $100 million. Owners equity at
December 31, 2010 was approximately $3.2 million. For
2010, we generated revenues from continuing operations of
approximately $3.5 million as compared to revenue from
continuing operations of $2.1 million for the same period
in 2009.
We expect the closing of the Woodbridge facility in the third
quarter of 2010 will save us approximately $6.0 million per
year in net cash expenditures. On October 18, 2010, we
entered into an Exchange Agreement with the sole bond holder of
$17.5 million bonds whereby we exchanged the Bonds for
17,500 shares of our newly authorized 1% Series A
Convertible Preferred Stock, which is convertible into an
aggregate of 32,228,361 shares of our Common Stock. In
addition, the Bond Holder agreed to waive all interest accrued
and unpaid from February 1, 2010 until the date of the
Exchange Agreement on the Bonds totaling approximately $933,000,
and agreed to transfer to the us approximately $600,000 that we
had previously deposited into certain reserve accounts in
connection with the Bonds.
We entered into a Termination and Surrender Agreement with the
Woodbridge Facilitys landlord (the Lessor) on
October 18, 2010 whereby we agreed to transfer all
equipment, tools, and fixtures owned by us and presently located
at the premises, and granted the Lessor 892,857 shares our
Common Stock valued at $500,000 in satisfaction of claims of
approximately $1.5 million. In addition, we have deposits
totaling $415,000 with the Lessor that will not be returned to
us. On October 18, 2010, a court order was entered whereby
we agreed to issue to a third party a total of
20,726,980 shares of our Common Stock in full settlement of
approximately $1.7 million of promissory notes issued by us
to four contractors that had provided services to the Woodbridge
Facility. After the above transactions, Woodbridge had
approximately $2.5 million in current accounts payable
remaining.
Although the California fertilizer business is cash flow
positive, we believe that after the effect of the above
transactions along with our acquisition of TerraSphere (see
Acquisitions above) and the signing of our first
Industrial Wastewater agreement that we will continue to have
negative cash flow from operations in 2011 due to the costs
associated with corporate operations and funding the operations
of TerraSphere. In addition, we believe that we will require
additional cash to finance capital growth activities in order to
build out the IWR and TerraSphere projects planned for 2011. We
believe that if we achieve planned sales from our California
facility, establish additional operational Industrial Wastewater
sites, and complete the construction of a TerraSphere facility,
then we can become cash flow positive in the future. In order to
achieve these goals, however, we will need significant
additional financing for which we have no commitments.
Presently, our liquidity is limited to our cash on hand at
December 31, 2010 ($3.0 million) and the
$1.0 million that we received on March 3, 2011 as a
result of the sale of the additional notes available under our
December 17, 2010 financing agreement. In addition, on
February 28, 2011 we received shareholder approval to
permit the investor in the December 17, 2010 financing
agreement to exercise certain of its warrants, which could
provide us with an additional $4.9 million. However, since
receiving shareholder approval our stock price has closed at
both above and below the exercise price of these warrants, and
it is not likely that any warrants would be exercised unless the
price of our stock was greater than the exercise price of the
warrants. There is no assurance that the investor will exercise
the warrants, and as such, we may not receive these funds. As a
result of this uncertainty, we have entered into discussions
with an investor who would make available approximately
$3,850,000 with a convertible note under similar terms to our
December 17, 2010 financing agreement, though such an
arrangement has not been finalized.
30
If we do not receive additional funds in excess of the amount of
cash on hand, whether as a result of the exercise of the
warrants issued in our December 2010 financing, execution of the
contemplated convertible note, or otherwise, we will not be able
to continue our operations once the cash on hand is utilized.
Even in the event that we do receive additional funds, there is
no guarantee that such funds will be sufficient to continue
operations until we achieve a positive cash flow position. At
this time we do not have any commitments for additional
financing, and there is no assurance that capital in any form
will be available to us on terms and conditions that are
acceptable or at all.
Critical
Accounting Policies and Estimates
Our plan of operation is based in part upon the Companys
consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the
United States of America (GAAP). The preparation of
financial statements in accordance with GAAP requires management
to make estimates and assumptions that affect the reported
amounts of assets and liabilities, including the recoverability
of tangible and intangible assets, disclosure of contingent
assets and liabilities as of the date of the financial
statements, and the reported amounts of expenses during the
periods covered.
We evaluate our estimates on an on-going basis. The most
significant estimates relate to the recovery of long-lived
intangible assets, the estimate of the fair value of
consideration in business combinations, the fair value of
financial instruments related to equity and debt transactions
and estimations of valuation allowances. We base our estimates
on historical Company and industry experience and on various
other assumptions that we believe to be reasonable under the
circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources.. Estimates and
judgments used in the preparation of our consolidated financial
statements are, by their nature, uncertain and unpredictable,
and depend upon, among other things, many factors outside of our
control, such as the results of our operations and other
economic conditions. Accordingly, our estimates and judgments
may prove to be incorrect and actual results may differ, perhaps
significantly, from these estimates under different estimates,
assumptions or conditions.
The following is a brief discussion of our critical accounting
policies and methods, and the judgments and estimates used by us
in their application:
Revenue
Recognition
Our organic fertilizer operation generates revenues from two
sources: product sales and tip fees. Product sales revenue comes
from the sale of fertilizer products. Tip fee revenue is derived
from waste haulers who pay us fees for accepting food waste
generated by food distributors such as grocery stores, produce
docks and fish markets, food processors and hospitality venues
such as hotels, restaurants, convention centers and airports.
The IWWR operation will generate revenue by setting up treatment
systems on customers sites and processing their wastewater
on a
price-per-gallon
basis. Our vertical farming operation derives its revenues from
licensing fees and royalties, as well as the sale of equipment
and expects future revenue from operating facilities using our
patented technology.
Revenue is recognized when all of the following criteria are met:
|
|
|
|
|
Persuasive evidence of a sales arrangement exists;
|
|
|
|
Delivery of the product has occurred;
|
|
|
|
The sales price is fixed or determinable; and
|
|
|
|
Collectability is reasonably assured.
|
In those cases where all four criteria are not met, the Company
defers recognition of revenue until the period in which these
criteria are satisfied. Revenue is generally recognized upon
shipment of product for our fertilizer business, and for
Terrasphere we recognize technology license revenue immediately
upon completed performance if the term of exclusive technology
licenses is equal to the life of the associated intellectual
property, otherwise license revenue would be recognized over the
term of the license.
31
We recognize deferred revenue when payment has been received for
product sales but the revenue recognition criteria have not been
met. In addition, we defer revenue when payment has been
received for future services to be provided.
Share-Based
Compensation
We account for equity instruments exchanged for services in
accordance with the Financial Accounting Standards Board
(FASB) Accounting Standards Codification
(ASC) Section 718 Compensation
Stock Compensation (ASC 718) regarding
share-based compensation. Under the provisions of ASC 718,
share-based compensation issued to employees is measured at the
grant date, based on the fair value of the award, and is
recognized as an expense over the requisite service period
(generally the vesting period of the grant). Share-based
compensation issued to non-employees is measured at grant date,
based on the fair value of the consideration received or the
fair value of the equity instruments issued, whichever is more
readily measurable, and is recognized as an expense over the
requisite service period.
Long-Lived
Assets
We account for our long-lived assets (excluding goodwill) in
accordance with ASC Section 360 Property, Plant and
Equipment (ASC 360), which requires that
long-lived assets and certain intangible assets be reviewed for
impairment annually and whenever events or changes in
circumstances indicate that the carrying amount may not be
recoverable, such as technological changes or significantly
increased competition. If undiscounted expected future cash
flows are less than the carrying value of the assets, an
impairment loss is to be recognized based on the fair value of
the assets, calculated using an undiscounted cash flow model.
There is inherent subjectivity and judgments involved in cash
flow analyses such as estimating revenue and cost growth rates,
residual or terminal values and discount rates, which can have a
significant impact on the amount of any impairment.
Derivative
Instruments
We account for derivative instruments in accordance with
ASC 815 Derivatives and Hedging (ASC
815), which establishes accounting and reporting standards
for derivative instruments and hedging activities, including
certain derivative instruments embedded in other financial
instruments or contracts and requires recognition of all
derivatives on the balance sheet at fair value. Accounting for
changes in the fair value of derivative instruments depends on
whether the derivatives qualify as hedge relationships and the
types of relationships designated are based on the exposures
hedged. At December 31, 2010 and 2009, we did not have any
derivative instruments that were designated as hedges.
Discontinued
Operations
We discontinued the operations of our Woodbridge facility during
the third quarter of 2010. Assets and liabilities related to the
Woodbridge facility have been classified as discontinued
operations on the consolidated balance sheets at
December 31, 2010 and 2009 and its operations have been
classified as loss from discontinued operations on the
consolidated statements of operations and comprehensive loss for
the years ended December 31, 2010 and 2009.
Fair
Value Measurements
Fair value is a market-based measurement, not an entity-specific
measurement. Therefore, a fair value measurement should be
determined based on the assumptions that market participants
would use in pricing the asset or liability. As a basis for
considering market participant assumptions in fair value
measurements, ASC 820 establishes a fair value hierarchy
that distinguishes between market participant assumptions based
on market data obtained from sources independent of the
reporting entity (observable inputs that are classified within
Levels 1 and 2 of the hierarchy) and the reporting
entitys own assumptions about market participant
assumptions (unobservable inputs classified within Level 3
of the hierarchy):
|
|
|
|
|
Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical assets or liabilities that we have the
ability to access.
|
32
|
|
|
|
|
Level 2 inputs are inputs other than quoted prices included
in Level 1 that are observable for the asset or liability,
either directly or indirectly. Level 2 inputs may include
quoted prices for similar assets and liabilities in active
markets, as well as inputs that are observable for the asset or
liability (other than quoted prices), such as interest rates,
foreign exchange rates, and yield curves that are observable at
commonly quoted intervals.
|
|
|
|
Level 3 inputs are unobservable inputs for the asset or
liability which are typically based on an entitys own
assumptions, as there is little, if any, related market activity.
|
In instances where the determination of the fair value
measurement is based on inputs from different levels of the fair
value hierarchy, the level in the fair value hierarchy within
which the entire fair value measurement falls is based on the
lowest level input that is significant to the fair value
measurement in its entirety. Our assessment of the significance
of a particular input to the fair value measurement in its
entirety requires judgment, and considers factors specific to
the asset or liability.
Income
Taxes
We consider the valuation allowance for the deferred tax assets
to be a significant accounting estimate. In applying
ASC 740 Income Taxes, management estimates future
taxable income from operations and tax planning strategies in
determining if it is more likely than not that we will realize
the benefits of our deferred tax assets. Management believes the
Company does not have any uncertain tax positions.
Recently
Issued Accounting Pronouncements
In April 2010, the FASB issued Accounting Standards Update
(ASU)
No. 2010-17,
Milestone Method of Revenue Recognition. This ASU allows
entities to make a policy election to use the milestone method
of revenue recognition and provides guidance on defining a
milestone and the criteria that should be met for applying the
milestone method. The scope of this ASU is limited to the
transactions involving milestones relating to research and
development deliverables. The guidance includes enhanced
disclosure requirements about each arrangement, individual
milestones and related contingent consideration, substantive
milestones and factors considered in that determination. The
amendments in this ASU are effective prospectively to milestones
achieved in fiscal years, and interim periods within those
years, beginning after June 15, 2010. Early application and
retrospective application are permitted. We have evaluated this
new ASU and has determined that it will not have a significant
impact on the determination or reporting of our financial
results.
In December 2010, the FASB issued ASU
2010-28
(Topic 350) When to Perform Step 2 of the Goodwill
Impairment Test for Reporting Units with Zero or Negative
Carrying Amounts. The amendments in ASU
2010-28
modify Step 1 of the goodwill impairment test for reporting
units with zero or negative carrying amounts. For those
reporting units, an entity is required to perform Step 2 of the
goodwill impairment test if it is more likely than not that a
goodwill impairment exists. In determining whether it is more
likely than not that goodwill impairment exists, an entity
should consider whether there are any adverse qualitative
factors indicating that impairment may exist. ASU
2010-28 is
effective for fiscal years, and interim periods within those
years, beginning after December 15, 2010 for public
entities. Early adoption is not permitted. We will apply the
provisions of ASU
2010-29 on a
prospective basis.
In December 2010, the FASB issued ASU
2010-29,
Business Combinations (Topic 805): Disclosure of Supplementary
Pro Forma Information for Business Combinations. ASU
2010-29
specifies that when a public company completes a business
combination, the company should disclose revenue and earnings of
the combined entity as though the business combination occurred
as of the beginning of the comparable prior annual reporting
period. The update also expands the supplemental pro forma
disclosures under Topic 805 to include a description of the
nature and amount of material, non-recurring pro forma
adjustments directly attributable to the business combination
included in the pro forma revenue and earnings. The requirements
in ASU
2010-29 are
effective for business combinations that occur after the
beginning of the first annual reporting period beginning on or
after December 15, 2010. We will apply the provisions of
ASU 2010-29
on a prospective basis.
33
Results
of Operations
Summary
of Comprehensive Loss from All Operations
For the year ended December 31, 2010 we reported a
comprehensive loss attributable to Convertible Organics Inc. of
$50,562,336 compared to $21,105,788 for the year ended
December 31, 2009. The major components of this loss are as
follows:
|
|
|
|
|
|
|
|
|
|
|
Twelve months ending December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Loss from Continuing Operations
|
|
$
|
16,039,025
|
|
|
$
|
7,642,304
|
|
Loss from Discontinued Operations
|
|
|
34,690,358
|
|
|
|
13,463,484
|
|
Non-Controlling Interest and Foreign Currency
|
|
|
(167,047
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Comprehensive Loss Attributable to Converted Organics, Inc
|
|
|
50,562,336
|
|
|
|
21,105,788
|
|
|
|
|
|
|
|
|
|
|
Detail discussion of the above items is as follows:
Results
of Continuing Operations
For the year ended December 31, 2010 we had an after tax
net loss from continuing operations of $16.0 million
compared to $7.6 million for the year ended
December 31, 2009. The increase in the net loss of
$8.4 million is made up of the following favorable and
(unfavorable) major components, with further explanation and
details following the table:
|
|
|
$1,400,000
|
|
Increase in Sales
|
$(440,000)
|
|
Increase in Cost of Goods
|
$(7,500,000)
|
|
Increase in General and Administrative Expenses
|
$340,000
|
|
Decrease in R&D Expenses
|
$(6,000,000)
|
|
Decrease in Derivative Gains
|
$3,800,000
|
|
Decrease in Interest Expense
|
|
|
|
$(8,400,000)
|
|
Total Variance from Continuing Operations
|
|
|
|
For the year ended December, 2010, we had sales from continuing
operations of approximately $3.5 million compared to
$2.1 million for the year ended December 31. 2009. The
$1.4 million increase is composed of a $900,000 increase in
sales from our Gonzales facility (attributed to both an increase
in volume and price increases for some of our products), and a
$254,000 increase in sales from sales of our chicken
litter-based fertilizer product and $250,000 in sales from
TerraSphere licensing activities.
For the year ended December 31, 2010 we had cost of goods
sold from continuing operations of approximately
$2.5 million compared to $2.1 million cost of goods
sold for the same period in 2009. Of the approximately $443,000
increase in cost of goods, $309,000 is related to our Gonzales
facility and $134,000 is related to chicken litter fertilizer
product. For the Gonzales facility, in 2010 we had sales of
$3.0 million and cost of sales of $2.4 million, or a
gross margin of 20% (compared to only 1% gross margin in 2009).
However, for the $900,000 increase in sales over 2009 from
Gonzales, the cost of goods increased $309,000, generating a
gross margin of 65% on those incremental sales. We feel that
further increases in sales at the Gonzales facility will help
overall margin to increase as the increased sales are spread
over fixed costs at the facility. During 2010 we had sales from
our chicken based fertilizer products of $254,000 and cost of
goods of $134,000 generating a gross margin of 45%. We do not
expect sales from this product to continue into 2011.
We incurred General and Administrative expenses of approximately
$14.6 million and $7.1 million for the years ended
December 31, 2010 and 2009, respectively. The approximately
$7.5 million increase in general and administrative
expenses is due to increases of $1.5 million at the
corporate level related to additional personnel, non cash
compensation expense for the issuance of stock options, and
occupancy expenses; increased professional and consulting fees
of approximately $2.7 million due mainly to costs
associated with seeking potential acquisition candidates, as
well as increased sales and marketing costs of
$1.0 million. In addition, we incurred approximately
34
$2.3 million of General and Administrative expenses at
Terrasphere as we provided a reserve for certain accounts
receivable. We provided the reserve for accounts receivable at
December 31, 2010 as certain facts and circumstances
relating to collectibility of the receivables had changed since
the fair value was determined on the acquisition date.
We incurred Research and Development costs of $287,000 and
$626,000 for the years ended December 31, 2010 and 2009,
respectively. A major part of the decrease of $339,000 is
related to the impairment of a deposit on a second license of
$139,000, which was expensed in 2009. The remaining portion of
the decrease is due to less spending, as we had completed most
of our field testing on our products.
During 2010 we recognized derivative losses of approximately
$166,000 compared to derivative gains of $5.8 million for
2009 due to the
mark-to-market
adjustments of certain financial instruments. This item is a
noncash loss and did not use cash for the 2010 loss nor did it
contribute cash for the gain recorded in 2009.
Interest expense for the years ended December 31, 2010 and
2009 was $1.7 million and $5.5 million, respectively.
Interest expense in 2010 was associated with various notes held
by the company of approximately $200,000 and a non cash interest
expense of approximately $1,500,000 associated with the
derivative elements contained in our convertible debt, while the
components of interest expense for the year ended
December 31, 2009 are: (i) recognition of $562,000 of
interest expense associated with the extension of the
convertible debentures issued in January 2008, which became due
in January 2009 and which were extended until July 2009
(200,000 shares of Common Stock were issued in connection
with such extension), (ii) recognition of approximately
$660,000 of interest expense associated with the issuance of
warrants in connection with the March 6, 2009 financing
arrangement with the holders of our bonds, and approximately
$800,000 of interest expense associated with the issuances of
warrants related to the short-term non-convertible notes,
(iii) recognition of approximately $279,000 on our other
various borrowings, and (iv) recognition of approximately
$3.2 million in amortization of discounts on our financing
arrangement during the year ended December 31, 2009.
As of December 31, 2010, we had current assets of
approximately $4.3 million compared to $12.6 million
as of December 31, 2009. Our total assets were
approximately $19.6 million as of December 31, 2010
compared to approximately $35.1 million as of
December 31, 2009. The majority of the decrease in current
assets from December 31, 2009 to December 31, 2010 is
due to a decrease in cash used to operate the business and a
majority of the decrease in long term assets is represented by
the impairment of our Woodbridge, NJ facility of
$15.4 million offset by an increase in intangible assets if
approx $10.4 million generated as a result of the
TerraSphere Systems acquisition.
As of December 31, 2010, we had current liabilities of
approximately $7.7 million compared to $6.2 million at
December 31, 2009. This increase is due largely to an
increase in accounts payable and term notes payable offset by a
decrease in liabilities relating to discontinued operations. In
addition, we had long-term liabilities of approximately
$8.6 million as of December 31, 2010 as compared to
$20.1 million at December 31, 2009. The decrease is
due to settlement of long term liabilities associated with
discontinued operations ($18.5 million) offset by an
increase in derivative liabilities ($7.0 million).
For the year ended December 31, 2010 we had negative cash
flows from operating activities of approximately
$11.5 million, comprising loss from operations of
$50.7 million adjusted for certain non-cash items such as
depreciation, non-cash interest expense associated with the
issuance of convertible debt, the write-down of impaired assets
at our Woodbridge facility, amortization of deferred financing
fees, an early termination lease penalty and an increase in
accounts payable and accrued expenses. We also had negative cash
flows from investing activities of $400,000, primarily related
to purchase of fixed assets off-set by the release of restricted
cash The negative cash flows from both operating and investing
activities was offset by approximately $4.3 million in
positive cash flows from financing activities comprising
proceeds from our various debt and equity transactions. The
result of the above activities decreased our cash position by
approximately $7.6 million from December 31, 2009.
For the year ended December 31, 2009 we had negative cash
flow from operating activity of approximately $11 million,
comprising loss from operations of $21 million adjusted for
certain non-cash items such as derivative gains, depreciation,
non-cash interest expense associated with the issuance of
warrants, the write-down of impaired assets, amortization of
deferred financing fees and amortization of discounts on private
financing, and an increase in
35
accounts payable and accrued expenses. We also had negative cash
flow from investing activities of $2.5 million, primarily
related to construction at the New Jersey facility, offset by
the release of restricted cash set aside for that purpose. The
negative cash flow from both operating and investing activities
was offset by approximately $20.7 million in positive cash
flow from financing activities comprising proceeds from our
various debt and equity transactions. The result of the above
activities increased our cash position approximately
$7.3 million over our balance at December 31, 2008.
Results
of Discontinued Operations
On July 30, 2010, the Company temporarily halted production
at its Woodbridge facility in order to undertake steps to lower
its cost structure at the Woodbridge facility. Specifically, the
Company attempted to negotiate more favorable terms under its
operating lease and to lower certain utility costs. The Company
was unable to lower such costs and therefore, management
determined that the Company could not sustain the negative cash
flow from the Woodbridge facility and discontinued operations at
the Woodbridge plant during the quarter ended September 30,
2010. As a result, during the quarter ended September 30,
2010, the Company recognized an impairment charge on the
long-lived assets of the Woodbridge facility to reduce the
carrying value of the those assets to approximately
$1.5 million, which is the value that was expected to be
received from the disposition of those assets. The consolidated
statements of operations and comprehensive loss includes an
impairment charge pertaining to those long-lived assets of
approximately $15.4 million which is included in loss from
discontinued operations.
On October 18, 2010, the bonds payable and related accrued
interest totaling approximately $18.5 million were settled
and extinguished for $17.5 million of Company preferred
stock (See Note 11). In addition, as described below, the
Company entered into a series of transactions on
October 18, 2010 whereby certain assets and liabilities
were assigned, transferred and or extinguished.
On October 18, 2010, the Company and the Woodbridge
facilitys landlord (Lessor) entered into a
Termination and Surrender Agreement (Termination
Agreement) related to the termination of the Woodbridge
Facility lease. Pursuant to the Termination Agreement, the
Lessor and the Company agreed to terminate the lease
surrendering the premises and transferring all equipment, tools
and fixtures owned by the Company and presently located at the
premises. Under the lease, there were approximately
$9.1 million of future rental payments. In addition, the
Lessor asserted claims for (i) unpaid sewer and trash
removal charges; (ii) unpaid rent due Lessor for prior
periods; (iii) certain costs and expenses incurred by
Lessor in connection with certain litigation; (iv) damages
that may result from the condition of the premises at the time
of surrender; and (v) the required removal and disposal of
abandoned inventory and materials totaling approximately
$2.4 million. Pursuant to the terms of the Termination
Agreement, the Company agreed to transfer the Woodbridge
facilitys assets to the Lessor with a carrying value of
approximately $1.5 million and to issue the Lessor a total
of 892,857 shares of Company common stock valued at $0.56
per share totaling $500,000 and to surrender deposits totaling
$415,000 with the Lessor in exchange for settlement of the
asserted claims of approximately $2.4 million.
On October 18, 2010, the Superior Court of the State of
California for the County of Los Angeles entered an Order in the
matter entitled American Capital Management, LLC
(ACM) v. Converted Organics Inc. and Converted
Organics of Woodbridge, LLC and Does 1-10 Inclusive (the
Order). The Order provides for the full and final
settlement of $11.3 million of claims against the Company
held by ACM. The claims include the future rental payments of
$9.1 million discussed above, as well as approximately
$1.7 million of promissory notes issued by the Company to
four contractors that had provided services to the Woodbridge
Facility (See Note 11) and approximately $400,000 for
other facility costs which were acquired by ACM from the Lessor.
ACM purchased the claims from these parties pursuant to separate
claims purchase agreements. Pursuant to the terms of the Order,
the Company agreed to issue to ACM a total of
20,726,980 shares of Company common stock valued at $0,543
per share totaling $11.3 million in full and final
settlement of the claims.
The loss recognized on disposal includes the $9.1 million
loss on early termination of the lease, approximately $796,000
of prepaid facility costs and approximately $400,000 of other
facility costs, net of a gain of $1.0 million for bond
interest waived in conjunction with the settlement and
extinguishment of the bonds payable as described above.
36
The following table summarizes the components of the loss from
discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Revenue from discontinued operations
|
|
$
|
830,814
|
|
|
$
|
497,062
|
|
|
|
|
|
|
|
|
|
|
Results from discontinued operations including write downs to
fair value of $15.4 million in 2010 and $3.9 million
in 2009
|
|
$
|
(25,352,449
|
)
|
|
$
|
(13,463,484
|
)
|
Loss recognized on disposal
|
|
|
(9,337,909
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
34,690,358
|
|
|
$
|
13,463,484
|
|
|
|
|
|
|
|
|
|
|
The Company does not expect to have any continuing cash flows
from operations associated with the Woodbridge facility.
The following table provides the assets and liabilities of the
Woodbridge facility, classified as discontinued operations, in
the consolidated balance sheets dated December 31, 2010 and
2009:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Accounts receivable, net
|
|
$
|
14,500
|
|
|
$
|
59,746
|
|
Inventories
|
|
|
|
|
|
|
272,396
|
|
Prepaid expenses
|
|
|
|
|
|
|
629,933
|
|
Property and equipment, net
|
|
|
|
|
|
|
17,935,216
|
|
Deposits
|
|
|
|
|
|
|
444,329
|
|
Capitalized bond costs, net
|
|
|
|
|
|
|
814,341
|
|
|
|
|
|
|
|
|
|
|
Assets of discontinued operations
|
|
$
|
14,500
|
|
|
$
|
20,155,961
|
|
|
|
|
|
|
|
|
|
|
Term notes payable
|
|
$
|
|
|
|
$
|
3,247,752
|
|
Accounts payable
|
|
|
837,606
|
|
|
|
1,237,275
|
|
Accrued expenses
|
|
|
1,571,874
|
|
|
|
950,782
|
|
Other liabilities
|
|
|
28,773
|
|
|
|
40,575
|
|
Bonds payable
|
|
|
|
|
|
|
17,500,000
|
|
|
|
|
|
|
|
|
|
|
Liabilities of discontinued operations
|
|
$
|
2,438,253
|
|
|
$
|
22,976,384
|
|
|
|
|
|
|
|
|
|
|
Off-Balance
Sheet Transactions
We do not engage in material off-balance sheet transactions
|
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
As a smaller reporting company, we are not required to provide
information typically disclosed under this section.
37
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
CONVERTED
ORGANICS INC.
INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
|
39
|
|
Consolidated Balance Sheets at December 31, 2010 and 2009
|
|
|
40
|
|
Consolidated Statements of Operations for the years ended
December 31, 2010 and 2009
|
|
|
41
|
|
Consolidated Statements of Changes in Stockholders Equity
for the years ended December 31, 2010 and 2009
|
|
|
42
|
|
Consolidated Statements of Cash Flows for the years ended
December 31, 2010 and 2009
|
|
|
43
|
|
Notes to Consolidated Financial Statements
|
|
|
44
|
|
38
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors of Converted Organics
Inc.
We have audited the accompanying consolidated balance sheets of
Converted Organics Inc. and subsidiaries (the
Company) as of December 31, 2010 and 2009, and
the related consolidated statements of operations and
comprehensive loss, changes in stockholders equity and
cash flows for the years then ended. These consolidated
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial
statements are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of
its internal control over financial reporting. Our audits
included consideration of internal control over financial
reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Companys
internal control over financial reporting. Accordingly, we
express no such opinion. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the
consolidated financial statements, assessing the accounting
principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of Converted Organics Inc. and subsidiaries as of
December 31, 2010 and 2009, and the results of their
operations and their cash flows for the years then ended, in
conformity with accounting principles generally accepted in the
United States of America.
The accompanying consolidated financial statements have been
prepared assuming that Converted Organics Inc. and subsidiaries
will continue as a going concern. As reflected in the
consolidated financial statements, the Company has an
accumulated deficit at December 31, 2010 and has suffered
significant net losses and negative cash flows from operations,
which raise substantial doubt about the Companys ability
to continue as a going concern. Managements plans with
regard to these matters are disclosed in Note 2 to the
consolidated financial statements. The consolidated financial
statements do not include any adjustments that might result from
the outcome of this uncertainty.
Glastonbury, Connecticut
March 31, 2011
39
|
|
Item 1.
|
Financial
Statements
|
CONVERTED
ORGANICS INC.
DECEMBER 31, 2010 AND 2009
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
ASSETS
|
CURRENTASSETS
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
3,039,941
|
|
|
$
|
10,708,807
|
|
Restricted cash
|
|
|
|
|
|
|
613,162
|
|
Accounts receivable, net
|
|
|
579,946
|
|
|
|
80,911
|
|
Inventories
|
|
|
126,406
|
|
|
|
176,351
|
|
Prepaid expenses and other assets
|
|
|
251,589
|
|
|
|
73,194
|
|
Deferred financing costs, net
|
|
|
276,667
|
|
|
|
|
|
Current assets of discontinued operations
|
|
|
14,500
|
|
|
|
962,075
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
4,289,049
|
|
|
|
12,614,500
|
|
|
|
|
|
|
|
|
|
|
Deposits and other non-current assets
|
|
|
575,596
|
|
|
|
336,357
|
|
Property and equipment, net
|
|
|
1,477,589
|
|
|
|
1,002,709
|
|
Goodwill
|
|
|
1,667,957
|
|
|
|
|
|
Intangible assets, net
|
|
|
11,629,265
|
|
|
|
1,995,619
|
|
Non-current assets of discontinued operations
|
|
|
|
|
|
|
19,193,886
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
19,639,456
|
|
|
$
|
35,143,071
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Term note payable
|
|
$
|
350,000
|
|
|
$
|
|
|
Note payables related party
|
|
|
72,351
|
|
|
|
|
|
Accounts payable
|
|
|
2,393,388
|
|
|
|
552,057
|
|
Accrued expenses
|
|
|
656,412
|
|
|
|
843,203
|
|
Convertible notes payable, net of unamortized discount
|
|
|
306,404
|
|
|
|
355,164
|
|
Obligation to issue shares
|
|
|
1,560,715
|
|
|
|
|
|
Derivative liabilities current
|
|
|
5,199,572
|
|
|
|
|
|
Liabilities of discontinued operations
|
|
|
2,438,253
|
|
|
|
4,475,303
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
12,977,095
|
|
|
|
6,225,727
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
|
3,476,047
|
|
|
|
1,626,742
|
|
Convertible note payable, net of current portion
|
|
|
|
|
|
|
17,767
|
|
Non-current liabilities of discontinued operations
|
|
|
|
|
|
|
18,501,081
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
16,453,142
|
|
|
|
26,371,317
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES
|
|
|
|
|
|
|
|
|
STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
Preferred stock, $.0001 par value, authorized
10,000,000 shares; 17,500 ($1,000 stated value) shares
issued and outstanding
|
|
|
17,500,000
|
|
|
|
|
|
Common stock, $.0001 par value, authorized
250,000,000 shares at December 31, 2010 and
75,000,000 shares at December 31, 2009
|
|
|
8,547
|
|
|
|
3,777
|
|
Additional paid-in capital
|
|
|
85,555,990
|
|
|
|
58,660,042
|
|
Accumulated deficit
|
|
|
(100,453,292
|
)
|
|
|
(49,892,065
|
)
|
Accumulated other comprehensive loss
|
|
|
(1,109
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,610,136
|
|
|
|
8,771,754
|
|
Noncontrolling interests
|
|
|
576,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
3,186,314
|
|
|
|
8,771,754
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
19,639,456
|
|
|
$
|
35,143,071
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
40
CONVERTED
ORGANICS INC.
FOR THE YEARS ENDED DECEMBER 31, 2010 AND
2009
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Revenues
|
|
$
|
3,525,325
|
|
|
$
|
2,136,720
|
|
Cost of goods sold
|
|
|
2,522,305
|
|
|
|
2,079,740
|
|
|
|
|
|
|
|
|
|
|
Gross income
|
|
|
1,003,020
|
|
|
|
56,980
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
14,625,568
|
|
|
|
7,123,603
|
|
Research and development
|
|
|
287,550
|
|
|
|
626,652
|
|
Amortization of intangibles
|
|
|
367,461
|
|
|
|
288,007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,280,579
|
|
|
|
8,038,262
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations
|
|
|
(14,277,559
|
)
|
|
|
(7,981,282
|
)
|
Other income/(expenses)
|
|
|
|
|
|
|
|
|
Other income
|
|
|
131,197
|
|
|
|
23,524
|
|
Derivative gain (loss)
|
|
|
(166,712
|
)
|
|
|
5,766,035
|
|
Interest expense
|
|
|
(1,725,951
|
)
|
|
|
(5,450,581
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,761,466
|
)
|
|
|
338,978
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations before provision for income taxes
|
|
|
(16,039,025
|
)
|
|
|
(7,642,304
|
)
|
Provision for income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations
|
|
|
(16,039,025
|
)
|
|
|
(7,642,304
|
)
|
Loss from discontinued operations
|
|
|
(34,690,358
|
)
|
|
|
(13,463,484
|
)
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(50,729,383
|
)
|
|
|
(21,105,788
|
)
|
Net loss attributable to noncontrolling interest
|
|
|
(168,156
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to Converted Organics Inc. before other
comprehensive loss
|
|
|
(50,561,227
|
)
|
|
|
(21,105,788
|
)
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
|
(1,373
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
(50,562,600
|
)
|
|
|
(21,105,788
|
)
|
Comprehensive loss attributable to noncontrolling interest
|
|
|
(264
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss attributable to Converted Organics Inc.
|
|
$
|
(50,562,336
|
)
|
|
$
|
(21,105,788
|
)
|
|
|
|
|
|
|
|
|
|
Net loss per share, basic and diluted
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
(0.34
|
)
|
|
$
|
(0.39
|
)
|
Discontinued operations
|
|
|
(0.74
|
)
|
|
|
(0.69
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(1.08
|
)
|
|
$
|
(1.08
|
)
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
46,838,001
|
|
|
|
19,569,853
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
41
CONVERTED
ORGANICS INC.
FOR THE YEARS ENDED DECEMBER 31, 2010 AND
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Converted Organics Inc.
|
|
|
|
|
|
|
|
|
|
Preferred Stock Series A
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
Shares
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
Non-
|
|
|
Total
|
|
|
|
Issued and
|
|
|
|
|
|
Issued and
|
|
|
|
|
|
Paid-in
|
|
|
Members
|
|
|
Accumulated
|
|
|
Comprehensive
|
|
|
|
|
|
Controlling
|
|
|
Stockholders
|
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Capital
|
|
|
Equity
|
|
|
Deficit
|
|
|
Loss
|
|
|
Total
|
|
|
Interests
|
|
|
Equity
|
|
|
Balance, January 1, 2009, before cumulative effect of
change in accounting principle
|
|
|
|
|
|
$
|
|
|
|
|
7,431,436
|
|
|
$
|
743
|
|
|
$
|
31,031,647
|
|
|
$
|
619,657
|
|
|
$
|
(26,605,115
|
)
|
|
$
|
|
|
|
$
|
5,046,932
|
|
|
$
|
|
|
|
$
|
5,046,932
|
|
Cumulative effect of a change in accounting principle
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,936,250
|
)
|
|
|
|
|
|
|
(2,146,858
|
)
|
|
|
|
|
|
|
(5,083,108
|
)
|
|
|
|
|
|
|
(5,083,108
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2009, after cumulative effect of change
in accounting principle
|
|
|
|
|
|
|
|
|
|
|
7,431,436
|
|
|
|
743
|
|
|
|
28,095,397
|
|
|
|
619,657
|
|
|
|
(28,751,973
|
)
|
|
|
|
|
|
|
(36,176
|
)
|
|
|
|
|
|
|
(36,176
|
)
|
Members contributions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
915,651
|
|
|
|
|
|
|
|
|
|
|
|
915,651
|
|
|
|
|
|
|
|
915,651
|
|
Members distributions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(201,630
|
)
|
|
|
|
|
|
|
|
|
|
|
(201,630
|
)
|
|
|
|
|
|
|
(201,630
|
)
|
Deconsolidation of former variable interest entity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,367,982
|
)
|
|
|
|
|
|
|
|
|
|
|
(1,367,982
|
)
|
|
|
|
|
|
|
(1,367,982
|
)
|
Common stock issued to holders of convertible notes payable in
connection with extension
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
|
20
|
|
|
|
561,980
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
562,000
|
|
|
|
|
|
|
|
562,000
|
|
Common stock issued upon conversion of convertible notes payable
|
|
|
|
|
|
|
|
|
|
|
7,779,644
|
|
|
|
778
|
|
|
|
6,419,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,420,251
|
|
|
|
|
|
|
|
6,420,251
|
|
Common stock issued as compensation for services
|
|
|
|
|
|
|
|
|
|
|
151,528
|
|
|
|
15
|
|
|
|
139,198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
139,213
|
|
|
|
|
|
|
|
139,213
|
|
Warrants issued in connection with release of restricted cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
662,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
662,479
|
|
|
|
|
|
|
|
662,479
|
|
Issuance of stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,064
|
|
|
|
|
|
|
|
222,064
|
|
Common stock issued upon exercise of warrants
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
150
|
|
|
|
1,964,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,965,000
|
|
|
|
|
|
|
|
1,965,000
|
|
Issuance of common stock
|
|
|
|
|
|
|
|
|
|
|
20,711,600
|
|
|
|
2,071
|
|
|
|
20,594,601
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,596,672
|
|
|
|
|
|
|
|
20,596,672
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,304
|
|
|
|
(21,140,092
|
)
|
|
|
|
|
|
|
(21,105,788
|
)
|
|
|
|
|
|
|
(21,105,788
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
37,774,208
|
|
|
|
3,777
|
|
|
|
58,660,042
|
|
|
|
|
|
|
|
(49,892,065
|
)
|
|
|
|
|
|
|
8,771,754
|
|
|
|
|
|
|
|
8,771,754
|
|
Issuance of stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,310,252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,310,252
|
|
|
|
|
|
|
|
1,310,252
|
|
Common stock issued upon conversion of convertible notes payable
and accrued interest
|
|
|
|
|
|
|
|
|
|
|
646,500
|
|
|
|
65
|
|
|
|
413,894
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
413,959
|
|
|
|
|
|
|
|
413,959
|
|
Common stock issued as compensation for services
|
|
|
|
|
|
|
|
|
|
|
650,811
|
|
|
|
66
|
|
|
|
441,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
442,040
|
|
|
|
|
|
|
|
442,040
|
|
Issuance of common stock and warrants, net of
fair value of derivatives issued of $968,096
|
|
|
|
|
|
|
|
|
|
|
2,400,000
|
|
|
|
240
|
|
|
|
1,398,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,398,264
|
|
|
|
|
|
|
|
1,398,264
|
|
Issuance of common stock and warrants as
payment of accounts payable
|
|
|
|
|
|
|
|
|
|
|
2,780,740
|
|
|
|
278
|
|
|
|
1,501,322
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,501,600
|
|
|
|
|
|
|
|
1,501,600
|
|
Common stock issued upon exercise of employee stock options
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
5
|
|
|
|
33,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,000
|
|
|
|
|
|
|
|
34,000
|
|
Issuance of common stock as payment to settle obligations of
discontinued operations
|
|
|
|
|
|
|
|
|
|
|
21,619,837
|
|
|
|
2,162
|
|
|
|
11,752,588
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,754,750
|
|
|
|
|
|
|
|
11,754,750
|
|
Issuance of common stock related to the acquisition of
TerraSphere Systems, LLC
|
|
|
|
|
|
|
|
|
|
|
18,174,603
|
|
|
|
1,817
|
|
|
|
9,564,036
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,565,853
|
|
|
|
648,644
|
|
|
|
10,214,497
|
|
Issuance of common stock related to the acquisition of
GoLocalProduceRI, LLC
|
|
|
|
|
|
|
|
|
|
|
1,371,428
|
|
|
|
137
|
|
|
|
479,863
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
480,000
|
|
|
|
95,954
|
|
|
|
575,954
|
|
Issuance of preferred stock as payment of bond obligation
|
|
|
17,500
|
|
|
|
17,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,500,000
|
|
|
|
|
|
|
|
17,500,000
|
|
Foreign currency translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,109
|
)
|
|
|
(1,109
|
)
|
|
|
(264
|
)
|
|
|
(1,373
|
)
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(50,561,227
|
)
|
|
|
|
|
|
|
(50,561,227
|
)
|
|
|
(168,156
|
)
|
|
|
(50,729,383
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2010
|
|
|
17,500
|
|
|
$
|
17,500,000
|
|
|
|
85,468,127
|
|
|
$
|
8,547
|
|
|
$
|
85,555,990
|
|
|
$
|
|
|
|
$
|
(100,453,292
|
)
|
|
$
|
(1,109
|
)
|
|
$
|
2,610,136
|
|
|
$
|
576,178
|
|
|
$
|
3,186,314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
42
CONVERTED
ORGANICS INC.
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(50,729,383
|
)
|
|
$
|
(21,105,788
|
)
|
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Amortization expense
|
|
|
1,210,580
|
|
|
|
374,218
|
|
Depreciation and amortization expense of property and equipment
|
|
|
1,435,086
|
|
|
|
2,155,994
|
|
Provision for losses on accounts receivable
|
|
|
2,457,478
|
|
|
|
81,000
|
|
Amortization of discounts attributable to notes and warrants on
private financing
|
|
|
360,359
|
|
|
|
2,870,313
|
|
Interest expense in relation to issuance of convertible debt
|
|
|
1,368,695
|
|
|
|
1,475,678
|
|
Loss on disposal of discontinued operations
|
|
|
9,337,909
|
|
|
|
|
|
Common stock issued for extension of convertible note payable
|
|
|
|
|
|
|
562,000
|
|
Common stock issued as compensation
|
|
|
442,040
|
|
|
|
139,213
|
|
Stock option compensation expense
|
|
|
1,310,252
|
|
|
|
222,064
|
|
Loss on impairment of long lived assets
|
|
|
15,383,925
|
|
|
|
3,928,129
|
|
Warrants issued in connection with release of restricted cash
|
|
|
|
|
|
|
662,479
|
|
Obligations to issue shares revaluation
|
|
|
(123,214
|
)
|
|
|
|
|
Derivative loss (gain)
|
|
|
166,712
|
|
|
|
(5,766,035
|
)
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
(Increase) decrease in:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(104,792
|
)
|
|
|
19,784
|
|
Inventories
|
|
|
322,342
|
|
|
|
(159,018
|
)
|
Prepaid expenses and other current assets
|
|
|
(130,958
|
)
|
|
|
(239,261
|
)
|
Deposits and other non-current assets
|
|
|
280,551
|
|
|
|
376,042
|
|
Increase (decrease) in:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
2,804,450
|
|
|
|
2,869,851
|
|
Accrued expenses
|
|
|
2,705,381
|
|
|
|
714,900
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(11,502,587
|
)
|
|
|
(10,818,437
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(656,095
|
)
|
|
|
(3,923,715
|
)
|
Release of restricted cash
|
|
|
613,162
|
|
|
|
1,994,958
|
|
Deconsolidation of variable interest entity
|
|
|
|
|
|
|
(596,170
|
)
|
Patent costs
|
|
|
(1,106
|
)
|
|
|
|
|
Cash acquired in acquisitions
|
|
|
98,276
|
|
|
|
|
|
Purchase of other assets
|
|
|
(500,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(445,763
|
)
|
|
|
(2,524,927
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Repayment of debt obligations
|
|
|
(1,542,753
|
)
|
|
|
(4,466,891
|
)
|
Repayment of capital lease obligations
|
|
|
(11,802
|
)
|
|
|
(12,403
|
)
|
Members contributions
|
|
|
|
|
|
|
230,983
|
|
Members distributions
|
|
|
|
|
|
|
(201,630
|
)
|
Advances from (payments to) related party
|
|
|
(10,000
|
)
|
|
|
|
|
Net proceeds from exercise of options
|
|
|
34,000
|
|
|
|
|
|
Net proceeds from stock offering
|
|
|
2,366,360
|
|
|
|
20,596,672
|
|
Net proceeds from exercise of warrants
|
|
|
|
|
|
|
1,965,000
|
|
Net proceeds from short-term notes
|
|
|
3,444,555
|
|
|
|
2,582,500
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
4,280,360
|
|
|
|
20,694,231
|
|
|
|
|
|
|
|
|
|
|
Net effect of exchange rate changes on cash
|
|
|
(876
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCREASE (DECREASE) IN CASH
|
|
|
(7,668,866
|
)
|
|
|
7,350,867
|
|
Cash, beginning of year
|
|
|
10,708,807
|
|
|
|
3,357,940
|
|
|
|
|
|
|
|
|
|
|
Cash, end of year
|
|
$
|
3,039,941
|
|
|
$
|
10,708,807
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information:
|
|
|
|
|
|
|
|
|
Cash paid during the period for:
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
952,350
|
|
|
$
|
1,665,990
|
|
Non-cash financing activities:
|
|
|
|
|
|
|
|
|
Equipment acquired through assumption of capital lease
|
|
$
|
|
|
|
$
|
52,979
|
|
Equipment acquired through assumption of term note
|
|
|
|
|
|
|
118,250
|
|
Common stock issued upon conversion of convertible notes payable
and accrued interest
|
|
|
413,959
|
|
|
|
6,420,251
|
|
Fair value of derivatives issued in conjunction with debt and
equity financing
|
|
|
6,882,165
|
|
|
|
3,827,686
|
|
Common stock and warrants issued as payment for accounts payable
|
|
|
1,501,600
|
|
|
|
|
|
Fair value of contingent consideration in relation to acquisition
|
|
|
1,683,929
|
|
|
|
|
|
Issuance of common stock in conjunction with the acquisitions
|
|
|
10,045,853
|
|
|
|
|
|
Discount on convertible note issued in connection with financings
|
|
|
3,750,000
|
|
|
|
2,870,313
|
|
Preferred stock issued in satisfaction of bonds payable
|
|
|
17,500,000
|
|
|
|
|
|
Common stock issued as settlement of discontinued operations
obligations
|
|
|
11,754,750
|
|
|
|
|
|
Members contribution of convertible note
|
|
|
|
|
|
|
684,668
|
|
Conversion of accounts payable into notes payable
|
|
|
|
|
|
|
4,663,039
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
43
CONVERTED
ORGANICS INC.
NOTE 1
NATURE OF OPERATIONS
Converted Organics Inc. and its subsidiaries (collectively
the Company) utilize innovative clean
technologies to establish and operate environmentally friendly
businesses. The Company is dedicated to creating a cleaner,
greener future, and operates using sustainable business
practices that support this vision. The Company operates in
three business areas: Organic Fertilizer, Industrial Wastewater
Treatment and Vertical Farming.
Organic Fertilizer: The Company operates a
processing facility that converts food waste and other raw
materials into all-natural fertilizers, biostimulants, and soil
amendment products.
Industrial Wastewater Treatment: Utilizing an
innovative wastewater treatment process, Converted
Organics Industrial Wastewater Resources business
(IWWR) provides a means of treating aqueous waste
streams. This technology, which can use waste heat and renewable
energy as fuel, produces only two byproducts: clean water vapor
and landfill-appropriate solid residuals. IWWR is in the
developmental stage at December 31, 2010.
Vertical Farming: The Company engages in
vertical farming through our TerraSphere business, which builds
efficient systems for growing pesticide-free organic produce in
a controlled indoor environment using its patented technology.
A summary of the subsidiaries that comprise of the Company are
as follows:
Converted Organics of California, LLC (the Gonzales
facility), is a California limited liability company and
wholly-owned subsidiary of the Company. The Gonzales facility
operates a plant in Gonzales, California, in the Salinas Valley
and produces approximately 25 tons of organic fertilizer per
day, which is sold primarily to the California agricultural
market. The Gonzales facility employs a proprietary method
called High Temperature Liquid Composting (HTLC).
The facility has been upgraded to enable it to accept larger
amounts of food waste from waste haulers and may be upgraded,
depending on demand, to have the capability to produce a dry
product in addition to the current liquid fertilizer it produces.
Converted Organics of Woodbridge, LLC, is a New Jersey limited
liability company and wholly-owned subsidiary of the Company,
which was formed for the purpose of owning, constructing and
operating the Companys facility in Woodbridge, New Jersey
(the Woodbridge facility). The Woodbridge facility
was designed to service the New York-Northern New Jersey
metropolitan area. During the third quarter of 2010, the Company
discontinued operations at the Woodbridge plant. The Company has
reported the results of operations of Converted Organics of
Woodbridge, LLC as discontinued operations for the years ended
December 31, 2010 and 2009 within the consolidated
financial statements (See Note 5).
Converted Organics of Rhode Island, LLC, a Rhode Island limited
liability company and subsidiary of the Company, was formed in
July 2008 for the purpose of developing a facility at the Rhode
Island central landfill. Converted Organics of Rhode Island, LLC
has not had any activity since its formation. On
February 25, 2010, the Company signed a letter of intent
with the owners of the non-controlling interest in Converted
Organics of Rhode Island, LLC to sell substantially all of its
assets and a limited select amount of liabilities to the Rhode
Island Resource Recovery Corporation (RIRRC). No
sale has not taken place as of December 31, 2010.
On January 26, 2010, the Company formed Converted Organics
of Mississippi, LLC, a Mississippi limited liability company and
a wholly-owned subsidiary of the Company, for the purpose of
hiring a sales force and adding a poultry litter-based
fertilizer product to the Companys existing product lines.
The Company outsourced production of this product.
On May 20, 2010, the Company formed TerraSphere
Inc.(TerraSphere), a Delaware corporation and a
wholly-owned subsidiary of the Company, for the purpose of
acquiring the membership interests of TerraSphere Systems LLC
(TerraSphere Systems). On November 12, 2010,
TerraSphere acquired a 95% membership interest in TerraSphere
Systems (See Note 4). TerraSphere Systems has two
subsidiaries, wholly owned PharmaSphere, LLC
(PharmaSphere) and majority owned TerraSphere
Systems Canada, Inc. (TerraSphere Canada).
44
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 1
NATURE OF OPERATIONS Continued
PharmaSpheres business plan is to utilize the TerraSphere
Systems patented technology for the production of high
value biocompounds sourced from plants and used as active
pharmaceutical ingredients and for the production of transgenic
plants (genetically engineered plants) for the biotechnology
market. PharmaSphere has a wholly-owned subsidiary PharmaSphere
Worcester, LLC, which was formed to build a facility in
Worcester, Massachusetts utilizing PharmaSpheres business
plan. The building of the facility has not commenced.
PharmaSphere has no revenue to date. TerraSphere Canada, located
in Vancouver, British Columbia, operates the research and
manufacturing facility for TerraSphere and is eighty-five
percent owned by TerraSphere Systems.
On December 30, 2010, Converted Organic, Inc. purchased a
majority ownership interest of the vertical farming entity,
GoLocalProduceRI, LLC located in Rhode Island, marking its
entrance into the vertical farming industry as owners and
operators of what is expected to be the first TerraSphere
facility in the United States (See Note 4).
NOTE 2
GOING CONCERN
As reflected in consolidated financial statements for the year
ended December 31, 2010, the Company incurred a net loss of
approximately $50.7 million, and as of December 31,
2010 had an accumulated deficit of $100.5 million and had a
working capital deficiency of $8.7 million. During 2010,
the Company discontinued the operations at its Woodbridge
facility, acquired a license to treat Industrial Waste Water and
acquired the TerraSphere business. In addition to these events
the Company currently has manufacturing capabilities at its
Gonzales facility as a means to generate revenues and cash.
Although the California operations are currently cash flow
positive, the anticipated costs associated with corporate
overhead and for the operations of TerraSphere will cause the
Company to have negative cash flow in 2011. In addition, the
Company feels that it will require cash, either through
financing or equity transactions, in order to build out the IWWR
and TerraSphere projects planned for 2011. The Company feels
that if it achieves planned sales from its California facility,
establishes additional operational Industrial Wastewater sites,
and completes the construction of a TerraSphere facility, then
the Company will become cash flow positive in the future. In
order to achieve these goals, however, additional financing will
be needed.
Presently, our liquidity is limited to our cash on hand at
December 31, 2010 ($3.0 million) and the
$1.0 million that we received on March 3, 2011 as a
result of the sale of the additional notes available under our
December 17, 2010 financing agreement. In addition, on
February 28, 2011 we received shareholder approval to
permit the investor in the December 17, 2010 financing
agreement to exercise certain of its warrants, which could
provide us with an additional $4.9 million. However, since
receiving shareholder approval our stock price has closed at
both above and below the exercise price of these warrants, and
it is not likely that any warrants would be exercised unless the
price of our stock was greater than the exercise price of the
warrants. There is no assurance that the investor will exercise
the warrants, and as such, we may not receive these funds. As a
result of this uncertainty, we have entered into discussions
with an investor who would make funds available with a
convertible note under similar terms to our December 17,
2010 financing agreement, though such an arrangement has not
been finalized.
If we do not receive additional funds in excess of the amount of
cash on hand, whether as a result of the exercise of the
warrants issued in our December 2010 financing, execution of the
contemplated convertible note, or otherwise, we will not be able
to continue our operations once the cash on hand is utilized.
Even in the event that we do receive additional funds, there is
no guarantee that such funds will be sufficient to continue
operations until we achieve a positive cash flow position. At
this time we do not have any commitments for additional
financing, and there is no assurance that capital in any form
will be available to us on terms and conditions that are
acceptable or at all.
The Company has entered into discussions with an investor, who
would execute a convertible note under an agreement similar to
our December 17, 2010 financing agreement. There is no
guarantee that this transaction will be completed. Even if the
Company does receive this cash, it may be insufficient to last
until the Company becomes cash flow positive, in which case it
would not be able to continue operating.
45
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES
OF CONSOLIDATION AND BASIS OF PRESENTATION
The accompanying consolidated financial statements include the
balances of Converted Organics Inc. and its wholly-owned
subsidiaries, Converted Organics of California, LLC, Converted
Organics of Woodbridge, LLC, Converted Organics of Mississippi,
LLC and its majority-owned subsidiaries TerraSphere Inc.,
Converted Organics of Rhode Island, LLC and GoLocalProduceRI,
LLC. The minority-owned interest owned in its subsidiaries is
included in the Companys consolidated financial statements
as noncontrolling interest. All intercompany transactions and
balances have been eliminated in consolidation.
The preparation of consolidated financial statements in
conformity with accounting principles generally accepted in the
United States of America requires management to make estimates
and assumptions that affect the reported amounts and disclosures
in the consolidated financial statements. Actual results could
differ from those estimates.
FOREIGN
OPERATIONS
The accounting records of TerraSphere Canada are maintained in
Canadian dollars, its functional currency. Revenue and expense
transactions are translated to U.S. dollars using the
average exchange rate of the month in which the transaction took
place. Assets and liabilities are translated to
U.S. dollars using the exchange rate in effect as of the
balance sheet date. Equity transactions are translated to
U.S. dollars using the exchange rate in effect as of the
date of the equity transaction. Translation gains and losses are
reported as a component of accumulated other comprehensive
income or loss. Gains and losses resulting from transactions
which are denominated in other than functional currencies are
reported as foreign currency exchange gain or loss in the
statements of operations and comprehensive loss in the period
the gain or loss occurred.
CASH
AND CASH EQUIVALENTS
The Company defines cash equivalents as highly liquid
instruments with an original maturity of three months or less.
The Company had no cash equivalents at December 31, 2010
and 2009.
ACCOUNTS
RECEIVABLE
Accounts receivable represents balances due from customers, net
of applicable reserves for doubtful accounts. In determining the
need for an allowance, objective evidence that a single
receivable is uncollectible, as well as historical collection
patterns for accounts receivable are considered at each balance
sheet date. At December 31, 2010 and 2009, an allowance for
doubtful accounts of approximately $2,370,000 and $50,000 has
been established, respectively, against certain receivables that
management has identified as uncollectible. A charge of
approximately $2,320,000 and $34,000 is reflected in the
consolidated statements of operations and comprehensive loss for
the years ended December 31, 2010 and 2009, respectively,
to provide for doubtful accounts.
INVENTORIES
Inventories are valued at the lower of cost or market, with cost
determined by the first in, first out method. Inventories
consist primarily of raw materials, packaging materials and
finished goods, which consist of soil amendment products.
Inventory balances are presented net of applicable reserves.
There were no inventory reserves at December 31, 2010 or
2009.
GOODWILL
The Company evaluates the carrying value of goodwill during the
fourth quarter of each year and when events occur or
circumstances change that would more likely than not reduce the
fair value of the reporting unit below its
46
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING
POLICIES Continued
carrying amount. Such circumstances could include, but are not
limited to (1) a significant adverse change in legal
factors or in business climate, (2) unanticipated
competition, or (3) an adverse action or assessment by a
regulator. When evaluating whether goodwill is impaired, the
Company compares the fair value of the reporting unit to which
the goodwill is assigned to the reporting units carrying
amount, including goodwill. The fair value of the reporting unit
is estimated using a combination of the income, or discounted
cash flows, approach and the market approach, which utilizes
comparable companies data. If the carrying amount of a
reporting unit exceeds its fair value, then the amount of the
impairment loss must be measured. The impairment loss would be
calculated by comparing the implied fair value of reporting unit
goodwill to its carrying amount. In calculating the implied fair
value of reporting unit goodwill, the fair value of the
reporting unit is allocated to all of the other assets and
liabilities of that unit based on their fair values. The excess
of the fair value of a reporting unit over the amount assigned
to its other assets and liabilities is the implied fair value of
goodwill. An impairment loss would be recognized when the
carrying amount of goodwill exceeds its implied fair value. The
Company does not believe the goodwill it is carrying as of
December 31, 2010 is impaired as it was recorded at fair
value in the 4th quarter of 2010.
INTANGIBLE
ASSETS
The Company accounts for its intangible assets in accordance
with ASC 350 Intangibles Goodwill and Other
(ASC 350), which requires that intangible assets
with finite lives, such as the Companys license and
patents, be capitalized and amortized over their respective
estimated lives and reviewed for impairment whenever events or
other changes in circumstances indicate that the carrying amount
may not be recoverable. Intangible assets deemed to have
indefinite lives are not amortized and are subject to annual
impairment testing. This testing compares carrying values to
fair values and when appropriate, the carrying value of these
assets is reduced to fair value. During 2010 and 2009, there was
no impairment on intangible assets deemed to have indefinite
lives.
LONG-LIVED
ASSETS
Long-lived assets are reviewed for impairment whenever events or
changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Such reviews are based on a
comparison of the assets undiscounted cash flows to the
recorded carrying value of the asset. If the assets
recorded carrying value exceeds the sum of the undiscounted cash
flows expected to result from the use and eventual disposition
of the asset, the asset is written down to its estimated fair
value. Impairment charges, if any, are recorded in the period in
which the impairment is determined. The Company has incurred
impairment charges of $15.4 million and $3.9 million
related to its discontinued operations for the years ended
December 31, 2010 and 2009, respectively, as more fully
described in Note 5 and Note 8.
PROPERTY
AND EQUIPMENT
Property and equipment are stated at cost. Depreciation is
computed on the straight-line basis over estimated useful lives
of 7 to 20 years.
Construction-in-progress
includes construction costs, equipment purchases and capitalized
interest costs for assets not yet been placed in service at the
Gonzales facility and TerraSphere Canada.
CONVERTIBLE
DEBT
The Company accounts for its convertible debt by recognizing
discounts for the intrinsic value of beneficial conversion
features, if applicable, and discounts for the relative fair
value of any warrants issued in conjunction with the debt.
Discounts are amortized to interest expense over the related
term of the note.
47
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING
POLICIES Continued
DERIVATIVE
INSTRUMENTS
The Company accounts for derivative instruments in accordance
with ASC 815 Derivatives and Hedging (ASC
815), which establishes accounting and reporting standards
for derivative instruments and hedging activities, including
certain derivative instruments embedded in other financial
instruments or contracts and requires recognition of all
derivatives on the balance sheet at fair value. Accounting for
changes in the fair value of derivative instruments depends on
whether the derivatives qualify as hedge relationships and the
types of relationships designated are based on the exposures
hedged. At December 31, 2010 and 2009, the Company did not
have any derivative instruments that were designated as hedges.
DISCONTINUED
OPERATIONS
The Company discontinued the operations of its Woodbridge
facility during the third quarter of 2010 (see Note 5).
Assets and liabilities related to the Woodbridge facility have
been classified as discontinued operations on the consolidated
balance sheets at December 31, 2010 and 2009 and its
operations have been classified as loss from discontinued
operations on the consolidated statements of operations and
comprehensive loss for the years ended December 31, 2010
and 2009.
REVENUE
RECOGNITION
The Companys organic fertilizer operation generates
revenues from two sources: product sales and tip fees. Product
sales revenue comes from the sale of fertilizer products. Tip
fee revenue is derived from waste haulers who pay the Company
tip fees for accepting food waste generated by food
distributors such as grocery stores, produce docks and fish
markets, food processors and hospitality venues such as hotels,
restaurants, convention centers and airports. The IWWR operation
will generate revenue by setting up treatment systems on
customers sites and processing their wastewater on a
price-per-gallon
basis. The Companys vertical farming operation derives its
revenues from licensing fees and royalties, as well as the sale
of equipment and expects future revenue from operating
facilities using the Companys patented technology.
Revenue is recognized when all of the following criteria is met:
|
|
|
|
|
Persuasive evidence of a sales arrangement exists;
|
|
|
|
Delivery of the product has occurred;
|
|
|
|
The sales price is fixed or determinable; and
|
|
|
|
Collectability is reasonably assured.
|
In those cases where all four criteria are not met, the Company
defers recognition of revenue until the period in which these
criteria are satisfied. Revenue is generally recognized upon
shipment of product for its fertilizer business, and for
Terrasphere, the Company recognizes technology license revenue
immediately upon completed performance if the term of exclusive
technology licenses is equal to the life of the associated
intellectual property, otherwise license revenue would be
recognized over the term of the license.
SHIPPING
AND HANDLING COSTS
The Company records freight billed to customers for shipment of
product as revenue with an offsetting charge to cost of goods
sold for freight paid on shipments to customers.
48
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING
POLICIES Continued
SHARE
BASED COMPENSATION
The Company accounts for share based compensation paid to
employees in accordance with ASC 718
Compensation Stock Compensations (ASC
718). Under ASC 718 guidance, share-based
compensation issued to employees is measured at the grant date,
based on the fair value of the award, and is recognized as an
expense over the requisite service period (generally the vesting
period of the grant). The Company accounts for share based
compensation issued to non-employees in accordance with
ASC 505 Equity (ASC 505). Under
ASC 505 guidance, such compensation is measured at the
grant date, based on the fair value of the equity instruments
issued and is recognized as an expense over the requisite
service period.
RESEARCH
AND DEVELOPMENT COSTS
Research and development costs include the costs of engineering,
design, feasibility studies, outside services, personnel and
other costs incurred in development of the Companys
manufacturing facilities. All such costs are charged to expense
as incurred.
INCOME
TAXES
The Company accounts for income taxes following the asset and
liability method in accordance with ASC 740 Income
Taxes. Under such method, deferred tax assets and
liabilities are recognized for the future tax consequences
attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their
respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable
income in the years that the asset is expected to be recovered
or the liability settled. See Note 14 for additional
information.
The provisions of ASC 740 address the determination of
whether tax benefits claimed or expected to be claimed on a tax
return should be recorded in the financial statements. Under
ASC 740, the Company may recognize the tax benefit from an
uncertain tax position only if it is more likely than not that
the tax position will be sustained on examination by taxing
authorities, based on the technical merits of the position. The
Company has determined that it has no significant uncertain tax
positions.
FAIR
VALUE MEASUREMENTS
The Company applies ASC 820 Fair Value Measurements and
Disclosures (ASC 820), which defines fair value,
establishes a framework for measuring fair value, and expands
disclosures about fair value measurements. ASC 820 applies
to reported balances that are required or permitted to be
measured at fair value under existing accounting pronouncements.
ASC 820 emphasizes that fair value is a market-based
measurement, not an entity-specific measurement. Therefore, a
fair value measurement should be determined based on the
assumptions that market participants would use in pricing the
asset or liability. As a basis for considering market
participant assumptions in fair value measurements, ASC 820
establishes a fair value hierarchy that distinguishes between
market participant assumptions based on market data obtained
from sources independent of the reporting entity (observable
inputs that are classified within Levels 1 and 2 of the
hierarchy) and the reporting entitys own assumptions about
market participant assumptions (unobservable inputs classified
within Level 3 of the hierarchy).
Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical assets or liabilities that the Company has
the ability to access. Level 2 inputs are inputs other than
quoted prices included in Level 1 that are observable for
the asset or liability, either directly or indirectly.
Level 2 inputs may include quoted prices for similar assets
and liabilities in active markets, as well as inputs that are
observable for the asset or liability (other than quoted
prices), such as interest rates, foreign exchange rates and
yield curves that are observable at commonly
49
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING
POLICIES Continued
quoted intervals. Level 3 inputs are unobservable inputs
for the asset or liability, which are typically based on an
entitys own assumptions, as there is little, if any,
related market activity. In instances where the determination of
the fair value measurement is based on inputs from different
levels of the fair value hierarchy, the level in the fair value
hierarchy within which the entire fair value measurement falls
is based on the lowest level input that is significant to the
fair value measurement in its entirety which requires judgment,
and considers factors specific to the asset or liability.
EARNINGS
(LOSS) PER SHARE
Basic earnings (loss) per share (EPS) is computed by
dividing the net income (loss) attributable to the common
stockholders (the numerator) by the weighted average number of
shares of common stock outstanding (the denominator) during the
reporting periods. Diluted income (loss) per share is computed
by increasing the denominator by the weighted average number of
additional shares that could have been outstanding from
securities convertible into common stock, such as stock options
and warrants (using the treasury stock method), and
convertible preferred stock and debt (using the
if-converted method), unless their effect on net
income (loss) per share is antidilutive. Under the
if-converted method, convertible instruments are
assumed to have been converted as of the beginning of the period
or when issued, if later. The effect of computing the
Companys diluted income (loss) per share was antidilutive
and, as such, basic and diluted earnings (loss) per share are
the same for each of the years ended December 31, 2010 and
2009.
RECLASSIFICATIONS
As a result of the Woodbridge Facility operations being
discontinued during the third quarter of 2010, the comparative
years have been reclassified to conform with the current
presentation and has reclassified certain items as discontinued
operations. These reclassifications have no affect on previously
reported net income.
RECENTLY
ADOPTED ACCOUNTING PRONOUNCEMENTS
In April 2010, the FASB issued ASU
No. 2010-17,
Milestone Method of Revenue Recognition. This ASU allows
entities to make a policy election to use the milestone method
of revenue recognition and provides guidance on defining a
milestone and the criteria that should be met for applying the
milestone method. The scope of this ASU is limited to the
transactions involving milestones relating to research and
development deliverables. The guidance includes enhanced
disclosure requirements about each arrangement, individual
milestones and related contingent consideration, substantive
milestones and factors considered in that determination. The
amendments in this ASU are effective prospectively to milestones
achieved in fiscal years, and interim periods within those
years, beginning after June 15, 2010. Early application and
retrospective application are permitted. The Company has
evaluated this new ASU and has determined that it will not have
a significant impact on the determination or reporting of its
financial results.
In December 2010, the FASB issued ASU
2010-28
(Topic 350) When to Perform Step 2 of the Goodwill
Impairment Test for Reporting Units with Zero or Negative
Carrying Amounts. The amendments in ASU
2010-28
modify Step 1 of the goodwill impairment test for reporting
units with zero or negative carrying amounts. For those
reporting units, an entity is required to perform Step 2 of the
goodwill impairment test if it is more likely than not that a
goodwill impairment exists. In determining whether it is more
likely than not that goodwill impairment exists, an entity
should consider whether there are any adverse qualitative
factors indicating that impairment may exist. ASU
2010-28 is
effective for fiscal years, and interim periods within those
years, beginning after December 15, 2010 for public
entities. Early adoption is not permitted. The Company will
apply the provisions of ASU
2010-29 on a
prospective basis.
In December 2010, the FASB issued ASU
2010-29,
Business Combinations (Topic 805): Disclosure of Supplementary
Pro Forma Information for Business Combinations. ASU
2010-29
specifies that when a public
50
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 3
SIGNIFICANT ACCOUNTING
POLICIES Continued
company completes a business combination, the company should
disclose revenue and earnings of the combined entity as though
the business combination occurred as of the beginning of the
comparable prior annual reporting period. The update also
expands the supplemental pro forma disclosures under Topic 805
to include a description of the nature and amount of material,
non-recurring pro forma adjustments directly attributable to the
business combination included in the pro forma revenue and
earnings. The requirements in ASU
2010-29 are
effective for business combinations that occur after the
beginning of the first annual reporting period beginning on or
after December 15, 2010. The Company will apply the
provisions of ASU
2010-29 on a
prospective basis.
NOTE 4
ACQUISITIONS
TERRASPHERE
SYSTEMS LLC ACQUISITION
On November 12, 2010, we acquired 95% of the membership
interests of TerraSphere Systems LLC. The acquisition will
enable us to license TerraSpheres patented Growth System,
which is a system of modules and processes for growing plants in
a controlled environment. The system uses and controls precise
combinations of light, water, nutrition, gravity, centrifugal
forces, and gasses to produce growing conditions that can be
controlled and manipulated to result in desired plant growth and
maximum crop production.
The membership interest purchase agreement
(Agreement) entered on July 6, 2010 allows for
an election by TerraSphere members to accept
1) 27,777,778 shares of common stock upon closing of
the transaction (with a 6 month holding period)
(Option One) or 2) 15,873,016 shares of
Company common stock upon closing of the transaction with an
option to earn an additional 21,164,021 shares of Company
common stock in contingent consideration based upon TerraSphere
achieving certain milestones and agreeing to an 18 month
holding period on stock distributed to them (Option
Two). Based on 26% of TerraSphere members electing
Option One and 69% electing Option Two, the maximum total shares
that could be issued is 32,777,778 of Company common stock. Per
the Agreement, TerraSphere members who elected Option One
received 7,222,222 shares of Company common stock upon
closing and members electing Option Two received
10,952,381 shares of Company common stock upon closing with
an additional 14,603,175 shares of Company common stock
issueable upon achieving the following milestones (contingent
consideration):
Milestone One Payment: 4,563,492 shares
of Company common stock, if between the date of the Agreement
and the 90th day following the closing date or the
180th day following the date of the Agreement, the
following occurs: for a period of five consecutive trading days,
the Companys market capitalization exceeds the sum of:
(1) the Companys initial market capitalization on the
date of execution of the Agreement, plus (2) the closing
price per share, multiplied by the number of shares of Company
common stock to be issued at closing pursuant to the Agreement.
If between the date of the Agreement and the 90th day
following the closing date or the 180th day following the
date of the Agreement, the Company completes an equity
financing, the cash received from the equity financing during
such period shall be added to the market capitalization. If
between the closing date and December 31, 2011, the Company
sells equity of either the Company or any of the Companys
subsidiaries, any cash received from such equity sales during
such period shall be added to the market capitalization;
Milestone Two Payment: 1,825,397 shares
of Company common stock, if $2,000,000 of TerraSpheres
accounts receivable as of the date of the Agreement are received
prior to February 28, 2011. This Milestone was not met;
Milestone Three Payment: 4,563,492 shares
of Company common stock, if we generate gross margin of
$6,000,000 (gross margin target) from our operations during the
period commencing as of the date of the Agreement and ending on
December 31, 2011; provided that, if we generates gross
margin of at least $4,200,000 (gross margin threshold) from our
operations during such period, a pro rata portion of the Company
common stock shall be granted the applicable TerraSphere
members; and
51
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 4
ACQUISITIONS Continued
Milestone Four Payment: 3,650,794 shares
of Company common stock, if the Company generates gross margin
of $4,000,000 from its operations during any nine-month period
commencing on the Agreement date and ending on December 31,
2012; provided that, if the Company achieves the Milestone Three
gross margin threshold, but does not achieve the Milestone Three
gross margin target, 83.3% of the difference between the
Milestone Three gross margin target and the actual gross margins
achieved pursuant to the Agreement (the Milestone Three
Deficiency) may be added by the Sellers to the Milestone
Four Payment and the Milestone Four gross margin target.
Notwithstanding anything to the contrary herein, the total
amounts payable pursuant to the Milestone Three Payment and
Milestone Four Payment shall be no more than
8,214,286 shares of Company common stock.
In addition, the Agreement contains an anti-dilution provision
due to which the Company estimated it would need to issue an
additional 2,040,000 shares of Company common stock.
The estimated purchase price at fair value is as follows:
|
|
|
|
|
Election of Option One
|
|
$
|
2,961,000
|
|
Election of Option Two
|
|
|
4,490,000
|
|
Milestone one payment
|
|
|
1,403,000
|
|
Milestone two payment
|
|
|
711,000
|
|
Milestones three and four payments
|
|
|
1,684,000
|
|
Anti-dilution provision
|
|
|
837,000
|
|
|
|
|
|
|
|
|
$
|
12,086,000
|
|
|
|
|
|
|
The estimated purchase price has been allocated to the assets
acquired and liabilities assumed on a preliminary basis using
estimated fair value information currently available. The
allocation of the purchase price to the assets and liabilities
will be finalized within a year as the Company obtains more
information regarding asset valuations, liabilities assumed,
contingent consideration and revisions of preliminary estimates
of fair value made at the date of purchase. The fair value of
the noncontrolling interest totaling $648,644 was determined
based on the fair value assigned for the 95% of TerraSphere
Systems that the Company acquired.
The preliminary purchase price allocation for TerraSphere is as
follows:
|
|
|
|
|
Cash
|
|
$
|
41,679
|
|
Accounts receivable
|
|
|
2,690,000
|
|
Other assets
|
|
|
274,313
|
|
Leasehold improvements
|
|
|
176,181
|
|
Construction-in-process
|
|
|
97,306
|
|
Patents and patent related costs
|
|
|
10,000,000
|
|
Goodwill
|
|
|
1,193,600
|
|
Assumption of liabilities
|
|
|
(1,738,435
|
)
|
Noncontrolling interest
|
|
|
(648,644
|
)
|
|
|
|
|
|
Total allocation of purchase price
|
|
$
|
12,086,000
|
|
|
|
|
|
|
Changes in the fair value of contingent consideration that the
Company recognizes after the acquisition date may be the result
of additional information about facts and circumstances that
existed at the acquisition date that the Company obtained after
that date. Such changes are considered to be measurement period
adjustments and would adjust the purchase price to the extent
they occur within one year from the acquisition date. Contingent
52
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 4
ACQUISITIONS Continued
consideration classified as an asset or a liability that changes
beyond a year from the acquisition date is remeasured at fair
value and recognized in earnings.
Converted Organics, Inc recorded the investment in its
subsidiary, TerraSphere as follows on November 12, 2010:
|
|
|
|
|
Obligations to issue shares (Milestones Three and Four)
|
|
|
1,684,000
|
|
Derivative liability related to anti-dilution provision
|
|
|
837,000
|
|
Equity
|
|
|
9,565,000
|
|
|
|
|
|
|
Total
|
|
$
|
12,086,000
|
|
|
|
|
|
|
The Company determined that Milestones three and four contained
in the Agreement meet the definition of a liability under
ASC 480 Distinguishing Liabilities from Equity and
therefore this obligation to issue shares is treated as a
liability rather than equity when recording the fair value of
the acquisition. Obligations to issue shares represents the
estimated fair value of shares to be issued for Milestones three
and four as described above. In addition, the Company determined
that the anti-dilution provision contained in the Agreement
meets the definition of a derivative liability. The Company
considered various scenarios and possibilities of an occurrence
of an event that would trigger the anti-dilution provision.
Based on the various scenarios and possibilities the Company
estimated it would need to issue an additional
2,040,000 shares to the former members of TerraSphere
Systems related to this provision. All other aspects of the
transaction were recorded as equity.
GoLocalProduceRI,
LLC ACQUISITION
On December 30, 2010, the Company acquired 83.34% of
GoLocalProduceRI, LLC issuing 1,371,428 shares of Company
common stock valued at approximately $480,000, marking its
entrance into the vertical farming industry as owners and
operators of what is expected to be the first TerraSphere
facility in the United States.
The estimated purchase price has been allocated to the assets
acquired and liabilities assumed on a preliminary basis using
estimated fair value information currently available. The
allocation of the purchase price to the assets and liabilities
will be finalized within a year as the Company obtains more
information regarding asset valuations, liabilities assumed,
contingent consideration and revisions of preliminary estimates
of fair value made at the date of purchase. The fair value of
the noncontrolling interest totaling $95,954 was determined
based on the fair value assigned for the 83.34% of
GoLocalProduceRI, LLC that the Company acquired.
The preliminary purchase price allocation is as follows:
|
|
|
|
|
Cash
|
|
$
|
56,597
|
|
Prepaid and other current assets
|
|
|
45,000
|
|
Goodwill
|
|
|
474,357
|
|
Noncontrolling interest
|
|
|
(95,954
|
)
|
|
|
|
|
|
Total
|
|
$
|
480,000
|
|
|
|
|
|
|
53
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 4
ACQUISITIONS Continued
The unaudited pro forma consolidated financial information for
the years ended December 31, 2010 and 2009 as though the
above acquisitions had been completed at the beginning of the
respective years are as follows:
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
Revenue
|
|
$
|
8,862,980
|
|
|
$
|
2,670,514
|
|
Net loss
|
|
$
|
(48,629,191
|
)
|
|
$
|
(22,321,742
|
)
|
Net loss per share, basic and diluted
|
|
$
|
(0.65
|
)
|
|
$
|
(047
|
)
|
Weighted-average shares
|
|
|
74,276,495
|
|
|
|
47,094,769
|
|
NOTE 5
DISCONTINUED OPERATIONS
On July 30, 2010, the Company temporarily halted production
at its Woodbridge facility in order to undertake steps to lower
its cost structure at the Woodbridge facility. Specifically, the
Company attempted to negotiate more favorable terms under its
operating lease and to lower certain utility costs. The Company
was unable to lower such costs and therefore, management
determined that the Company could not sustain the negative cash
flow from the Woodbridge facility and discontinued operations at
the Woodbridge plant during the quarter ended September 30,
2010. As a result, during the quarter ended September 30,
2010, the Company recognized an impairment charge on the
long-lived assets of the Woodbridge facility to reduce the
carrying value of the those assets to approximately
$1.5 million, which is the value that was expected to be
received from the disposition of those assets. The consolidated
statements of operations and comprehensive loss includes an
impairment charge pertaining to those long-lived assets of
approximately $15.4 million which is included in loss from
discontinued operations.
On October 18, 2010, the bonds payable and related accrued
interest totaling approximately $18.5 million were settled
and extinguished for $17.5 million of Company preferred
stock (See Note 11). In addition, as described below, the
Company entered into a series of transactions on
October 18, 2010 whereby certain assets and liabilities
were assigned, transferred and or extinguished.
On October 18, 2010, the Company and the Woodbridge
facilitys landlord (Lessor) entered into a
Termination and Surrender Agreement (Termination
Agreement) related to the termination of the Woodbridge
Facility lease. Pursuant to the Termination Agreement, the
Lessor and the Company agreed to terminate the lease
surrendering the premises and transferring all equipment, tools
and fixtures owned by the Company and presently located at the
premises. Under the lease, there were approximately
$9.1 million of future rental payments. In addition, the
Lessor asserted claims for (i) unpaid sewer and trash
removal charges; (ii) unpaid rent due Lessor for prior
periods; (iii) certain costs and expenses incurred by
Lessor in connection with certain litigation; (iv) damages
that may result from the condition of the premises at the time
of surrender; and (v) the required removal and disposal of
abandoned inventory and materials totaling approximately
$2.4 million. Pursuant to the terms of the Termination
Agreement, the Company agreed to transfer the Woodbridge
facilitys assets to the Lessor with a carrying value of
approximately $1.5 million and to issue the Lessor a total
of 892,857 shares of Company common stock valued at $0.56
per share totaling $500,000 and to surrender deposits totaling
$415,000 with the Lessor in exchange for settlement of the
asserted claims of approximately $2.4 million.
On October 18, 2010, the Superior Court of the State of
California for the County of Los Angeles entered an Order in the
matter entitled American Capital Management, LLC
(ACM) v. Converted Organics Inc. and Converted
Organics of Woodbridge, LLC and Does 1-10 Inclusive (the
Order). The Order provides for the full and final
settlement of $11.3 million of claims against the Company
held by ACM. The claims include the future rental payments of
$9.1 million discussed above, as well as approximately
$1.7 million of promissory notes issued by the Company to
four contractors that had provided services to the Woodbridge
Facility (See Note 11) and approximately $400,000 for
other facility costs which were acquired by ACM from the Lessor.
ACM purchased the
54
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 5
DISCONTINUED
OPERATIONS Continued
claims from these parties pursuant to separate claims purchase
agreements. Pursuant to the terms of the Order, the Company
agreed to issue to ACM a total of 20,726,980 shares of
Company common stock valued at $0.543 per share
totaling $11.3 million in full and final settlement of the
claims.
The loss recognized on disposal includes the $9.1 million
loss on early termination of the lease, approximately $796,000
of prepaid facility costs and approximately $400,000 of other
facility costs, net of a gain of $1.0 million in bond
interest waived in conjunction with the settlement and
extinguishment of the bonds payable as described above.
The following table summarizes the components of the loss from
discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Revenue from discontinued operations
|
|
$
|
830,814
|
|
|
$
|
497,062
|
|
|
|
|
|
|
|
|
|
|
Results from discontinued operations including write downs to
fair value of $15.4 million in 2010 and $3.9 million
in 2009
|
|
$
|
(25,352,449
|
)
|
|
$
|
(13,463,484
|
)
|
Loss recognized on disposal
|
|
|
(9,337,909
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
34,690,358
|
|
|
$
|
13,463,484
|
|
|
|
|
|
|
|
|
|
|
The Company does not expect to have any continuing cash flows
from operations associated with the Woodbridge facility.
The following table provides the assets and liabilities of the
Woodbridge facility, classified as discontinued operations, in
the consolidated balance sheets dated December 31, 2010 and
2009:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Accounts receivable, net
|
|
$
|
14,500
|
|
|
$
|
59,746
|
|
Inventories
|
|
|
|
|
|
|
272,396
|
|
Prepaid expenses
|
|
|
|
|
|
|
629,933
|
|
Property and equipment, net
|
|
|
|
|
|
|
17,935,216
|
|
Deposits
|
|
|
|
|
|
|
444,329
|
|
Capitalized bond costs, net
|
|
|
|
|
|
|
814,341
|
|
|
|
|
|
|
|
|
|
|
Assets of discontinued operations
|
|
$
|
14,500
|
|
|
$
|
20,155,961
|
|
|
|
|
|
|
|
|
|
|
Term notes payable
|
|
$
|
|
|
|
$
|
3,247,752
|
|
Accounts payable
|
|
|
837,606
|
|
|
|
1,237,275
|
|
Accrued expenses
|
|
|
1,571,874
|
|
|
|
950,782
|
|
Other liabilities
|
|
|
28,773
|
|
|
|
40,575
|
|
Bonds payable
|
|
|
|
|
|
|
17,500,000
|
|
|
|
|
|
|
|
|
|
|
Liabilities of discontinued operations
|
|
$
|
2,438,253
|
|
|
$
|
22,976,384
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2010, the Company wrote-off accounts
receivable totaling approximately $193,000 which is included in
the consolidated statements of operations and comprehensive loss
as loss from discontinued operations. The Company is actively
working with its vendors to satisfy the liabilities outstanding
at December 31, 2010. On January 25, 2011, the Company
paid cash of $150,000 and issued 3.2 million shares of
Company common stock totaling $1,494,000 in payment for
consulting services accrued at December 31, 2010 related to
the settlement of certain Woodbridge obligations (See Note 19).
55
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 6
FINANCIAL MEASUREMENTS
CONCENTRATIONS
OF CREDIT RISK
The Companys financial instruments that are exposed to a
concentration of credit risk are cash and accounts receivable.
The Company places its cash in highly rated financial
institutions, which are continually reviewed by senior
management for financial stability. Effective December 31,
2010, extending through December 31, 2012, all
noninterest-bearing transaction accounts are fully insured,
regardless of the balance of the account. Generally the
Companys cash and cash equivalents in interest-bearing
accounts exceeds financial depository insurance limits. However,
the Company has not experienced any losses in such accounts and
believes that its cash and cash equivalents are not exposed to
significant credit risk. As of December 31, 2009, the
Company had approximately $613,000 of cash which was restricted
under its bond agreement. Restrictions on these cash balances
were released in 2010 (Note 11).
In 2010 and 2009, three customers accounted for 55% and 69% of
sales, respectively. One customer and four customers accounted
for 47% and 97% of accounts receivable at December 31, 2010
and 2009, respectively. The Company maintains allowances for
doubtful accounts for estimated losses resulting from the
inability of its customers to make required payments. If the
financial condition of the Companys customers were to
deteriorate, resulting in an impairment of their ability to make
such payments, additional allowances may be required. An
increase in allowances for customer non-payment would increase
the Companys expenses during the period in which such
allowances are made. Based upon the Companys knowledge at
December 31, 2010 and 2009 a reserve for doubtful accounts
was recorded of approximately $2,370,000 and $50,000,
respectively.
FAIR
VALUE MEASUREMENTS
The Companys liabilities that are reported at fair value
in the accompanying consolidated balance sheets as of
December 31, 2010 and 2009 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level of
|
|
Balance
|
|
|
Hierarchy
|
|
2010
|
|
2009
|
|
Derivative warrants and anti-dilution provision liabilities
|
|
|
Level 3
|
|
|
$
|
8,675,619
|
|
|
$
|
1,626,742
|
|
The following table reflects the change in Level 3 fair
value of the Companys derivative liabilities for the years
ended December 31, 2010 and 2009:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Balance, beginning of year
|
|
$
|
(1,626,742
|
)
|
|
$
|
|
|
Cumulative effect of change in accounting principle
|
|
|
|
|
|
|
(5,083,108
|
)
|
Settlements
|
|
|
|
|
|
|
1,518,017
|
|
Issuances
|
|
|
(6,882,165
|
)
|
|
|
(3,827,686
|
)
|
Net gains (losses)
|
|
|
(166,712
|
)
|
|
|
5,766,035
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
(8,675,619
|
)
|
|
$
|
(1,626,742
|
)
|
|
|
|
|
|
|
|
|
|
The Company has other non-derivative financial instruments, such
as cash, accounts receivable, accounts payable, accrued expenses
and long-term debt, for which carrying amounts approximate fair
value.
56
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 7
INVENTORIES
The Companys inventories consisted of the following at
December 31:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Finished goods
|
|
$
|
104,690
|
|
|
$
|
137,027
|
|
Raw materials
|
|
|
21,716
|
|
|
|
39,324
|
|
|
|
|
|
|
|
|
|
|
Total inventories
|
|
$
|
126,406
|
|
|
$
|
176,351
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 8
PROPERTY AND EQUIPMENT
The Companys property and equipment, excluding assets of
discontinued operations at December 31 consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Building and improvements
|
|
$
|
840,562
|
|
|
$
|
147,894
|
|
Machinery and equipment
|
|
|
755,831
|
|
|
|
687,125
|
|
Vehicles
|
|
|
42,570
|
|
|
|
42,570
|
|
Office equipment and furniture
|
|
|
17,925
|
|
|
|
7,838
|
|
Construction-in-progress
|
|
|
136,607
|
|
|
|
311,046
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,793,495
|
|
|
|
1,196,473
|
|
Less: Accumulated depreciation and amortization
|
|
|
(315,906
|
)
|
|
|
(193,764
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
1,477,589
|
|
|
$
|
1,002,709
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The components of depreciation and amortization expense for the
years ended December 31, 2010 and 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Continuing operations cost of goods sold
|
|
$
|
104,158
|
|
|
$
|
96,241
|
|
Continuing operations operating expenses
|
|
|
17,984
|
|
|
|
11,511
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122,142
|
|
|
|
107,752
|
|
Discontinued operations (See Note 5)
|
|
|
1,312,944
|
|
|
|
2,048,242
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization expense
|
|
|
1,435,086
|
|
|
|
2,155,994
|
|
|
|
|
|
|
|
|
|
|
Changes in accumulated depreciation and amortization at
December 31, 2010 and 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Balance, beginning of year
|
|
$
|
1,934,324
|
|
|
$
|
405,250
|
|
Additions
|
|
|
1,435,086
|
|
|
|
2,155,994
|
|
Disposals
|
|
|
(3,053,504
|
)
|
|
|
(626,920
|
)
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
315,906
|
|
|
$
|
1,934,324
|
)
|
|
|
|
|
|
|
|
|
|
During the third quarter of 2010, the Company discontinued
operations at its Woodbridge facility (See Note 5). As a
result, the Company impaired the Woodbridge facilitys
assets to reduce the carrying value to approximately
$1.5 million, which is the value expected to be received
from the transfer of those assets. The consolidated statements
of operations and comprehensive loss includes an impairment
charge in loss from discontinued operations pertaining to
long-lived assets of approximately $15.4 million as of
December 31, 2010.
57
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 8
PROPERTY AND
EQUIPMENT Continued
In November 2009, the Company discovered corrosion in the walls
of one of its Woodbridge facilitys 120,000 gallon
digesters and determined that the corrosion was due to the
manufacturing process and the unsatisfactory performance of a
protective coating that was applied at the time of installation.
Through subsequent ultrasound wall thickness testing it was
determined that the corrosion was significant in two digesters
and that the Company would not be able to use those digesters
for their intended purpose in the manufacturing process and that
they would have to be repaired or replaced. The Company
determined that repair of the digesters was not feasible and, as
such, they would have to be replaced, accordingly, those assets
have been fully impaired. The consolidated statements of
operations and comprehensive loss, includes a charge in loss
from discontinued operations of $3.9 million in the year
ended December 31, 2009, comprising the net book value of
the impaired property and equipment of $3.4 million and the
related intellectual property of $500,000.
NOTE 9
DEFERRED FINANCING COSTS
In connection with its various private financings, the Company
incurs fees which are capitalized and are being amortized over
the term of the related loans. Amortization expense associated
with private financings totaled $28,778 and $22,042 for the
years ended December 31, 2010 and 2009, respectively.
NOTE 10
INTANGIBLE ASSETS
The Company entered into a license technology agreement with a
third party related to its Woodbridge facility. The Company
determined at December 31, 2009 that the value of this
license was impaired due to corrosion of the machinery that is
utilized in the technology (see Note 8), and its subsequent
decision to use its own technology to manufacture product in the
Woodbridge facility. Accordingly, the carrying value of the
license of $552,750 was fully impaired and charged off at
December 31, 2009 and a non-refundable deposit of $139,978
to purchase a second license was expensed for the year ended
December 31, 2009. The consolidated statements of
operations and comprehensive loss, loss from discontinued
operations includes $16,500 of amortization expense and an
expense of $692,728 in the year ended December 31, 2009
related to these charges.
The Company identified and assigned a value of $10 million
to the patents acquired in its purchase of TerraSpherre Systems
(See Note 4). The fair value of these patents is being
amortized over their various expected remaining lives of
14-20 years.
Intangible assets consist of the following at December 31:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Definite-lived intangible assets:
|
|
|
|
|
|
|
|
|
Existing customer relationships
|
|
$
|
2,030,513
|
|
|
$
|
2,030,513
|
|
Technological know-how
|
|
|
271,812
|
|
|
|
271,812
|
|
Patents and related patent costs
|
|
|
10,001,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,303,432
|
|
|
|
2,302,325
|
|
Less: accumulated amortization
|
|
|
(902,355
|
)
|
|
|
(534,894
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
11,401,077
|
|
|
|
1,767,431
|
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
Trade name
|
|
|
228,188
|
|
|
|
228,188
|
|
|
|
|
|
|
|
|
|
|
Net intangibles assets
|
|
$
|
11,629,265
|
|
|
$
|
1,995,619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The consolidated statements of operations and comprehensive loss
include amortization expense of $367,461 and $288,007
related to these intangible assets for the years ended
December 31, 2010 and 2009,
58
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 10
INTANGIBLE ASSETS Continued
respectively. Amortization expense for these intangibles is
estimated to be $884,734 annually for each of the next five
years and $6,977,407 thereafter.
NOTE 11
DEBT
TERM
NOTES
The Company entered into a financing agreement with an equipment
financing company to acquire equipment for its Woodbridge
facility. The note is for $118,250, bears an imputed interest
rate of 9% and has a three year term, maturing January, 2012.
During the fourth quarter of 2010, the Company was in default of
the note and the equipment was repossessed. The value of the
equipment repossessed exceeded the Companys obligation
therefore the Company was released from its financing agreement.
At December 31, 2009 the amount outstanding is $70,720
which is classified as liabilities of discontinued operations in
the consolidated balance sheet at December 31, 2009 (See
Note 5). Interest expense of $3,530 and $7,629 has been
recorded related to this note during the years ended
December 31, 2010 and 2009, respectively and included in
the consolidated statements of operations and comprehensive
loss, loss from discontinued operations.
On April 1, 2009, the Company agreed to convert certain
accounts payable into a 12 month note with its former
landlord at the New Jersey facility, Recycling Technology
Development Corporation (Recycling Technology). The
note bears interest at 9%, payable quarterly in arrears
commencing September 30, 2009. The note requires payments
of $263,573 on October 1, 2009 and January 1, 2010, to
be applied first to accrued interest and then to principal. A
final installment of $318,832 was due on March 31, 2010.
The note was paid in full in accordance with its terms as of
December 31, 2010. The outstanding balance at
December 31, 2009 totaled $562,728 which is classified as
liabilities of discontinued operations in the consolidated
balance sheet at December 31, 2009 (See Note 5).
During 2009, the Company agreed to convert certain accounts
payable to four contractors totaling approximately $3,872,000,
related to the construction of the Woodbridge facility (the
construction term notes), into term notes ranging
from 12 to 24 months at various rates ranging from 0% to 9%
with payment terms maturing through September 2011. The Company
has recorded a discount on certain of the notes representing
imputed interest of approximately $54,000, which is being
amortized during the non-interest bearing period of the notes.
The outstanding balance of these term notes was approximately
$2,614,000 at December 31, 2009 and they are classified as
current and non-current liabilities of discontinued operations
in the consolidated balance sheet at December 31, 2009. On
October 18, 2010, the term notes were extinguished (See
Note 5).
In connection with the Companys acquisition of TerraSphere
Systems, the Company assumed a note payable from a third party
in the amount of $350,000, with a fixed interest rate of 15% per
annum. Interest only payments totaling $4,375 are due monthly
with the principal balance due August, 27, 2011. The Company has
accrued interest and incurred interest expense totaling $4,459
as of December 31, 2010. Subsequent to December 31,
2010, the above note was extinguished by the holder for a
payment of $125,000 (See Note 19).
|
|
NOTE PAYABLE
|
RELATED
PARTY
|
The Company had a term note payable to its CEO, Edward J.
Gildea. The unsecured term note for $89,170 was dated
April 30, 2007 with an original maturity of April 30,
2009 and accrued interest at 12% per annum. The note had been
extended for one year until April 30, 2010. The Company
paid accrued interest of $21,400 upon extension of the
notes due date on June 30, 2009. This note was
subordinate to the New Jersey EDA bonds. On December 18,
2009, the Company repaid the principal balance of the note plus
accrued interest of $6,777.
In connection with the Companys acquisition of TerraSphere
Systems, the Company assumed an unsecured note payable to
William Gildea, Secretary of the Company and brother of Edward
Gildea, President of the
59
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 11
DEBT Continued
Company, that has an interest rate of 10% per annum. The
principal amount due totaled $72,351 at December 31, 2010.
The Company incurred interest expense totaling $3,486 for the
year ended as of December 31, 2010.
BOND
FINANCING
On February 16, 2007, concurrent with its initial public
offering, the Companys wholly-owned subsidiary, Converted
Organics of Woodbridge, LLC, completed the sale of $17,500,000
of New Jersey Economic Development Authority Bonds. The Bonds
are classified as liabilities of discontinued operations in the
consolidated balance sheet at December 31, 2009 (See
Note 5). Direct financing costs related to this issuance
totaled approximately $953,000 and were being amortized over the
term of the bond. Capitalized bond costs, net of amortization
totaling $814,341 has been classified as non-current assets of
discontinued operations at December 31, 2009 (See
Note 5). On October 18, 2010, the Bonds payable were
settled and extinguished, resulting in the expensing of the
remaining unamortized capitalized bond costs of $774,617 and
included in the loss from discontinued operations in the
consolidated statement of operations and comprehensive loss for
the year ended December 31, 2010. Amortization of
capitalized bond issuance costs totaled $39,720 and $47,669 for
the years ended December 31, 2010 and 2009, respectively,
and are included in the loss from discontinued operations in the
consolidated statement of operations and comprehensive loss for
the years ended December 31, 2010 and 2009. The bonds
carried a stated interest rate of 8% and were to mature on
August 1, 2027. The bonds were secured by a leasehold
mortgage and a first lien on the equipment of the Woodbridge
facility. In addition, Woodbridge had agreed to, among other
things, establish a fifteen month capitalized interest reserve
and to comply with certain financial statement ratios. The
Company provided a guarantee to the bondholders on behalf of
Woodbridge for the entire bond offering. The bonds also had
certain covenants requirements.
On March 6, 2009, the Company entered into an agreement
with the holders of the New Jersey Economic Development
Authority Bonds to release $2.0 million for capital
expenditures on its New Jersey facility and to defer interest
payments on the bonds through July 30, 2009. These funds
had been held in a reserve for bond principal and interest
payments along with a reserve for lease payments. As
consideration for the release of the reserve funds, the Company
issued the bond holders 2,284,409 Class B warrants. The
Class B warrants are exercisable at $11.00 per warrant. The
expense associated with these warrants of $662,000 is reflected
as interest expense and classified in the consolidated
statements of operations and comprehensive loss, as loss from
discontinued operations for the year ended December 31,
2009. On July 30, 2009 the deferred interest payments were
paid in full. In September of 2009, the holders of the bonds
agreed to continue to defer monthly deposits to the interest
escrow through January, 2010. The Company funded the escrow
following its secondary public offering in October, 2009. The
escrow balance of approximately $613,000 is reflected as current
restricted cash in the balance sheet as of December 31,
2009.
On October 18, 2010, Converted Organics Inc. entered into
an Exchange Agreement (the Exchange Agreement) with
the sole Bond Holder of $17,500,000 New Jersey Economic
Development Authority Bonds (the Bonds) that were
issued on behalf of Woodbridge. Pursuant to the Exchange
Agreement, the Bond Holder agreed to exchange: (i) the
Bonds, and (ii) class B warrants to purchase
2,284,409 shares the Companys common stock (the
Class B Warrants) for 17,500 shares of the
Companys newly authorized 1% Series A Convertible
Preferred Stock (the Series A Preferred Stock).
In addition, the Bond Holder agreed to waive all interest
accrued and unpaid from February 1, 2010 until the date of
the Exchange Agreement on the Bonds totaling approximately
$1 million, and agreed to transfer to the Company
approximately $600,000 that the Company had previously deposited
into certain escrow accounts in connection with the Bonds.
The Series A Preferred Stock is convertible into the number
of shares of Common Stock equal to (1) the stated value of
the share ($1,000), divided by (2) $0.543 (the
Conversion Price). Holders of the Series A
Preferred are entitled to receive cumulative dividends at the
rate per share (as a percentage of the stated value per share)
of 1% per annum (subject to increase in certain circumstances),
payable annually and on each conversion date. The dividends
60
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 11
DEBT Continued
are payable, during the first three years after issuance, at the
election of the Company, and thereafter, at the election of the
holder, in cash or in shares of Company common stock valued at
the Conversion Price (or in some combination thereof).
CONVERTIBLE
NOTES PAYABLE
On January 24, 2008, in conjunction with the purchase of
the net assets of the Gonzales facility, the Company issued a
note payable to the former sole member in the amount of
$1,000,000. The note bore interest of 7% per annum and was to
mature on February 1, 2011; monthly principal and interest
payments are $30,877. The note became convertible by the holder
six months after issuance. The Company recognized a discount
related to the intrinsic value of the beneficial conversion
feature of the note. That amount was calculated to be $7,136,
and has been recorded as a component of additional paid-in
capital.
During the year ended December 31, 2009, the holder of the
note commenced converting the principal and accrued interest to
shares of common stock. During the year ended 2009, the Company
issued 281,500 shares of common stock to the note holder,
representing principal and accrued interest of approximately
$316,000. The principal balance of the note was approximately
$373,000 at December 31, 2009. During the year ended 2010,
the Company issued 646,500 shares of common stock
representing principal and accrued interest of approximately
$414,000 in satisfaction of its convertible debt obligation
issued in connection with the acquisition of the Gonzales
facility.
On December 17, 2010, the Company entered into a Securities
Purchase Agreement (Purchase Agreement) with certain
institutional investors (the Buyers). Upon the terms
and subject to the Purchase Agreement, the Company agreed to
sell to Buyers certain notes and warrants. Pursuant to the terms
of the Purchase Agreement, the Company agreed to sell to Buyers
convertible notes in the aggregate original principal amount of
$4,990,000 (the Notes), which are convertible into
shares of common stock. These Notes are to be purchased by
Buyers in two tranches, the first of which involved the sale of
Notes in the aggregate original principal amount of $3,939,473
(the Initial Notes). The closing of the purchase of
the Initial Notes occurred simultaneously with the execution of
the Purchase Agreement. The Initial Notes are non interest
bearing and were issued with an original issue discount of
approximately 4.8%, and the proceeds from the Initial Notes were
$3,444,555. The Company recorded the initial fair values of the
conversion feature and the warrants up to the net proceeds of
the note ($3,750,000) as a discount on the Note (see
Note 12) which will be amortized ratably over the
six-month term. At December 31, 2010, the carrying value of
this convertible debt totaled $306,404, which was attributable
to the amortization of the debt discount for the year ended
December 31, 2010.
The second tranche will involve the sale of Notes in the
aggregate original principal amount of $1,050,527 (the
Additional Notes) and shall be consummated upon the
satisfaction (or waiver) of the conditions to closing set forth
in the Purchase Agreement. The Additional Notes will also be
issued with an original issue discount of approximately 4.8%,
and the proceeds from the Additional Notes was $1,000,000 (see
Note 19). The Notes are not interest bearing, unless the Company
is in default on the Notes, in which case the Notes carry an
interest rate of 18% per annum.
The Notes are initially convertible into shares of Common Stock
at a conversion price of $1.00 per share, provided that if the
Company makes certain dilutive issuances (with limited
exceptions), the conversion price of the Notes will be lowered
to the per share price for the dilutive issuances. The Company
also has the right, at its option, to permit the holder of the
Notes to convert at a lower price specified by the Company for a
period specified by the Company. The Company is required to
repay the Notes in six equal installments commencing
February 1, 2011 (with respect to the Initial Notes),
either in cash or in shares of is common stock. If the Company
chooses to utilize shares of its common stock for the payment,
the Company must make an irrevocable decision to use shares
22 trading days prior to the installment payment date, and
the value of its shares will be equal to the lower of
(i) the conversion price then in effect and (ii) 85%
of the average of the three lowest closing sale prices of its
common stock during the 20 trading day period prior to payment
of the installment amount. If the Company chooses to make
61
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 11
DEBT Continued
an installment payment in shares of its common stock, it must
make a pre-installment payment of shares to the Note holder 20
trading days prior to the applicable installment date based on
the value of its shares during the 20 trading days preceding the
delivery of the notice to elect to pay in its shares. On the
installment date, to the extent the Company owes the Note holder
additional shares in excess of the pre-installment shares to
satisfy the installment payment, it will issue the Note holder
additional shares, and to the extent we have issued excess
shares, such shares will be applied to future payments.
If an event of default occurs under the Note, the Company must
redeem the Notes in cash at the greater of 135% of the
unconverted principal amount or 135% of the greatest equity
value of the shares of common stock underlying the Notes from
the date of the default until the redemption is completed. The
conversion price of all the Notes is subject to adjustment in
the case of stock splits, stock dividends, combinations of
shares and similar recapitalization transactions. The
convertibility of the Notes may be limited if, upon exercise,
the holder or any of its affiliates would beneficially own more
than 4.9% of our Common Stock.
PRIVATE
FINANCING
On January 24, 2008, the Company entered into a private
financing with three investors (the Investors) for a
total amount of $4,500,000 (the Financing). The
Financing was offered at an original issue discount of 10%. As
consideration for the Financing, the Investors received a note
issued by the Company in the amount of $4,500,000 with interest
accruing at 10% per annum to be paid monthly and the principal
balance to be paid in full one year from the closing date (the
Note). In addition, the Company issued to the
Investors 750,000 Class A Warrants and 750,000 Class B
Warrants, which may be exercised at $8.25 and $11.00 per
warrant, respectively (the Warrants). The Company
further agreed not to call any Warrants until a registration
statement registering all of the Warrants was declared
effective. A placement fee of $225,000 was paid from the
proceeds of this loan.
In connection with the Financing, the Company had agreed that
within 75 days of the closing date the Company would have a
shareholder vote to seek approval to issue a convertible
debenture with an interest rate of 10% per annum, which would be
convertible into common stock pursuant to terms of the debenture
agreement, or such other price as permitted by the debenture
(the Convertible Debenture). Upon shareholder
approval, the Note was replaced by this Convertible Debenture
and one half of each of the Class A Warrants and
Class B Warrants issued were returned to the Company. Under
the conversion option, the Investors shall have the option, at
any time on or before the maturity date (January 24, 2009),
to convert the outstanding principal of this Convertible
Debenture into fully-paid and non assessable shares of the
Companys common stock at the conversion price equal to the
lowest of (i) the fixed conversion price of $6.00 per
share, (ii) the lowest fixed conversion price (the lowest
price, conversion price or exercise price set by the Company in
any equity financing transaction, convertible security, or
derivative instrument issued after January 24, 2008), or
(iii) the default conversion price (if and so long as there
exists an event of default, then 70% of the average of the three
lowest closing prices of common stock during the twenty day
trading period immediately prior to the notice of conversion).
The Company held a special shareholders meeting on
April 3, 2008 to vote on this matter, at which time it was
approved.
In connection with the Financing, the Company entered into a
Security Agreement with the Investors whereby the Company
granted the Investors a security interest in Converted Organics
of California, LLC and any and all assets that are acquired by
the use of the funds from the Financing. In addition, the
Company granted the Investors a security interest in Converted
Organics of Woodbridge, LLC and all assets subordinate only to
the current lien held by the holder of the bonds issued in
connection with the Woodbridge facility.
In connection with the Financing, the Company issued
1.5 million warrants to purchase common stock, which were
deemed to have a fair value of $5,497,500. The Company recorded
the relative fair value of the warrants to the underlying notes
of $2,227,500 as additional paid-in capital and established a
discount on the debt. The discount was being amortized over the
life of the note (12 months). On April 17, 2008, the
Investors returned to the Company
62
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 11
DEBT Continued
750,000 warrants that had been held in escrow. This reduced the
value assigned to the warrants and, accordingly, the value
assigned to the debt discount attributable to the warrants by
$1,113,750.
On April 7, 2008, the shareholders of the Company approved
the issuance of additional shares so that convertible notes
could be issued to the note holders to replace the original
notes dated January 24, 2008. The Company recognized a
discount for the intrinsic value of the beneficial conversion
feature of the notes, which is to be recognized as interest
expense through the redemption date of the notes, which is
January 24, 2009. That amount was calculated to be
$3,675,000, and recognition was limited to $2,936,250, as the
debt discount was limited to the proceeds allocated to the
convertible instrument of $4,500,000. That discount is being
amortized over the life of the loan. The Company recognized
interest expense of $-0- and $230,492 related to this discount
for the years ended December 31, 2010 and 2009,
respectively.
On January 24, 2009 the convertible notes became due.
Because the Company did not have sufficient cash to repay the
notes, the Company agreed to convert the notes to shares at the
default rate, although no event of default had occurred. As of
December 31, 2009, the note holders had converted the full
principal amount of $4,500,000 into 7,366,310 shares of
common stock. In consideration for entering into this agreement,
the Company granted 200,000 shares of common stock to the
note holders. An expense of $562,000 is included in the
statement of operations and comprehensive loss for the year
ended December 31, 2009 for this stock grant, which
represents the market value of 200,000 shares on the date
they were granted. In addition, the notes accrued interest at
10% of their declining balance as they were paid off through the
issuance of stock. An additional 131,834 shares of common
stock were issued on April 23, 2009 for accrued interest.
Accrued interest of $7,232 has been converted to shares of
common stock during 2010.
PRIVATE
FINANCING
On May 7, 2009, the Company entered into an agreement with
an institutional investor (the Investor), wherein
the Company agreed to sell to the Investor, for the sum of
$1,182,500, six-month non-convertible original issue discount
notes with principal amounts totaling $1,330,313 (the
Notes). The agreement provides that if the Company
raises over $1.33 million while the Notes are outstanding,
the first $1,330,313 must be used to repay the Notes. The Notes
were repaid on May 22, 2009, with the proceeds from the
issuance of the Companys common stock on May 19, 2009
(see Note 13). See Note 13 for a description of
warrants issued to the Investor in consideration for this
transaction.
On September 8, 2009, the Company entered into an agreement
with an institutional investor (the Investor),
wherein the Company agreed to sell to the Investor, for the sum
of $1,400,000, six-month convertible original issue discount
notes with principal amounts totaling $1,540,000 (the
Notes). The agreement provides that if the Company
raises over $1.54 million while the Notes are outstanding,
the first $1,540,000 must be used to repay the Notes. The Notes
were repaid on October 20, 2009, from the proceeds of the
Companys secondary public offering of common stock (see
Note 13). See Note 13 for a description of warrants
issued to the Investor in consideration for this transaction.
NOTE 12
DERIVATIVE INSTRUMENTS
On January 1, 2009, the Company adopted the guidance of
ASC 815 related to derivatives and hedging activities and
at that time, determined that the conversion features within the
convertible notes payable issued in the January 2008 Financing
to be embedded derivatives which were required to be bifurcated
and shown as a derivative liability subject to
mark-to-market
adjustment each reporting period. The fair value of the
conversion feature was determined using a Black-Scholes model
and resulted in a fair value of $5,083,108. The fair value at
January 1, 2009 was recognized as a cumulative effect of a
change in accounting principle in the Companys
consolidated statement of changes in stockholders equity.
63
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 12
DERIVATIVE
INSTRUMENTS Continued
During the year ended December 31, 2009, the convertible
note and all conversion features for the above financing were
converted to common stock at the default rate in accordance with
the agreement dated January 29, 2009 with the note holders,
resulting in a derivative gain of $3,565,091 being recognized in
the Companys consolidated statements of operations and
comprehensive loss.
In addition, after January 1, 2009 the Company entered into
transactions which also required the estimation of the fair
value of warrant and conversion feature derivatives. For the
period from January 1, 2009 to September 30, 2010, the
Company estimated the fair value of these derivatives using the
Black-Scholes valuation method. During the fourth quarter of
2010, the Company determined that the binomial lattice option
pricing model was a more appropriate valuation technique and
used it to estimate the fair value of its December 17, 2010
financing transaction and also applied this new valuation
technique in calculating the 2010
mark-to-market
adjustment for all of its warrants and conversion features
recognized as derivative instruments. The effect of the change
in valuation techniques on previous financial statements was
immaterial.
In addition to the convertible note above, the Company
recognized the following warrant and conversion features as
derivatives in 2009:
On May 7, 2009, in connection with the Notes issued
pursuant to the financing agreement described in Note 10,
the Investor received five-year warrants to purchase
750,000 shares and 350,000 shares of Company common
stock, with exercise prices of $1.00 per share and $1.50 per
share (which were subsequently repriced to $1.02 per share),
respectively, (Class C and D warrants, respectively). An
investment banker also was issued 135,000 Class C warrants
and 65,000 Class D warrants. These warrants are subject to
certain anti-dilution right for issuance below the exercise
prices and are not registered and cannot be traded. The Company
has determined that the warrant provisions providing for
protection for issuances below the warrant exercise prices could
result in modification of the exercise price based on a variable
that is not an input to the fair value for a
fixed-for-fixed
option. Therefore the Company has determined that the warrants
issued in connection with this financing to be a derivative
instrument which is required to be shown as a derivative
liability subject to
mark-to-market
adjustment each reporting period. The fair value of the warrants
was determined using a Black-Scholes model with the following
assumptions: risk-free interest rate of 2.05%; no dividend
yield; volatility of 96.7% and an expected term of 5 years.
The resulting derivative liability on May 7, 2009 was
approximately $1,841,100 of which $1,558,000 was recorded as
interest expense, because of the immediate payment of the notes,
and $283,000 was recorded as general and administrative expense
on the consolidated statement of operations and comprehensive
loss for the year ended December 31, 2009. The liability
was revalued as of December 31, 2009 using a Black-Scholes
model and the following assumptions: risk-free interest rate of
2.35%; no dividend yield, volatility of 98.6%, resulting in a
revalued liability of approximately $563,500 and a derivative
gain of approximately $1,278,000. The liability was revalued as
of December 31, 2010 using the binomial lattice pricing
option method with the following assumptions: risk-free interest
rate of 1.02%; no dividend yield, volatility of 136.2%,
resulting in a revalued liability of approximately $338,255.
On September 8, 2009, in connection with the Notes issued
pursuant to the financing agreement on that date described more
fully in Note 10, the Investor received a five-year warrant
to purchase 2,500,000 shares of the Companys common
stock, with an exercise price of $1.25 per share, subject to
certain anti-dilution rights for issuances below such exercise
price; provided that absent shareholder approval, the exercise
price may not be reduced to less than $1.08 per share
(Class G warrants). These warrants are not registered and
cannot be traded. The Company has determined that the warrant
provisions providing for issuances below the warrant exercise
price could result in modification of the exercise price based
on a variable that is not an input to the fair value for a
fixed-for-fixed
option. The Company has determined that the warrants issued in
connection with this financing are a derivative instrument which
is required to be shown as a derivative liability subject to
mark-to-market
adjustment each reporting period. The fair value of the
derivative liability was determined on September 8, 2009
using a Black-Scholes model and the following assumptions;
risk-free interest rate of 2.38%; no dividend yield; volatility
of
64
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 12
DERIVATIVE
INSTRUMENTS Continued
94.3%; expected term of 5 years. The resulting liability of
$1,986,600 was recorded as a discount on the Note to the extent
of the Note balance of $1.4 million, and was amortized over
the six month note term, and the remaining $587,000 was recorded
as interest expense in the year ended December 31, 2009.
The derivative liability was revalued as of December 31,
2009 using a Black-Scholes model and the following assumptions:
risk-free interest rate of 2.35%; no dividend yield; volatility
of 98.6%, resulting in a revalued liability of approximately
$1,063,200 and a derivative gain of approximately $923,000. The
liability was revalued as of December 31, 2010 using the
binomial lattice pricing option method with the following
assumptions: risk-free interest rate of 1.02%; no dividend
yield, volatility of 136.2%, resulting in a revalued liability
of approximately $696,760
The total derivative liability as of December 31, 2009
relating to the above two issuances was approximately $1,626,700
and the derivative gain for the year ended December 31,
2009 relating to the above two transactions and the January 2008
convertible note was approximately $5,766,000.
In addition to the above 2009 transactions, the Company entered
into the following warrant and conversion feature derivatives
transactions in 2010:
On April 22, 2010, in connection with common stock issued
pursuant to a financing agreement on that date, an investor
received a five-year warrant to purchase 1,163,362 shares
of the Companys common stock, with an original exercise
price of $1.06 per share, subject to certain anti-dilution
rights for issuances below such exercise price (Class I
warrants). These warrants are not registered and cannot be
traded. The Class I warrants are exercisable one year from
the date of issuance. The Company has determined that the
warrant provisions providing for protection for issuances below
the warrant exercise price could result in modification of the
exercise price based on a variable that is not an input to the
fair value for a
fixed-for-fixed
option. The Company has determined the warrants issued in
connection with this financing are a derivative instrument which
is subject to
mark-to-market
adjustment each reporting period. On April 22, 2010 the
fair value of the derivative liability was determined to be
$968,000 using a Black-Scholes model and the following
assumptions; risk-free interest rate of 1.27%; no dividend
yield; volatility of 122.3%; expected term of 5 years. The
liability was revalued as of December 31, 2010 using the
binomial lattice pricing option method with the following
assumptions: risk-free interest rate of 2.01%; no dividend
yield, volatility of 136.2%, resulting in a revalued liability
of approximately $347,441.
On December 17, 2010, the Company issued notes convertible
into shares of the Companys common stock (see
Note 11) at the lower of i) the conversion price
then in effect or (ii) 85% of the average of the three
lowest closing sales price of the Companys common stock
during a 20 trading day prior to payment. The initial conversion
price of $1.00 is subject to certain anti-dilution provisions
which the Company identified as embedded derivatives. At
December 17, 2010 the Company determined a fair value of
the debt derivative to be $2,057,184 using the Binomial Lattice
Option Pricing Model based on the following assumptions:
risk-free interest rate of 2.01%; no dividend yield; volatility
of 136.2%; expected term of 6 months and assumptions of
possible exercise prices and a probability of occurrence of
each. The debt derivative liability was revalued as of
December 31, 2010 using the binomial lattice pricing option
method with the following assumptions: risk-free interest rate
of 2.01%; no dividend yield; volatility of 136.2%; expected term
of 5 months, and assumption of three possible exercise
prices and a probability of occurrence of each, resulting in a
revalued liability of approximately $2,900,204.
In connection with the December 17, 2010 convertible notes
issuance the Company issued three series of warrants
(Series A, Series B, Series C) for an
aggregate of 7,876,948 warrants to purchase the Companys
common stock at exercise prices of $1.00 a share for one to five
years. These warrants contain certain anti-dilution provisions,
therefore the Company classified the fair value of these
warrants as a derivative liability at the date of issuance. At
December 17, 2010 the Company determined the fair value of
the debt derivative to be $3,020,486 using the Binomial Lattice
Option Pricing Model based on the following assumptions:
risk-free interest rate of 2.01%; no dividend yield; volatility
of 136.2%; expected term of 6 months and assumptions of
possible exercise prices and a probability of occurrence of
each. The debt derivative liability was revalued as of
December 31, 2010 using the binomial lattice pricing option
method with the
65
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 12
DERIVATIVE
INSTRUMENTS Continued
following assumptions: risk-free interest rate of 2.01%; no
dividend yield, volatility of 136.2%, expected term of
5 months, and assumption of three possible exercise prices
and a probability of occurrence of each, resulting in a revalued
liability of approximately $3,617,758.
The Company recorded the initial fair values of the conversion
feature ($2,057,184) and the warrants $(3,020,486) up to the net
proceeds of the note ($3,750,000) as a discount on the Note
which is amortized ratably over the six-month term. The excess
fair value of $1,327,670 was charged to interest expense in the
consolidated statement of operations and comprehensive loss at
the date of issuance.
In addition to the above derivative transactions that were
valued on December 31, 2010 using the Binomial Lattice
option pricing model, on November 12, 2010, the Company
completed the acquisition of Terrasphere Systems LLC, ( See
Note 4 ) where it determined that as a result of an
anti-dilution provision included in the purchase agreement that
certain additional shares may have to be issued. The Company
estimated that approximately 2,040,000 shares could be
issued, and based on the closing day market price of $.41 on
that date, classified the potential issuance as a derivative
liability of $836,000. As of December 31, 2010 the Company
revalued the derivative liability to $775,200, based on the
closing share price of the stock on that date.
The total derivative liability reflected on the consolidated
balance sheet at December 31, 2010 taking into account all
of the 2009 and 2010 transactions listed above and revalued at
December 31, 2010 totaled $8,675,619 and the derivative
loss for the year ended December 31, 2010 was $166,712
NOTE 13
STOCKHOLDERS EQUITY
AUTHORIZED
SHARES
At the June 25, 2009 annual meeting of shareholders, the
shareholders approved a resolution to increase the number of
common shares that the Company is authorized to issue from
40,000,000 to 75,000,000. On June 30, 2010, the
Companys stockholders approved the amendment to the
Companys Certificate of Incorporation to increase the
number of shares of common stock that the Company is authorized
to issue from 75,000,000 shares to 250,000,000 shares.
On October 18, 2010, the Board approved the issuance
17,500 shares of the Companys preferred stock which
was then designated Series A Preferred stock. Each share of
Series A Preferred is convertible into a number of shares
of common stock equal to (1) the stated value of the share
($1,000), divided by (2) $0.543 (the Conversion
Price) which aggregates to 32,228,361 shares of
Company common stock. Holders of the Series A Preferred are
entitled to receive cumulative dividends at the rate per share
(as a percentage of the stated value per share) of 1% per annum
(subject to increase in certain circumstances), payable annually
and on each conversion date. The dividends are payable, during
the first three years after issuance, at the election of the
Company, and thereafter, at the election of the holders, in cash
or in shares of common stock valued at the Conversion Price (or
in some combination thereof).
STOCK
ISSUANCES
On January 24, 2009, the Company issued 200,000 shares
of its common stock to the holders of its convertible debentures
as consideration for the refinancing described in Note 11.
On March 10, 2009, the Company granted 121,528 shares
of common stock to a consultant providing development services
related to the Companys proposed Rhode Island facility.
The grant was measured using the closing price of the
Companys stock on the date of grant. The statement of
operations and comprehensive loss includes a charge of $120,316
for the year ended December 31, 2009 related to this grant,
which was credited to additional paid-in capital.
66
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
On May 19, 2009, the Company entered into an agreement with
an institutional investor (the Investor) whereby the
Investor agreed to purchase 1,500,000 shares of the
Companys common stock under its shelf registration
statement, for $1.40 per share, providing the Company with
$2.1 million before fees and expenses of $172,000, which
were charged to additional paid-in capital. The May 7, 2009
non-convertible short-term note described in Note 10 was
immediately paid off with proceeds of this offering. In
addition, and as an inducement to enter into this transaction,
the Company issued the Investor 1,500,000 warrants, with a
strike price of $1.40 and a 90 day term. On May 26,
2009, the Investor exercised the warrants and received
1,500,000 shares of common stock, providing net proceeds to
the Company of $2.1 million before expenses of $135,000.
On July 15, 2009, the Company entered into a Securities
Purchase Agreement with an institutional investor. Pursuant to
the Securities Purchase Agreement, the Company agreed to issue
to the investor: (a) 1,961,000 shares of the
Companys common stock at $1.02 per share; and
(b) warrants to purchase an additional 585,000 shares
of the Companys common stock at an exercise price of $1.25
per share. The Warrants may be exercised commencing
January 15, 2010 until July 15, 2014.
On October 20, 2009, the Company closed its second public
offering of 17,250,600 units, including
2,250,000 units reflecting the exercise in full of the
underwriters over-allotment option, at a price per unit of
$1.06 to the public. Each unit consists of one share of common
stock and one newly created Class H warrant, with each
Class H warrant exercisable for one share of common stock
at an exercise price of $1.30 per share. The warrants will
expire on October 14, 2014. The net proceeds of
approximately $16.4 million, after deducting the
underwriting discounts and commissions and other estimated
offering expenses, were used to further develop and execute the
Companys sales and marketing plan, strategic growth
initiatives, other general corporate purposes, and to repay the
six-month note the Company issued in September 2009 in the
principal amount of $1,540,000.
On December 15, 2009, the Company granted
30,000 shares of common stock to a consultant who provides
professional services to the Company as remuneration for
services rendered. The grant was measured using the closing
price of the Companys stock on the date of grant. The
statement of operations and comprehensive loss includes a charge
of $18,897 for the year ended December 31, 2009 related to
this grant, which was credited to additional paid-in capital.
On March 17, 2010, the Company granted 165,000 shares
of common stock to a consultant who provided investor relations
consulting services to the Company. The grant was measured using
the closing price of the Companys stock on the date of
grant. The statements of operations and comprehensive loss
includes a charge of $160,050 for the year ended
December 31, 2010 related to this grant, which was credited
to common stock and additional paid-in capital.
On April 22, 2010, Converted Organics Inc. entered into a
Securities Purchase Agreement with a single institutional
investor. Pursuant to the Securities Purchase Agreement, the
Company agreed to issue to the investor:
(a) 2,400,000 shares of its common stock at $1.06 per
share and (b) five-year warrants to purchase
1,163,362 shares of its common stock at an exercise price
of $1.06 per share (Class I Warrants). The warrants may be
exercised at any time on or following a date one year after the
date of issuance and will expire five years from the date of
issuance. The transaction provided the Company with net proceeds
of approximately $2.4 million.
On July 19, 2010, the Company issued 1,623,333 shares
of its common stock and warrants (Class J Warrants) to
acquire 1,623,333 shares of common stock to Atlas Advisors,
LLC (Atlas). The warrants will expire five years
from the date of issuance and have a strike price of $0.54 per
share. The issuance to Atlas was made pursuant to an agreement
between the parties regarding payments due to Atlas pursuant to
a Business Development Agreement dated January 29, 2010.
Under the Business Development Agreement, the Company had agreed
to compensate Atlas in the event of any mergers
and/or
acquisitions that were a result of the services provided by
Atlas, such payment was to have included both cash payments and
equity payments. Pursuant to the agreement reached between the
parties, in exchange for the equity consideration listed herein,
Atlas agreed that no further
67
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
consideration be paid to it in connection with the
Companys proposed acquisition of TerraSphere Systems, LLC.
The stock and warrant payment was made to Atlas at a share price
of $0.54, which was the closing price of the Companys
common stock on the date of the TerraSphere acquisition
agreement. The warrants issued to Atlas were issued at an
exercise price equal to the price at which the common shares
were issued.
During the year ended 2010, the Company issued
646,500 shares of common stock representing principal and
interest payments of approximately $414,000 in satisfaction of
its convertible debt obligation issued in connection with the
acquisition of the Gonzales facility.
The Company issued 320,811 shares of its common stock as
severance payments to certain employees during the third quarter
of 2010. The statements of operations and comprehensive loss
includes a charge of approximately $190,000 for the year ended
December 31, 2010, which was credited to common stock and
additional paid-in capital.
On August 30, 2010, the Company issued
1,157,407 shares of its common stock and warrants
(Class K Warrants) to acquire 1,157,407 shares of
common stock to Atlas. The warrants will expire five years from
the date of issuance and have a strike price of $0.54. The
issuance to Atlas was made as consideration for the termination
of a Business Development Agreement dated January 29, 2010
by and between the Company and Atlas. The statements of
operations and comprehensive loss includes a charge of
approximately $625,000 for the year ended December 31,
2010, which was credited to common stock and additional paid-in
capital.
On October 18, 2010, the Company granted
165,000 shares of common stock to a consultant who provided
investor relations consulting services to the Company. The grant
was measured using the closing price of the Companys stock
on the date of grant. The statements of operations and
comprehensive loss includes a charge of $92,400 for the year
ended December 31, 2010 related to this grant, which was
credited to common stock and additional paid-in capital.
On October 18, 2010, Converted Organics Inc. entered into
an Exchange Agreement (the Exchange Agreement) with
the sole Bond Holder of $17,500,000 New Jersey Economic
Development Authority Bonds (the Bonds) that were
issued on behalf of Woodbridge. Pursuant to the Exchange
Agreement, the Bond Holder agreed to exchange: (i) the
Bonds, and (ii) class B warrants to purchase
2,284,409 shares the Companys common stock (the
Class B Warrants) for 17,500 shares of the
Companys newly desiganted 1% Series A Convertible
Preferred Stock (the Series A Preferred Stock).
The Series A Preferred Stock is convertible into the number
of shares of Common Stock equal to (1) the stated value of
the share ($1,000), divided by (2) $0.543 (the
Conversion Price) which aggregates to
32,228,361 shares of Company common stock. Holders of the
Series A Preferred are entitled to receive cumulative
dividends at the rate per share (as a percentage of the stated
value per share) of 1% per annum (subject to increase in certain
circumstances), payable annually and on each conversion date.
The dividends are payable, during the first three years after
issuance, at the election of the Company, and thereafter, at the
election of the holder, in cash or in shares of Company common
stock valued at the Conversion Price (or in some combination
thereof).
On October 18, 2010, the Company and the Woodbridge
Facilitys landlord (Lessor) entered into a
Termination and Surrender Agreement (Termination
Agreement) related to the termination of the Woodbridge
Facility lease. Pursuant to the terms of the Termination
Agreement, the Company agreed to issue the Lessor a total of
892,857 shares of Company common stock valued at $0.56 per
share totaling $500,000 (see Note 5).
On October 18, 2010, the Superior Court of the State of
California for the County of Los Angeles entered an Order in the
matter entitled American Capital Management, LLC
(ACM) v. Converted Organics Inc. and Converted
Organics of Woodbridge, LLC and Does 1-10 Inclusive (the
Order). Pursuant to the terms of the Order, the
Company agreed to issue to ACM a total of 20,726,980 shares
of Company common stock valued at $0.543 per
68
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
share totaling approximately $11,255,000 in full and final
settlement of the claims related to the Woodbridge facility (see
Note 5).
On November 12, 2010, the Company acquired 95% of
TerraSphere Systems, LLC by issuing 18,174,603 shares of
Company common stock at the closing valued at approximately
$9,565,000. The Company is obligated to issue additional shares
of common stock if certain milestones are met and/or certain
anti-dilution provisions are triggered (see Note 4).
On December 31, 2010, the Company acquired 83.34% of
GoLocalProduceRI, LLC for $480,000 issuing 1,371,428 shares
of Company common stock at $0.35 based on the 30 day
average at the time of the agreement (Note 4).
WARRANTS
On February 16, 2007, in connection with the Companys
initial public offering, the Company sold 1,800,000 equity
units consisting of one share of common stock, one Class A
warrant and one Class B warrant. On March 13, 2007,
the Class A and Class B warrants began to trade as
separate securities. The Class A warrants are exercisable
for one share of common stock, plus accumulated stock dividends,
for $8.25. The Class A warrants expire on February 16,
2012 and, if certain conditions are met, the Company may redeem
these warrants at a price of $0.25 per warrant prior to the
expiration date. The warrants were redeemed during 2008, as more
fully described below. The Class B warrants are exercisable
for one share of common stock, plus accumulated stock dividends,
for $11.00. The Class B warrants expire on
February 16, 2012 and there is no provision for the Company
to redeem these warrants prior to the expiration date.
On January 24, 2008, in conjunction with the private
financing arrangement of the Company described in Note 11,
the Company issued 750,000 Class A and 750,000 Class B
Warrants to the Investors. Such warrants are exercisable for one
share of the Companys common stock, adjusted for
dividends, at $8.25 and $11.00, respectively. Once the
Companys registration statement related to the underlying
shares was declared effective, one-half of the warrants were
returned to the Company by the Investors, as described in
Note 11.
On March 6, 2009, the Company entered into an agreement
with the holders of the New Jersey Economic Development
Authority Bonds to release $2.0 million for capital
expenditures on its New Jersey facility and to defer interest
payments on the bonds through July 30, 2009. These funds
had been held in a reserve for bond principal and interest
payments along with a reserve for lease payments. As
consideration for the release of the reserve funds, the Company
issued the bond holders 2,284,409 Class B warrants. The
Class B warrants are exercisable at $11.00 per warrant. The
expense associated with these warrants of $662,000 is reflected
as interest expense in the consolidated statements of operations
and comprehensive loss for the year ended December 31, 2009.
On May 7, 2009, the Company issued 885,000 Class C
warrants and 415,000 Class D warrants in connection with
securing a private financing agreement more fully described in
Note 10. Each Class C and Class D warrant may be
exchanged for one share of common stock at an exercise price of
$1.00 and $1.02, respectively. The shares underlying these
warrants have not been registered and these warrants cannot be
traded.
On May 19, 2009, in connection with the issuance of
1,500,000 shares of common stock, the Company issued
1,500,000 warrants with an exercise price of $1.40. These
warrants were exercised on May 26, 2009.
On May 26, 2009, as an inducement for the Investor to
exercise 1,500,000 warrants at $1.40, the Company issued the
Investor an additional 1,500,000 Class E warrants with an
exercise price of $1.63 and an expiration date of May 27,
2014. Each warrant may be exchanged for one share of common
stock.
69
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
On July 15, 2009, in connection with the issuance of
1,961,000 shares to an institutional investor, the Company
issued Class F warrants to purchase 585,000 shares of
the Companys common stock at an exercise price of
$1.25 per share. The Warrants may be exercised commencing
January 15, 2010 until July 15, 2014.
On September 8, 2009, the Company issued 2,500,000
Class G warrants in connection with the Notes issued
pursuant to the financing agreement described more fully in
Note 11. Each Class G warrant may be exchanged for one
share of common stock at an exercise price of $1.25 per share,
subject to certain anti-dilution rights for issuances below such
exercise price; provided that absent shareholder approval, the
exercise price may not be reduced to less than $1.08 per share.
The shares underlying these warrants have not been registered
and these warrants cannot be traded.
On October 20, 2009, the Company issued 17,250,000
Class H warrants in conjunction with its secondary public
offering, described above. Each Class H warrant may be
exchanged for one share of common stock at an exercise price of
$1.30, and have an expiration date of October 14, 2014.
Each warrant may be exchanged for one share of common stock.
On April 22, 2010, in connection with the issuance of
2,400,000 shares to an institutional investor, the Company
issued Class I warrants to purchase 1,163,362 shares
of its common stock at an exercise price of $1.06 per share. The
Warrants may be exercised commencing April 22, 2011 until
April 21, 2016.
On July 19, 2010, in connection with the issuance of
1,623,333 shares to Atlas, the Company issued Class J
warrants to purchase 1,623,333 shares of its common stock
at an exercise price of $0.54 per share. The Warrants may be
exercised commencing July 19, 2010 until July 18, 2015.
On August 30, 2010, in connection with the issuance of
1,157,407 shares to Atlas, the Company issued Class K
warrants to purchase 1,157,407 shares of its common stock
at an exercise price of $0.54 per share. The Warrants may be
exercised commencing August 30, 2010 until August 29,
2015.
On December 17, 2010, pursuant to the terms of the Purchase
Agreement, the Company issued to the Buyers warrants to acquire
shares of common stock, in the form of three warrants:
(i) Series A Warrants,
(ii) Series B Warrants, and
(iii) Series C Warrants (collectively, the
Warrants). The Warrants will be issued in two
tranches on the dates the Initial Notes and Additional Notes are
issued, on a pro rata basis based on the principal amount being
issued in the applicable closing based on the aggregate
principal amount that could be issued at both closings.
The Series B Warrants are exercisable anytime after the
occurrence of the earlier of obtaining shareholder approval or
the date on which the Initial Notes are no longer outstanding
and expires upon the earlier to occur of: (i) the first
anniversary of the date on which it becomes exercisable and
(ii) the nine (9) month anniversary of the date on
which shareholder approval is obtained. The Series B
Warrants provide that the holders are initially entitled to
purchase an aggregate of 4,990,000 shares (warrants to
purchase 3,939,473 shares of Common Stock were issued at
the Initial Closing and a warrant to purchase
1,050,527 shares of Common Stock will be issued at the
Additional Closing if it occurs) at an initial exercise price of
$1.00 per share. If the Company makes certain dilutive issuances
(with limited exceptions), the exercise price of the
Series B Warrants will be lowered to the per share price
for the dilutive issuances. In addition, the exercise price of
the Series B Warrants will adjust to the average of the
Installment Conversion Prices used to repay the Initial Notes.
The floor price for the exercise price of the Series B
Warrants is $0.345. The number of shares underlying the
Series B Warrants will adjust whenever the exercise price
adjusts, such that at all times the aggregate exercise price of
the Series B Warrants will be $4,990,000 ($3,939,473 for
the Series B Warrants issued in the Initial Closing and
$1,050,527 for the Series B Warrants to be issued at the
Additional Closing if it occurs).
To the extent we enter into a fundamental transaction (as
defined in the Series B Warrants and which include, without
limitation, our entering into a merger or consolidation with
another entity, our selling all or substantially all
70
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
of our assets, or a person acquiring 50% of our Common Stock),
the Company has agreed to purchase the Series B Warrant
from the holder at its Black-Scholes value.
If the Companys common stock trades at a price at least
200% above the Series B Warrants exercise price for a
period of 10 trading days at any time after it gets shareholder
approval, the Company may force the exercise of the
Series B Warrants if it meets certain conditions.
The Series A and Series C Warrants are exercisable
anytime after the earlier to occur of: (i) the date on
which shareholder approval is obtained and (ii) the six
month and one day anniversary of the Initial Closing and have a
five year term. The Series A Warrants provide that the
holders are initially entitled to purchase an aggregate of
2,495,000 shares (warrants to purchase
1,969,737 shares of common stock were issued at the Initial
Closing and warrants to purchase 525,263 shares of common
stock will be issued at the Additional Closing if it occurs) at
an initial exercise price of $1.00 per share. The Series C
Warrants provide that the holders are initially entitled to
purchase an aggregate of 2,495,000 shares (warrants to
purchase 1,969,737 shares of common stock were issued at
the Initial Closing and warrants to purchase 525,263 shares
of common stock will be issued at the Additional Closing if it
occurs) at an exercise price of $1.00 per share; provided that
the Series C Warrants may only be exercised by each holder
in the same proportion as such holder has already exercised its
Series B Warrants.
If the Company makes certain dilutive issuances (with limited
exceptions), the exercise price of the Series A and
Series C Warrants will be lowered to the per share price
for the dilutive issuances. In addition, the exercise price of
the Series A and Series C Warrants will adjust to the
average of the Installment Conversion Prices used to repay the
Initial Notes. Until the Company obtains shareholder approval,
the floor price of the Series A and Series C Warrants
is $0.345.
To the extent the Company enters into a fundamental transaction
(as defined in the Series A and Series C Warrants and
which include, without limitation, our entering into a merger or
consolidation with another entity, our selling all or
substantially all of our assets, or a person acquiring 50% of
our Common Stock), the Company has agreed to purchase the
Series A and Series C Warrants from the holder at its
Black-Scholes value.
The exercise price of all the Warrants is subject to adjustment
in the case of stock splits, stock dividends, combinations of
shares and similar recapitalization transactions. The
exercisability of the Warrants may be limited if, upon exercise,
the holder or any of its affiliates would beneficially own more
than 4.9% of our Common Stock. Neither the Notes nor the
Series B Warrants may be converted or exercised, as
applicable, if the total number of shares that would be issued
would exceed 19.99% of the Company common stock on the date the
Purchase Agreement was executed prior to our receiving
shareholder approval.
WARRANT
EXERCISE
On May 26, 2009, the Investor exercised its 1,500,000
warrants at $1.40, providing the Company with $2.1 million
before fees and expenses of $135,000, which were charged to
Additional Paid-in Capital. The Company issued
1,500,000 shares of common stock upon exercise of these
warrants.
The intrinsic value of the Companys warrants is $0 as of
December 31, 2010 and 2009.
71
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
The following table sets forth the outstanding warrants as of
December 31, 2010 and 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at
|
|
|
Excercisable at
|
|
|
|
|
|
|
January 1,
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
Warrants
|
|
Price
|
|
|
2009
|
|
|
Issued
|
|
|
Excercised
|
|
|
Canceled
|
|
|
2009
|
|
|
Issued
|
|
|
Excercised
|
|
|
Canceled
|
|
|
2010
|
|
|
2010
|
|
|
Class B
|
|
$
|
11.00
|
|
|
|
2,648,029
|
|
|
|
2,284,409
|
|
|
|
|
|
|
|
|
|
|
|
4,932,438
|
|
|
|
|
|
|
|
|
*
|
|
|
(2,284,409
|
)
|
|
|
2,648,029
|
|
|
|
2,648,029
|
|
Class C
|
|
$
|
1.00
|
|
|
|
|
|
|
|
885,000
|
|
|
|
|
|
|
|
|
|
|
|
885,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
885,000
|
|
|
|
885,000
|
|
Class D
|
|
$
|
1.02
|
|
|
|
|
|
|
|
415,000
|
|
|
|
|
|
|
|
|
|
|
|
415,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
415,000
|
|
|
|
415,000
|
|
May 19, 2009 Warrants
|
|
$
|
1.40
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
(1,500,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class E
|
|
$
|
1.63
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
Class F
|
|
$
|
1.25
|
|
|
|
|
|
|
|
585,000
|
|
|
|
|
|
|
|
|
|
|
|
585,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
585,000
|
|
|
|
585,000
|
|
Class G
|
|
$
|
1.25
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
2,500,000
|
|
Class H
|
|
$
|
1.30
|
|
|
|
|
|
|
|
17,250,000
|
|
|
|
|
|
|
|
|
|
|
|
17,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,250,000
|
|
|
|
17,250,000
|
|
Class I
|
|
$
|
1.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,163,362
|
|
|
|
|
|
|
|
|
|
|
|
1,163,362
|
|
|
|
|
|
Class J
|
|
$
|
0.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,623,333
|
|
|
|
|
|
|
|
|
|
|
|
1,623,333
|
|
|
|
1,623,333
|
|
Class K
|
|
$
|
0.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,157,407
|
|
|
|
|
|
|
|
|
|
|
|
1,157,407
|
|
|
|
1,157,407
|
|
December 17, 2010 Series A
|
|
$
|
0.345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,969,737
|
|
|
|
|
|
|
|
|
|
|
|
1,969,737
|
|
|
|
1,969,737
|
|
December 17, 2010 Series B
|
|
$
|
0.345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,939,474
|
|
|
|
|
|
|
|
|
|
|
|
3,939,474
|
|
|
|
3,939,474
|
|
December 17, 2010 Series C
|
|
$
|
0.345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,969,737
|
|
|
|
|
|
|
|
|
|
|
|
1,969,737
|
|
|
|
1,969,737
|
|
|
|
|
* |
|
On October 18, 2010, 2,284,409 Class B warrants were
retired by the Bond holder (see Note 12). |
In the event all outstanding warrants are exercised, the Company
has adequate shares authorized to meet these obligations.
STOCK
OPTIONS
The Companys Board of Directors and stockholders approved
the 2006 Stock Option Plan (the Option Plan). The
Option Plan authorizes the grant and issuance of options and
other equity compensation to employees, officers and consultants.
On June 27, 2009, the Company granted 233,500 stock options
under its 2006 Stock Option Plan. The options have an exercise
price of $1.10 and expire ten years from the date of grant. The
exercise price was based on the closing price of the stock on
the date of grant. The expense associated with this option grant
was calculated using a Black-Scholes model and the following
assumptions: risk-free interest rate of 2.85%; no dividend
yield; volatility of 96.7%; and an expected term of
5 years. The resulting expense of $190,000 is included in
general and administrative expense on the consolidated statement
of operations and comprehensive loss for the year ended
December 31, 2009.
On November 19, 2009, the Company granted 100,000 stock
options under its 2006 Stock Option Plan to a consultant of the
Company who provides odor control services. The options may be
exercised for a price of $.75 per share. One half of the options
vested upon grant, and one half will vest on November 30,
2010 if the consultant continues to be retained by the Company.
The Company is recording the issuance of these options in
accordance with ASC
Section 505-50.
The expense associated with the options that vest immediately
was calculated using a Black-Scholes model and the following
assumptions: risk-free interest rate of 2.35%; no dividend
yield; volatility of 96.6%; expected term of 5 years. The
resulting expense of $27,602 is included in general and
administrative expense on the consolidated statement of
operations and comprehensive loss for the year ended
December 31, 2009. The expense associated with the options
that vest on November 30, 2010, was calculated with a
Black-Scholes model and the same assumptions, except an expected
term of 4.5 years. The resulting expense of $26,639 will be
recognized as expense ratably over the vesting period.
Accordingly, an expense of $22,000 and $4,440 is included in
general and administrative expense on the consolidated statement
of operations and comprehensive loss for the years ended
December 31, 2010 and 2009.
72
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 13
STOCKHOLDERS
EQUITY Continued
On January 4, 2010, the Companys Compensation
Committee approved an employee and director stock option grant
under the Amended and Restated 2006 Stock Option Plan. A total
of 2,458,500 options were granted with an exercise price of
$.68, which was the closing price as of the date of grant. The
cost associated with this option grant was calculated using a
Black-Scholes model and the following assumptions: risk-free
interest rate of 2.35%; no dividend yield; volatility of 98.6%;
expected term of 5 years. The resulting expense of
approximately $1,188,000 is reflected in the Companys
consolidated statement of operations and comprehensive loss for
the year ended December 31, 2010.
On March 12, 2010, the Companys Compensation
Committee approved a stock option grant under the Amended and
Restated 2006 Stock Option Plan. A total of 50,000 options were
granted with an exercise price of $.97, which was the closing
price as of the date of grant. The cost associated with this
option grant was calculated using a Black-Scholes model and the
following assumptions: risk-free interest rate of 2.35%; no
dividend yield; volatility of 98.6%; expected term of
5 years. The resulting expense of approximately $48,500 is
reflected in the Companys consolidated statement of
operations and comprehensive loss for the year ended
December 31, 2010.
As of December 31, 2010, the Company had 3,638,047 options
available to grant under the plan.
Stock option activity for 2010 and 2009 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Average
|
|
|
Average
|
|
|
|
Stock
|
|
|
Price per
|
|
|
Exercise
|
|
|
Remaining
|
|
|
|
Options
|
|
|
Share
|
|
|
Price
|
|
|
Life (Years)
|
|
|
Outstanding and exercisable at January 1, 2009
|
|
|
1,256,735
|
|
|
$
|
4.50
|
|
|
$
|
4.50
|
|
|
|
9.5
|
|
Granted
|
|
|
233,500
|
|
|
|
1.10
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
100,000
|
|
|
|
.75
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(359,940
|
)
|
|
|
5.02
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable at December 31, 2009
|
|
|
1,230,295
|
|
|
$
|
3.54
|
|
|
$
|
3.54
|
|
|
|
8.5
|
|
Granted
|
|
|
2,458,500
|
|
|
|
.68
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
50,000
|
|
|
|
.97
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(45,000
|
)
|
|
|
.89
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(50,000
|
)
|
|
|
.68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable at December 31, 2010
|
|
|
3,643,795
|
|
|
$
|
1.64
|
|
|
$
|
1.64
|
|
|
|
8.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The aggregate intrinsic value of options outstanding and
exercisable at December 31, 2010 and 2009 is $0 and $0,
respectively. The aggregate intrinsic value represents the total
pretax intrinsic value, based on options with an exercise price
less than the Companys closing stock price of $0.38 and
$0.67 as of December 31, 2010 and 2009, respectively, which
would have been received by the option holders had those option
holders exercised their options as of that date.
At December 31, 2010, there was no unrecognized
compensation cost related to non-vested share-based compensation
arrangements granted under the Companys stock option plan.
As of December 31, 2009 the Company has estimated that its
unrecognized compensation cost related to non-vested share-based
compensation arrangements was approximately $22,000. During the
year ended December 31, 2010, the Company has received
approximately $34,000 as a result of the exercise of 50,000
options. No options were exercised in the year ended
December 31, 2009.
73
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 14
INCOME TAXES
At December 31, 2010, the Company had accumulated net
operating losses of approximately $88,300,000 which may be
offset against future taxable income, if any, expiring at
various dates through 2030.
The effective tax rate based on the federal and state statutory
rates is reconciled to the actual tax rate for the years ended
December 31, 2010 and 2009 as follows:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Statutory federal income tax rate
|
|
|
34
|
%
|
|
|
34
|
%
|
Statutory state income tax rate
|
|
|
6
|
|
|
|
6
|
|
Valuation allowance on net deferred tax assets
|
|
|
(40
|
)
|
|
|
(40
|
)
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
|
%
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The components of the net deferred tax asset (liability) at
December 31, 2010 and 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating losses
|
|
$
|
33,255,000
|
|
|
$
|
13,470,000
|
|
Accrued compensation
|
|
|
120,000
|
|
|
|
120,000
|
|
Stock options
|
|
|
1,925,000
|
|
|
|
1,410,000
|
|
Valuation allowance
|
|
|
(35,300,000
|
)
|
|
|
(15,000,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
The Company has fully reserved the approximately $35,300,000
deferred tax benefit with a valuation allowance of the same
amount, because the likelihood of realization of the tax benefit
cannot be determined to be more likely than not.
The Companys valuation allowance increased $20,300,000 and
$7,412,000 for the years ended December 31, 2010 and 2009,
respectively.
The Company has a tax benefit of approximately $1,925,000
related to the grant of common stock to certain key employees
and advisors. Pursuant to guidance provided by Sections 505
and 718 of the ASC, the benefit will be recognized and recorded
to APIC when the benefit is realized through the reduction of
taxes payable.
The Company complies with the provisions of ASC
Section 740. The guidance addresses the determination of
whether tax benefits claimed or expected to be claimed on a tax
return should be recorded in the financial statements. Under
Section 740, the Company may recognize the tax benefit from
an uncertain tax position only if it is more likely than not
that the tax position will be sustained on an examination by the
taxing authorities, based on the technical merits of the
position. The Company has determined that the Company has no
uncertain tax positions requiring recognition under the guidance.
The Company is subject to U.S. federal income tax as well
as income tax of certain state jurisdictions. The Company has
not been audited by the U.S. Internal Revenue Service or
any states in connection with its income taxes. The periods from
January 1, 2007 to December 31, 2009 remain open to
examination by the U.S. Internal Revenue Service and state
authorities.
The Companys net operating loss carryforwards may be
limited subject to the provisions of Section 382 the
Internal Revenue Code.
74
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 15
SEGMENT REPORTING
The Company has three lines of business, which are
(1) organic fertilizer, (2) vertical farming and
(3) industrial wastewater treatment. Based on the nature of
products and services offered, the Company has determined that
there are two reportable segments: (1) organic fertilizer
and (2) vertical farming at December 31, 2010. The
industrial wastewater treatment segment is not separately
reported as it is in the developmental stage and there is no
discreet financial information to report at December 31,
2010.
The Company evaluates performance based on several factors, of
which the primary financial measure is business segment
operating income. There were no intersegment sales as of
December 31, 2010. The discreet financial information
presented below is derived from the continuing operations as of
December 31, 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic
|
|
Vertical
|
|
Corporate and
|
|
|
|
|
Fertilizer
|
|
Farming
|
|
Eliminations
|
|
Consolidated
|
|
Revenues
|
|
$
|
3,275,325
|
|
|
$
|
250,000
|
|
|
$
|
|
|
|
$
|
3,525,325
|
|
Operating loss from continuing operations(1)
|
|
|
(1,279,055
|
)
|
|
|
(2,562,517
|
)
|
|
|
(12,197,453
|
)
|
|
|
(16,039,025
|
)
|
Depreciation and amortization(2)
|
|
|
369,544
|
|
|
|
85,403
|
|
|
|
34,656
|
|
|
|
489,603
|
|
Interest expense(3)
|
|
|
|
|
|
|
11,169
|
|
|
|
1,714,782
|
|
|
|
1,725,951
|
|
Total assets net of discontinued operations(4)
|
|
|
2,973,568
|
|
|
|
12,618,892
|
|
|
|
4,032,496
|
|
|
|
19,624,956
|
|
Goodwill
|
|
|
|
|
|
|
1,667,957
|
|
|
|
|
|
|
|
1,667,957
|
|
Property and equipment additions
|
|
|
294,878
|
|
|
|
29,157
|
|
|
|
|
|
|
|
324,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Operating loss from continuing operations of the principal
businesses exclude corporate compensation, marketing expense,
professional fees and other unallocated expenses. |
|
(2) |
|
Depreciation and amortization expense associated with property
and equipment and intangibles. Corporate amortization expense
relates to intangible asset technological know-how. |
|
(3) |
|
Corporate interest expense is primarily related to a convertible
note payable. |
|
(4) |
|
Total business assets are the owned or allocated assets used by
each business. Corporate assets consist of cash, intangibles and
certain other assets. |
Revenues are attributable to geographic areas based on location
of the customer, primarily within the continental United States.
Converted Organics derived approximately $1.9 million or
63% of its revenues from three customers and TerraSphere Inc.
derived 100% of its revenue from one customer as of
December 31, 2010.
As of December 31, 2009, the Company was a single
reportable segment.
NOTE 16
RELATED PARTY TRANSACTIONS
As of December 31, 2010 and 2009 the Company has an accrued
liability totaling $395,001 and $697,602, respectively,
representing accrued compensation to officers, directors and
consultants.
The Company had a term note payable to its CEO, Edward J.
Gildea. The unsecured term note for $89,170 was dated
April 30, 2007 with an original maturity of April 30,
2009 and accrued interest at 12% per annum. The note had been
extended for one year until April 30, 2010. The Company
paid accrued interest of $21,400 upon extension of the
notes due date on June 30, 2009. This note was
subordinate to the New Jersey EDA bonds. On December 18,
2009, the Company repaid the principal balance of the note plus
accrued interest of $6,777.
In connection with the Companys acquisition of TerraSphere
Systems, the Company assumed an unsecured note payable to
William Gildea, Secretary of the Company and brother of Edward
Gildea, the Companys Chairman and Chief Executive Officer,
that has an interest rate of 10% per annum. The principal amount
due totaled $72,351 at December 31, 2010. The Company has
accrued interest totaling $18,973 at December 31, 2010 and
incurred interest expense totaling $3,486 for the year ended
December 31, 2010.
75
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 16
RELATED PARTY
TRANSACTIONS Continued
The President of TerraSphere Inc. is Mark Gildea, a brother of
Edward Gildea, the Companys Chairman and Chief Executive
Officer and of William Gildea, Secretary. In addition, one of
the members of the Companys Board of Directors, Marshal
Sterman, is an officer, shareholder and director of a
TerraSphere licensee.
Converted Organics of Rhode Island, LLC was formed for the
purpose of developing and operating a waste to fertilizer
facility in Johnston, Rhode Island. A development consultant who
has provided services to the Company holds a 5% non-controlling
interest in Converted Organics of Rhode Island, LLC. For the
year ended December 31, 2009, the consultant was paid
$60,000 for services rendered, and was granted
121,528 shares of the Companys common stock. No
services were rendered for the year ended December 31, 2010.
|
|
NOTE 17
|
PROFIT
SHARING PLAN
|
The Company has a 401(k) plan for its employees. The plan allows
for employees to have a pretax deduction of up to 15% of pay set
aside for retirement. The plan also allows for a Company match
and profit sharing contribution. As of December 31, 2010
and 2009, the Company has not provided a match of employee
contributions nor did the Company contribute a profit sharing
amount to the plan.
|
|
NOTE 18
|
COMMITMENTS
AND CONTINGENCIES
|
LEASES
The Company leases many of its operating and office facilities
for various terms under long-term, non-cancelable operating
lease agreements. The leases expire at various dates through
2017 and provide for renewal options ranging from one year to
fifteen years. The Company expects that these leases will be
renewed or replaced by leases on other properties.
Rent expense incurred in connection with these leases was
approximately $360,000 and $244,000 of which $25,000 and
$110,000 was is included in Research and Development on the
consolidated statements of operations and comprehensive loss for
the years ended December 31, 2010 and 2009, respectively.
Rent expense related to the Woodbridge facility was
approximately $596,000 and $742,000 for the years ended
December 31, 2010 and 2009 and included in the consolidated
statements of operations and comprehensive loss as loss from
discontinued operations.
The following table sets for the Companys aggregate future
payments under its operating lease commitments as of
December 31, 2010:
|
|
|
|
|
Year ending December 31,
|
|
|
|
|
2011
|
|
$
|
329,772
|
|
2012
|
|
|
323,532
|
|
2013
|
|
|
219,681
|
|
2014
|
|
|
207,631
|
|
2015
|
|
|
132,504
|
|
2016 and thereafter
|
|
|
288,796
|
|
|
|
|
|
|
|
|
$
|
1,501,916
|
|
|
|
|
|
|
|
|
|
|
|
LEGAL
PROCEEDINGS
The Company is not currently aware of any pending or threatened
legal proceeding to which it is or would be a party, or any
proceedings being contemplated by governmental authorities
against it, or any of its executive officers or directors
relating to the services performed on the Companys behalf
except as follows.
76
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 18
|
COMMITMENTS
AND CONTINGENCIES Continued
|
On December 11, 2008, the Company received notice that a
complaint had been filed in a putative class action lawsuit on
behalf of 59 persons or entities that purchased units
pursuant to a financing terms agreement, or FTA, dated
April 11, 2006, captioned Gerald S. Leeseberg, et
al. v. Converted Organics, Inc., filed in the
U.S. District Court for the District of Delaware. The
lawsuit alleges breach of contract, conversion, unjust
enrichment, and breach of the implied covenant of good faith in
connection with the alleged failure to register certain
securities issued in the FTA, and the redemption of the
Companys Class A warrants in November 2008. The
lawsuit seeks damages related to the failure to register certain
securities, including alleged late fee payments, of
approximately $5.25 million, and unspecified damages
related to the redemption of the Class A warrants. In
February 2009, the Company filed a Motion for Partial Dismissal
of Complaint. On October 7, 2009, the Court concluded that
Leeseberg has properly stated a claim for actual damages
resulting from the Companys alleged breach of contract,
but that Leeseberg has failed to state claims for conversion,
unjust enrichment and breach of the implied covenant of good
faith, and the Court dismissed such claims. On November 6,
2009, the Company filed its answer to the Complaint with the
Court. On March 4, 2010, the parties participated in a
conference, and began discussing discovery issues. Plaintiff
filed a Motion for Class Certification on June 22,
2010, which was denied on November 22, 2010. On
March 3, 2011, the court denied the Companys motion
for partial summary judgment. On March 25, 2011, some
individual investors filed a new complaint against the Company
asserting similar claims to those in the Leeseberg litigation.
This case will likely be consolidated with the Leeseberg action.
The Company plans to vigorously defend these matters and is
unable to estimate any losses that may or may not be incurred as
a result of this litigation and new complaint and their eventual
disposition. Accordingly, no loss has been recorded related to
these matters.
Related to the above matter, in December 2009, the Company filed
a complaint in the Superior Court of Massachusetts for the
County of Suffolk, captioned Converted Organics Inc. v.
Holland & Knight LLP. The Company claims that in the
event it is required to pay any monies to Mr. Leeseberg and
his proposed class in the matter of Gerald S. Leeseberg, et
al. v. Converted Organics, Inc., that Holland &
Knight should make the Company whole, because its handling of
the registration of the securities at issue in the Leeseberg
lawsuit caused any loss that Mr. Leeseberg and other
putative class members claim to have suffered.
Holland & Knight has not yet responded to the
complaint. Holland and Knight has threatened to bring
counterclaims against Converted Organics for legal fees
allegedly owed, which we would contest vigorously. On
May 12, 2010, the Superior Court stayed the proceedings,
pending resolution of the Leeseberg litigation. At this early
stage in the case, the Company is unable to predict the
likelihood of an unfavorable outcome, or estimate any loss/gain.
On May 19, 2009, the Company received notice that a
complaint had been filed in the Middlesex County Superior Court
of New Jersey, captioned Lefcourt Associates, Ltd. v.
Converted Organics of Woodbridge, et al. The lawsuit alleged
private and public nuisances, negligence, continuing trespasses
and consumer common-law fraud in connection with the odors
emanating from the Woodbridge facility and its alleged,
intentional failure to disclose to adjacent property owners the
possibility of the facility causing pollution and was later
amended to allege adverse possession, acquiescence and easement.
The lawsuit sought enjoinment of any and all operations which in
any way cause or contribute to the alleged pollution,
compensatory and punitive damages, counsel fees and costs of
suit and any and all other relief the Court deems equitable and
just. On April 12, 2010, the Middlesex County Superior
Court of New Jersey issued an administrative order settlement
dismissing without prejudice the matter of Lefcourt Associates,
Ltd. v. Converted Organics of Woodbridge, et al. On
June 8, 2010, Lefcourt Associates, Ltd re-filed their
lawsuit but before a different court, the Chancery Division in
Bergen County. The Company filed a motion to transfer the action
back to the original court in Middlesex County, which was
granted and sought to have the lawsuit dismissed, which was
granted in part on August 27, 2010. The Court limited the
plaintiffs claims to the events in part that occurred after the
dismissal of the prior action. The case was recently transferred
to the Law Division and a trial date as to damages is currently
scheduled for June 6, 2011. The Company plans to vigorously
defend this matter and is unable to estimate any losses that may
or may not be incurred as a result of this litigation and its
eventual disposition. Accordingly, no loss has been recorded
related to this matter.
77
CONVERTED
ORGANICS INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 19
SUBSEQUENT EVENTS
During the period from January 3, 2011 to March 31,
2011 the Company has issued 6,411,000 shares of its common
stock in order to reduce the balance due of the convertible note
agreement entered into on December 17, 2010
On January 10, 2011, the Company signed an agreement with
South Canyon Waste Systems, LLC
(Waste Systems), a waste management company
providing operations management services to Glenwood Springs
Landfill Enterprises (Enterprise) South Canyon
Landfill, to operate an industrial wastewater facility on the
landfill. The Company agreed to purchase, operate and maintain
an LM-HT Concentrator from Waste Systems for $1.6 million,
in return for which Waste Systems agreed to pay the Company 100%
of all payments it receives from Enterprise for waste water
services, less certain agreed upon reimbursements and
deductions. The Companys facility will evaporate 15,000
gallons of waste water per day with zero-liquid-discharge.
On January 25, 2011, the Company paid $150,000 in cash and
issued 3.2 millions shares of Company common stock to a
consultant satisfying a $1,494,000 payable for services rendered
in connection with the October 18, 2010 refinancing
transactions.
On February 23, 2011, the Companys Compensation
Committee issued six-month restricted shares to certain
employees under the Amended and Restated 2006 Stock Option Plan.
A total of 2,165,000 restricted shares were issued at $.35,
which was the closing price as of the date of issuance. The
resulting expense of approximately $758,000 will be reflected in
the Companys consolidated statement of operations and
comprehensive loss for the quarter ended March 31, 2011.
On March 3, 2011, the Company issued the second convertible
note available under its December 17, 2010 financing
agreement for $1,059,000 providing the Company net of proceeds
of $1,000,000. On March 9, 2011, the Company issued
595,000 shares of its common stock to reduce the balance
due on the note.
On March 9, 2011, the Company entered into an agreement
with a third party regarding its $350,000 promissory note
payable. In consideration of receiving a lump sum cash payment
of $125,000, the third party released and discharged the Company
from all obligations under the note.
During March 2011, the Company entered into discussions with an
investor to obtain approximately $3.8 million in additional
financing through the issuance of a convertible note and
warrants.
78
|
|
ITEM 9.
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
There have been no disagreements with our accountants on
accounting and financial disclosures.
|
|
ITEM 9A.
|
CONTROLS
AND PROCEDURES
|
Evaluation
of Disclosure Controls and Procedures
The Companys management, with the participation and under
the supervision of its Principal Executive Officer and Principal
Financial Officer, reviewed and evaluated the effectiveness of
the Companys disclosure controls and procedures, as
defined by
Rule 13a-15(e)
of the Exchange Act, as of the end of the fiscal year covered by
this report. Based upon their evaluation, the Companys
principal executive officer and principal financial officer
concluded that, as of the end of such period, our disclosure
controls and procedures are effective and sufficient to ensure
that we record, process, summarize, and report information
required to be disclosed in the reports we file under the
Securities Exchange Act of 1934 within the time periods
specified by the Securities and Exchange Commissions rules
and regulations.
Managements
Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as defined
in
Rules 13a-15(f)
and
15d-15(f)
under the Exchange Act. Our system of internal control over
financial reporting is designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with accounting principles generally accepted in the
United States of America and includes policies and procedures
that:
|
|
|
|
|
pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and
dispositions of our assets;
|
|
|
|
provide reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and
that our receipts and expenditures are being made only in
accordance with authorizations of our management and
directors; and
|
|
|
|
provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition of our
assets that could have a material effect on our financial
statements.
|
Our management conducted an evaluation of the effectiveness of
our internal control over financial reporting as of
December 31, 2010, based on the framework in Internal
Control Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission. Based on
this evaluation, our management concluded that our internal
control over financial reporting was effective as of
December 31, 2010.
Changes
in Internal Control over Financial Reporting
There have been no significant changes in our internal control
over financial reporting (as defined in
Rules 13a-15(f)
and
15d-15(f)
under the Exchange Act) or in other factors that occurred during
the period of our evaluation or subsequent to the date we
carried out our evaluation which have significantly affected, or
are reasonably likely to significantly affect, our internal
control over financial reporting.
|
|
ITEM 9B.
|
OTHER
INFORMATION
|
None.
79
|
|
ITEM 10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
The information required by Item 10 regarding directors,
executive officers, promoters and control persons is
incorporated by reference to the information appearing under the
caption Directors and Executive Officers in the
Companys definitive Proxy Statement relating to its 2011
Annual Meeting of Stockholders to be filed with the Securities
and Exchange Commission within 120 days after the close of
its fiscal year.
|
|
ITEM 11.
|
EXECUTIVE
COMPENSATION
|
The information required by Item 11 is incorporated by
reference to the information appearing under the caption
Executive Compensation in the Companys
definitive Proxy Statement relating to its 2011 Annual Meeting
of Stockholders to be filed with the Securities and Exchange
Commission within 120 days after the close of its fiscal
year.
|
|
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
Securities
authorized for issuance under equity compensation
plans
The information required by Item 12 is incorporated by
reference to the information appearing under the caption
Security Ownership in the Companys definitive
Proxy Statement relating to its 2011 Annual Meeting of
Stockholders to be filed with the Securities and Exchange
Commission within 120 days after the close of its fiscal
year.
|
|
ITEM 13.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
|
The information required by Item 13 is incorporated by
reference to the information appearing under the caption
Certain Relationships and Related Transactions in
the Companys definitive Proxy Statement relating to its
2011 Annual Meeting of Stockholders to be filed with the
Securities and Exchange Commission within 120 days after
the close of the fiscal year.
|
|
ITEM 14.
|
PRINCIPAL
ACCOUNTING FEES AND SERVICES
|
The information required by Item 14 is incorporated by
reference to the information appearing under the caption
Principal Accounting Fees and Services in the
Companys definitive Proxy Statement relating to its 2011
Annual Meeting of Stockholders to be filed with the Securities
and Exchange Commission within 120 days after the close of
its fiscal year.
80
|
|
ITEM 15.
|
EXHIBITS,
FINANCIAL STATEMENT SCHEDULES
|
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
2
|
.1
|
|
Asset Purchase Agreement between the Registrant and United
Organic Products, LLC, dated January 21, 2008 (incorporated
by reference to Exhibit 2.02 to our current report on
Form 8-K
filed January 29, 2008)
|
|
2
|
.2
|
|
Asset Purchase Agreement between the Registrant and Waste
Recovery Industries, LLC, dated January 21, 2008
(incorporated by reference to Exhibit 2.03 to our current
report on
Form 8-K
filed January 29, 2008)
|
|
3
|
.1
|
|
Registrants Certificate of Incorporation (incorporated by
reference to Exhibit 3.1 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
3
|
.2
|
|
Registrants Bylaws (incorporated by reference to
Exhibit 3.2 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
3
|
.3
|
|
Registrants Certificate of Amendment of Certificate of
Incorporation (incorporated by reference to Exhibit 3.3 to
our Registration Statement on
Form S-1
filed September 15, 2009)
|
|
*3
|
.4
|
|
Certificate of Designation of Preferences, Rights and
Limitations of Series A Convertible Preferred Stock, dated
October 18, 2010
|
|
4
|
.1
|
|
Form of Common Stock Certificate (incorporated by reference to
Exhibit 4.1 to our
Form SB-2/A
filed January 25, 2007)
|
|
4
|
.2
|
|
Form of Class B Warrant (incorporated by reference to
Exhibit B to Exhibit 4.5 on Post-Effective Amendment
No. 1 to our Registration Statement on
Form SB-2
filed February 20, 2007)
|
|
4
|
.3
|
|
Form of Unit Certificate issued in initial public offering
(incorporated by reference to Exhibit 4.4 on
Post-Effective
Amendment No. 1 to our Registration Statement on
Form SB-2
filed February 20, 2007)
|
|
4
|
.4
|
|
Class B Warrant Agreement between the Registrant and
Computershare Shareholder Services, Inc. and Computershare
Trust Company N.A., dated February 16, 2007
(incorporated by reference to Exhibit 4.5 on Post-Effective
Amendment No. 1 to our Registration Statement on
Form SB-2
filed February 20, 2007)
|
|
4
|
.5
|
|
Form of Representatives Purchase Warrant issued in initial
public offering (incorporated by reference to Exhibit 4.6
to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
4
|
.6
|
|
Registration Rights Agreement between the Registrant and
Professional Offshore Opportunity Fund, Ltd., Professional
Traders Fund, LLC and High Capital Funding, LLC, dated
January 24, 2008 (incorporated by reference to
Exhibit 2.06 to our current report on
Form 8-K
filed January 29, 2008)
|
|
4
|
.7
|
|
Form of Class H Warrant (incorporated by reference to
Exhibit 4.1 to our Quarterly Report on
Form 10-Q
filed November 16, 2009)
|
|
4
|
.8
|
|
Form of Unit Certificate issued in October 2009 offering
(incorporated by reference to Exhibit 4.2 to our Quarterly
Report on
Form 10-Q
filed November 16, 2009)
|
|
4
|
.9
|
|
Form of Warrant issued in May 2009 offering (incorporated by
reference to Exhibit 4.1 to our
Form 8-K
filed on May 20, 2009)
|
|
4
|
.10
|
|
Form of Warrant issued in July 2009 offering (incorporated by
reference to Exhibit 4.1 to our
Form 8-K
filed on July 16, 2009)
|
|
4
|
.11
|
|
Class G Common Stock Purchase Warrant (incorporated by
reference to Exhibit 10.5 to our
Form 8-K
filed on September 14, 2009)
|
|
4
|
.12
|
|
Class H Warrant Agreement between the Registrant and
Computershare Trust Company N.A., dated October 20,
2009 (incorporated by reference to Exhibit 10.3 to our
Form 8-K
filed on October 21, 2009)
|
|
4
|
.13
|
|
Unit Conversion Agreement between the Registrant and
Computershare Trust Company N.A., dated October 20,
2009 (incorporated by reference to Exhibit 10.2 to our
Form 8-K
filed on October 21, 2009)
|
|
10
|
.1
|
|
Form of Bridge Loan Documents dated March 2, 2006
(incorporated by reference to Exhibit 10.1 to our
Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
10
|
.1A
|
|
Form of Bridge Loan Documents dated April 11, 2006
(incorporated by reference to Exhibit 10.1A to our
Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
10
|
.2
|
|
Amended and Restated 2006 Stock Option Plan and Form of Stock
Option Agreement (incorporated by reference to Exhibit 10.2
to Annex A of our Definitive Proxy Statement filed
March 5, 2008)
|
|
10
|
.3
|
|
Service Agreement between the Registrant and ECAP, LLC, dated
March 1, 2006 (incorporated by reference to
Exhibit 10.3 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
81
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
10
|
.4
|
|
Lease Agreement between the Registrant and Recycling Technology
Development, LLC, dated June 2, 2006 (incorporated by
reference to Exhibit 10.4 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
10
|
.4A
|
|
Amendment to the Lease Agreement between the Registrant and
Recycling Technology Development dated January 18, 2007
(incorporated by reference to Exhibit 10.4A to our
Form SB-2/A
filed January 25, 2007)
|
|
10
|
.4B
|
|
Second Amendment to the Lease Agreement between the Registrant
and Recycling Technology Development dated June 30, 2008
(incorporated by reference to Exhibit 10.4B on
Form 10-K
filed on March 31, 2010)
|
|
10
|
.4C
|
|
Third Amendment to the Lease Agreement between the Registrant
and Recycling Technology Development dated March 31, 2009
(incorporated by reference to Exhibit 10.4C on
Form 10-K
filed on March 31, 2010)
|
|
10
|
.5
|
|
Employment Agreement between the Registrant and Edward J.
Gildea, dated March 2, 2006 (incorporated by reference to
Exhibit 10.5 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
10
|
.6
|
|
Employment Agreement between the Registrant and John A.
Walsdorf, dated March 2, 2006 (incorporated by reference to
Exhibit 10.7 to our Registration Statement on
Form SB-2
filed June 21, 2006)
|
|
10
|
.7
|
|
Agreement between the Registrant and Weston Solutions, Inc.,
dated May 29, 2003 and modification dated October 6,
2004 (incorporated by reference to Exhibit 10.9 to our
Registration Statement on
|